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Abstract 
 
This thesis describes the synthesis and ring opening reactions of aziridines 
performed under batch as well as continuous flow conditions. Chapter 1 gives a 
brief introduction to the synthesis and ring opening reactions of aziridines. 
 
Chapter 2 gives a brief introduction to flow chemistry, and describes the synthesis 
of aziridines from 1,2-amino alcohols, as well as their subsequent ring opening 
reactions. Using continuous flow methodology, various aziridines were 
successfully synthesized in moderate to good yields. Ring opening of these 
aziridines with different nucleophiles was also possible in flow. These two 
processes could be combined in a telescoped sequence, enabling the continuous 
flow synthesis of functionalized products directly from the 1,2-amino alcohols, 
without having to isolate the aziridine intermediates. 
 
Chapter 3 describes the aziridination of alkenes using soluble aryliminoiodanes 
under continuous flow. The aziridination of alkenes could be combined with 
further ring opening reactions via a telescoped, continuous flow process. This 
enabled the direct synthesis of ring opened products directly from the alkene, via 
in situ formed aziridines, in moderate to good yields. This second approach had 
broader scope than the method described in Chapter 2. 
 
Chapter 4 reports the stereocontrolled aziridinations of alkenes with different N-
tosyl aryliminoiodanes. Under some conditions, the asymmetric aziridination of 
styrene gave different enantioselectivities when the aryl group of ArI=NTs was 
changed. The diastereoselective aziridination of a chromene was also briefly 
investigated. 
 
Chapter 5 gives a summary of the key findings, as well as possible future work. 
 
In Chapter 6, detailed experimental procedures for the work carried out in 
Chapters 2 – 4 are provided.  
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1.1 Aims of project 
 
This thesis describes the synthesis and ring opening reactions of aziridines under 
batch and continuous flow conditions. We hoped to explore various methods to 
synthesize aziridines under batch conditions, and adapt these chemistries to 
continuous flow methodology for the first time. Ultimately we hoped to effect the 
in situ synthesis of aziridine 1 from a variety of aziridine precursors, and directly 
react the aziridine with nucleophiles in telescoped processes to give 2, under 
continuous flow conditions (Scheme 1.1). Such new methodology has a number of 
potential advantages. Primarily, it would reduce the need to handle and isolate the 
potentially hazardous aziridines. 
 
The chemistry and properties of aziridines have been extensively reviewed.1-7 In 
this chapter we do not aim to exhaustively survey this work, rather to provide a 
summary of the relevant chemistry for the synthesis and ring openings of 
aziridines.  
 
Scheme 1.1. Synthesis and ring opening of aziridine under continuous flow. 
Chapter 1: Introduction 
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1.2 Aziridines 
 
Aziridines (3) are three membered heterocycles, with a ring made up of two 
carbon atoms and one nitrogen atom. Aziridines are extremely important 
intermediates in organic chemistry, and are most commonly used as “spring 
loaded” electrophiles for nucleophilic ring opening reactions (Scheme 1.2).1 
 
 
1.3 Properties of aziridines 
 
As a three membered ring, the internal angles of aziridines are close to 60°, 
compared to the normal tetrahedral (sp3) angle of 109.5°. This introduces 
significant ring strain of around 27 kcal mol−1 to the aziridine ring.6 Consequently, 
aziridines are prone to nucleophilic ring opening to relieve this ring strain. 
 
Aziridines have a pKa (conjugate acid) of around 8, and are less basic compared 
with most amines.2 The energy required for pyramidal inversion at nitrogen is 
higher in aziridines, as more energy is required to promote the lone pair to a p 
orbital in the planar transition state during the inversion process. However, the 
energy barrier is still low enough that inversion occurs at room temperature if 
there is no electron withdrawing group on nitrogen.2  
 
Scheme 1.2. A generalized aziridine undergoing nucleophilic ring opening. 
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1.4 Biological properties of aziridines 
 
Aziridines are prone to nucleophilic attack and are potentially powerful alkylating 
agents. For example the simplest aziridine, ethylenimine has been classified as 
being possibly carcinogenic to humans and is considered extremely hazardous due 
to its ability to alkylate DNA.8 Some natural products such as Mitomycin C (5)9 and 
Azinomycin B (6)10 that contain aziridine rings are useful as antitumor agents 
because of their ability to cross-link DNA bases in tumors (Figure 1.1). 
 
1.5 Synthesis of aziridines 
 
Aziridines can be synthesized in four main ways: addition to alkenes, addition to 
imines, addition to azirines, or ring closure of 1,2-amino derivatives (Scheme 1.3).  
 
Figure 1.1. Aziridine containing natural products. 
 
Scheme 1.3. General routes to aziridines. 
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18 
 
1.5.1 Addition to alkenes 
 
The synthesis of aziridines by addition to alkenes can be classified into either 
nitrene (or nitrenoid) methods, or non-nitrene methods. The direct aziridination 
of alkenes by nitrenes (or nitrenoids) is currently more popular, as conditions 
required are usually milder with broader substrate scope. Therefore, most of the 
following discussion will focus on nitrene additions, but there will be reference to 
non-nitrene methods when a substrate class allows comparison with non-nitrene 
based methods. 
 
1.5.1.1 Nitrenes 
 
Both nitrenes and nitrenoids (in which the nitrene is bound to a metal centre) can 
be either singlet or triplet. Singlet nitrenes (and nitrenoids) add to alkenes in a 
single step (but often asynchronously) to give 7 (Scheme 1.4). 
 
Triplet nitrenes (and nitrenoids) add stepwise to alkenes, and free rotation in the 
diradical intermediate 8 gives rise to a cis/trans mixture of products 9 (Scheme 
1.5). Unless otherwise specified, nitrenes will be used to refer to both free nitrenes 
and nitrenoids in this text.  
 
Scheme 1.4. Concerted addition of singlet nitrene 
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1.5.1.2 Aziridinations from organic azides 
 
It has been known since the 1960s that the thermal or photodecomposition of acyl 
azides produce free nitrenes, which can undergo addition with alkenes to give 
aziridines. For example, Lwowski et al. investigated the photodecomposition of 
ethyl azidoformate (10) in cyclohexene as solvent to give the aziridine 11 (Scheme 
1.6).11-12 Based on the side products formed, he concluded that a nitrene pathway 
was most likely. However, due to moderate yields and side reactions, 
aziridinations of alkenes using organic azides as a nitrene source was not a popular 
method until much more recently. 
 
The transition metal catalysed aziridination of alkenes using organic azides as a 
nitrene source has gained popularity since 2000 due to concerns about atom 
economy and green chemistry. Using various transition metal complexes, such as 
12 – 18 (Figure 1.2), both aliphatic and aromatic alkenes can be aziridinated with 
a range of organic azides (Scheme 1.7).  
 
Scheme 1.5. Stepwise addition of triplet nitrene. 
 
Scheme 1.6. Aziridination of cyclohexene with ethyl azidoformate. 
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Jenkins et al. reported that using FeII(tetracarbene) complex 12, various aliphatic 
alkenes could be aziridinated racemically using aryl azides as nitrene source to 
give aziridines in moderate to good yields.13-14 Cenini et al. reported a 
complementary method; using Ru(TPP)CO (15), aromatic alkenes could be 
aziridinated to give racemic N-aryl aziridines in moderate to good yields.15-16  
 
Figure 1.2. Various catalysts used in aziridination of alkenes with organic azides. 
 
Scheme 1.7. Aziridination of alkenes with organic azides. 
Chapter 1: Introduction 
21 
 
Katsuki et al. reported the asymmetric synthesis of N-sulfonylaryl aziridines from 
aromatic alkenes to give aziridines in moderate to good yields and high ee using 
Ru(salen) complex 13.17 Using Ru(salen) complex 14, Katsuki et al. effected the 
asymmetric synthesis of both aromatic and aliphatic N-Ses aziridines in high yields 
and ee.18 Zhang et al. have also investigated the aziridination of alkenes using 
organic azides as nitrene source using CoII(porphyrin) complexes 16 – 18 giving a 
broad range of N-sulfonyl and N-phosphoryl aziridines both racemically19 and 
asymmetrically.20-21 
 
Organic azides can also form aziridines by non-nitrene methods. For example, 
alkenes can undergo 1,3-dipolar cycloadditions with aryl azides to give the 1,2,3-
triazoline 20 which can lose nitrogen to give aziridine 21 (Scheme 1.8).22-23 
However, yields are moderate, and this is not a popular method. 
 
 
Organic azides can also undergo conjugate addition with alkenes conjugated with 
a carbonyl group, and loss of nitrogen gives the aziridine. For example, Johnston et 
al. reported that various alkyl azides could undergo conjugate addition with but-
3-en-2-one under TfOH catalysis, and ring closure via intermediate 22 gives 
aziridine 23 in moderate to good yields (Scheme 1.9).24  
 
Scheme 1.8. Aziridines from cycloaddition with azides, followed by loss of N2. 
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1.5.1.3 Aziridinations by α-elimination 
 
Nitrenes can also be generated from the α-elimination of certain organic 
substrates such as ethyl (4-nitrobenzenesulfonyloxy)carbamate 25 or haloamine 
salts. In 1967, as part of an investigation into the properties of singlet and triplet 
nitrene, Lwowski et al. reported that a cis/trans mixture of aziridine 26 was 
produced when cis-alkene 24 was reacted with 25 in the presence of NEt3 (Scheme 
1.10).25 
 
More recently, Lebel et al. reported that styrene derivatives are aziridinated in 
moderate to good yields from the α-decomposition of N-tosyloxycarbamate 27 in 
the presence of (pyr)4Cu(BF4)2 (Scheme 1.11.).26  
 
Scheme 1.9. Aziridination of but-3-en-2-one. 
 
Scheme 1.10. Aziridination from α-elimination. 
 
Scheme 1.11. Lebel et al.’s aziridination with N-tosyloxycarbamate 27. 
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Using chiral N-toxyloxycarbamate 29 and a chiral Rh(II) complex 30, styrene 
derivatives could be aziridinated in good yields with moderate to high dr, using the 
alkene as the limiting reagent (Scheme 1.12).27 However, neither of these methods 
worked with aliphatic alkenes. 
 
Zhang et al. investigated the racemic aziridinations of both aromatic and aliphatic 
alkenes using bromamine-T (32) and Co(II)28 or Fe(II)29 metalloporphyrins. They 
found that Co(II) porphyrin complex 33 was extremely efficient at catalysing the 
aziridination, and required only 1 eq of the alkene (Scheme 1.13). 
 
Chloramine-T (35) can also be used as a nitrene source for the aziridination of 
aliphatic and aromatic alkenes, instead of bromamine-T. Komatsu et al. reported 
that CuCl as well as other copper salts such as CuCl2, Cu(acac)2, Cu(OTf)2 catalysed 
the nitrene transfer from anhydrous chloramine-T to various alkenes.30  
 
Scheme 1.12. Lebel et al.’s stereoselective aziridinations. 
 
Scheme 1.13. Zhang et al.’s aziridination with bromamine-T. 
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In the absence of copper salts, no aziridine was formed. Other methods for 
aziridination of alkenes via nitrene transfer from chloramine-T using other 
transition metal salts such as Fe(IV)31 or Ag(I)32 have been reported. 
 
Chloramine-T is also known to aziridinate alkenes by non-nitrene pathways. In the 
presence of a positive bromine or iodine source such as iodine33 or N-
bromosuccinimide,34 attack of chloramine-T on the cation 36 followed by 
cyclization of 37 gives the aziridine 38 (Scheme 1.14); both aliphatic and aromatic 
N-tosyl aziridines can be synthesized by this method. 
 
 
Closely related to these haloamine salts 32 and 35 are N,N-dichloroamine-T (39) 
and N,N-dibromoamine-T (40) (Figure 1.3). Both can be used to synthesize N-tosyl 
aziridines from alkenes, but whether a halonium, radical, or nitrene mechanism is 
involved is a contested issue.35-40  
 
Scheme 1.14. Iodine catalysed aziridine synthesis. 
 
Figure 1.3. N,N-dihaloamine-T 39 and 40. 
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A number of reagents that could undergo α-elimination can undergo conjugate 
addition with α,β-unsaturated aldehydes and ketones. These reactions are often 
organocatalyzed by chiral amines such as 43 and 44, with high stereoselectivity 
and yields. The mechanism proceeds through an iminium intermediate 45 
(Scheme 1.15). Cordova et al. investigated the asymmetric synthesis of aziridines 
from various α,β-unsaturated aldehydes and found that high yields and ee could 
be obtained with proline-derived chiral amine catalysts.41 Other chiral amines can 
also be used,42 but derivatives based on proline are the most common.43-44 
 
1.5.1.4 Aziridinations with amines 
 
Recently, Jat et al. reported the Rh2(esp)2 catalysed aziridination of alkenes, using 
hydroxylamines 48 and 49 (Scheme 1.16).45  
 
Scheme 1.15. Synthesis of aziridines from α,β-unsaturated aldehydes and ketones. 
 
Scheme 1.16. Jat et al.’s aziridination with hydroxylamines. 
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Both aliphatic and aromatic alkenes could be aziridinated to give the NH and NMe 
aziridines in good yield. Jat et al. reported that the evidence pointed to a Rh-nitrene 
pathway.45 
 
N-Amino heterocycles such as 52 can form aziridines with alkenes in the presence 
of Pb(OAc)4 (Scheme 1.17). These reactions were originally thought to involve a 
nitrene intermediate,46-47 but this is no longer thought to be the case.48-49 Work to 
understand the exact mechanism is still ongoing.50 However, these reactions are of 
limited value due to the high toxicity of Pb(OAc)4. 
 
Aziridines can also be synthesized from chalcones. Shi et al. reported that 
hydroxylamine 55 is capable of synthesizing NH aziridine 59 from chalcone 54 in 
the presence of N-methylmorpholine (56) through addition of in situ formed 
hydrazinium 57 (Scheme 1.18).51  
 
Scheme 1.17. Synthesis of aziridines with Pb(OAc)4. 
 
Scheme 1.18. Shi et al.’s synthesis of aziridines from chalcones. 
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Cardillo et al. explored the Gabriel-Cromwell conjugate addition of amines with 
α,β-unsaturated α-bromo carbonyl compound 60 (Scheme 1.19).52 Addition of the 
amine gives 61, which yields aziridine 63 after cyclization of 62. This method has 
been extended to diasterocontrolled aziridine synthesis through use of chiral 
auxiliaries or chiral amines.53-54 
 
1.5.1.5 Aziridinations with phenyliminoiodanes 
 
N-(Tosyl)iminophenyliodinane (PhI=NTs, 65) was first prepared by Okawara et al. 
in 1975 (Scheme 1.20).55 Since then, other PhI=NSO2R derivatives have been 
prepared from sulfonamides.56-57 The most popular and frequently used 
iminoiodanes are PhI=NTs (65) and PhI=NSes (66). These PhI=NSO2R derivatives 
are capable of acting as a nitrene source for the aziridination of alkenes in the 
presence of transition metal catalysts (Scheme 1.21).58-59 If chiral ligands60-62 or 
catalysts63 (Figure 1.4) are used, enantioselectivity can be achieved. Aromatic 
alkenes tend to give better yields compared to aliphatic alkenes.  
 
Scheme 1.19. Aziridines by Gabriel-Cromwell reactions. 
 
Scheme 1.20. Preparation of PhI=NSO2R. 
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Aziridinations can be done with either alkene or PhI=NSO2R as the limiting 
reagent. However, a large excess of alkene is often used to get the best yields. These 
reactions can be done racemically with CuI/II salts, or asymmetrically when chiral 
ligands such as those developed by Jacobsen,60 Ma,61 or Evans62 et al. are used 
together with CuI/II salts. Manganese complexes, such as those developed by 
Katsuki et al.63 can also be used for aziridinations of alkenes. 
 
A major limitation with aziridinations by this method is that the aziridine nitrogen 
has to have an arylsulfonyl group on it. However, NSes aziridines are also 
accessible, making sulfonamide removal more facile.57  
 
Scheme 1.21. Aziridinations of alkenes with PhI=NSO2R. 
 
 
Figure 1.4. Some chiral ligands and catalysts used with PhI=NSO2R. 
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It is not always necessary to isolate the iodinane, and there are examples in 
literature where the PhI=NSO2R is generated in situ from RSO2NH2 and 
PhI(OAc)2.64-66 
 
1.5.2 Addition to imines 
 
As with additions to alkenes to give aziridines, additions to imines can either 
involve carbene (or carbenoid) or non-carbene methods. The reagents used to 
generate both types of intermediates can be the same, with conditions, catalysts 
and substrates dictating whether a carbene (or carbenoid) is involved in addition. 
 
1.5.2.1 Carbenes 
 
As with nitrenes, carbenes can also exist in the singlet and triplet states. However, 
while the distinction between singlet and triplet state carbenes is important in 
cyclopropanation reactions, most reactions with imines appear to involve the 
carbene behaving as if it were in the singlet state. As with nitrenes, carbenes can 
exist as both free carbenes or as metal-bound carbenoids.  
 
1.5.2.2 Additions from α-elimination of chloroform 
 
The addition of free dichlorocarbene (:CCl2) generated from the alkoxide induced 
α-elimination of CHCl3 to imines to give aziridines has been known since the 
1950s.67 Recently, Komatsu et al. reported use of KF/Al2O3 as a solid supported 
base for the generation of dichlorocarbene to aziridinate C-aryl imine 72 (Scheme 
1.22).68  
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The reaction is thought to proceed by addition of the lone pair of the imine to 
dichlorocarbene to give ylide 73, which ring closes to give aziridine 74.69 Other 
methods for aziridination with dichlorocarbene involve phase transfer catalyst.70-
72 Examples of aziridinations involving C-alkyl imines and dichlorocarbene are 
extremely rare.73 
 
1.5.2.3 Additions from diazo compounds 
 
In 1995, Jacobsen et al. reported the enantioselective aziridination of imines with 
ethyl diazoacetate using copper(I) complexed to bis(oxazoline) ligand 75 (Scheme 
1.23).74  
 
Scheme 1.22. Komatsu et al.’s aziridination of imines with dichlorocarbene. 
 
Scheme 1.23. Proposed mechanism for CuI catalysed carbenoid transfer to imines. 
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Jørgensen et al. reported a similar but racemic process using Cu(OTf)2 without the 
chiral ligand.75 In both cases, a cis/trans mixture of aziridines was formed; with 
Jacobsen’s asymmetric carbenoid transfer, yields were low and the ee of the 
cis/trans aziridines formed moderate. Jacobsen rationalized this by proposing that 
chiral intermediate 79 could dissociate to give achiral 81, which would then 
cyclize to give a racemic mixture of cis/trans aziridine 82. 
 
Rh(II) complexes known to catalyse the cyclopropanation of aromatic alkenes with 
diazo compounds have also been investigated in the aziridination of imines.76 In 
an interesting example, Zhang et al. reported the highly diastereoselective 
synthesis of cis-aziridines from imine 83 (Scheme 1.24).77 They rationalized this 
selectivity by considering the relative stability of presumed intermediates 86 and 
87.  
 
Scheme 1.24. Zhang et al.’s aziridination of imine. 
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Other transition metal catalysed aziridination of imines may not involve carbene 
transfer.78-79 Mezzetti et al. reported that Ru(II) complex 91 effected the synthesis 
of aziridine 92 from imine 89 but carbene complex 90 failed to give any aziridine 
(Scheme 1.25).80 These authors proposed that for some transition metal catalysed 
reactions of imines with ethyl diazoacetate, the transition metal might be 
increasing the nucleophilicity of ethyl diazoacetate towards nucleophilic attack on 
the imine, rather than directly forming a carbene complex. 
 
Another approach to the synthesis of aziridines from imines and diazocompounds 
involves using Lewis or Brønsted acid catalysis. In this approach, the imine 
coordinates to the acid first to form a charged iminium 97, which is activated 
towards attack by the carbon of the diazo compound (Scheme 1.26). Loss of N2 
from the intermediate 98 then gives the aziridine 99.81-82 Asymmetric variants are 
possible with chiral acid catalysts (Figure 1.5).83-88  
 
Scheme 1.25. Reaction of imine 89 with Ru(II) complexes. 
 
Scheme 1.26. Acid-catalyzed aziridine synthesis with achiral diazo compounds. 
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Jørgensen et al. investigated the synthesis of racemic cis-aziridines from N-aryl 
imines using Lewis acids such as Yb(OTf)3.81 Johnston et al. found that using TfOH 
as Brønsted acid allowed the synthesis of N-alkyl cis-aziridines in moderate to 
good yields.82 Using chiral Brønsted acid (R)-93, Maruoka et al. found that N-Boc 
trans-aziridines were synthesized in moderate to good yields with high ee.83 In 
closely related work, Zeng et al. found that chiral phosphoric (R)-94 gave chiral N-
Boc trans-aziridines with high yields and ee.84 Another approach pioneered by 
Wulff et al. is based on chiral Lewis acids derived from (S)-VAPOL (95) or (R)-
VANOL (96).85-88 Both give high yields and ee, with up to 50:1 preference for the 
cis-aziridine from N-alkyl imines. 
 
An alternative approach to using chiral acid catalysts in order to effect 
enantioselectivity is to use a chiral auxiliary on the diazo compound. Using the 
chiral diazo compound 100, Maruoka et al. synthesized aziridine 101 in moderate 
to high yield with more than 20:1 dr (Scheme 1.27).89  
 
Figure 1.5. Various chiral acids/ acid precusors. 
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The synthesis of aziridines from imines using diazo compounds without a carbonyl 
group is not as well explored.90-91 Pellicciari et al. reported an In(OTf)3 catalyzed 
synthesis of cis-aziridine 104 with diisopropyl diazomethylphosphonate (103) 
from C-aryl imine 102 (Scheme 1.28).91 
 
1.5.2.4 Additions of ylides 
 
The reaction of ylides with imines is another useful approach to synthesize 
aziridines. While the synthesis of aziridine 108 was reported by Ochiai et al.92 
using in situ generated iodonium ylide 106 (Scheme 1.29), the usage of sulfur 
ylides has attracted a lot more attention.  
 
Scheme 1.27. Maruoka et al.’s synthesis of chiral aziridines. 
 
Scheme 1.28. Pellicciari et al.’s synthesis of cis-aziridines. 
 
Scheme 1.29. Ochiai et al.’s racemic synthesis of aziridines with ylide 106. 
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Ruano93-94 and Davis95 independently investigated the synthesis of aziridines from 
various chiral sulfinyl imines with sulfur ylides. Later work by Stockman 
established that chiral t-butylsulfinyl imine 109 gave the best diastereo-
selectivities.96-97 High yields and de could be obtained with C-aryl or C-alkyl imine 
109 (Scheme 1.30). The diastereoselectivity was rationalized by attack of the 
sulfur ylide onto the Re face, opposite to the t-butyl group. 
 
Another approach to sulfur ylide additions to imines is to use a chiral sulfur 
ylide.98-99 Aggarwal et al. reported using chiral sulfide 114 as a catalyst for the 
enantioselective synthesis of chiral, trans-aziridine 116. Various C-aryl imines 
with N-sulfonyl or N-carbonyl protecting groups can be used (Scheme 1.31).98 In 
this method, Rh2(OAc)4 catalyzed a carbene transfer from 113 to 114 to give the 
sulfur ylide 115 in situ, which then reacts with the imine 112.  
 
Scheme 1.30. Stockman et al.’s synthesis of aziridines from sulfinylimine 109. 
 
Scheme 1.31. Aggarwal et al.’s asymmetric synthesis of aziridines with chiral sulfide 114. 
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1.5.2.5 Additions of anions with a leaving group 
 
The addition of anions with leaving groups onto imines follows a similar 
mechanism to that described for ylides in 1.5.2.4., and ring closure via loss of the 
leaving group gives the aziridine. The synthesis of aziridines by addition of α-
haloenolates to imines was first reported by Deyrup, albeit with unpredictable 
diastereoselecivity.100-101 Approaches using chiral α-haloenolates102-103 or chiral 
sulfinylimines104 have been developed, with improved diastereoselectivity. For 
example, Sweeney et al. reported the synthesis of N-diphenylphosphinyl cis-
aziridine 121 from N-diphenylphosphinyl imine 117 with almost complete 
diastereocontrol in good yields (Scheme 1.32).102-103 
 
Other anions with leaving groups can also add to imines and form aziridines by 
loss of the leaving group. For example, Davis et al. reported that the anion derived 
from iodophosphonate 123 reacted with N-sulfinyl imine 122 to give cis-aziridine 
124 in high yields and de (Scheme 1.33).105-106  
 
Scheme 1.32. Sweeney et al.’s synthesis of aziridine using chiral α-haloenolate. 
 
Scheme 1.33. Davis et al.’s synthesis of 2-phosphonate cis-aziridines. 
Chapter 1: Introduction 
37 
 
Yadav et al. reported that 1-bromoalkane 126 reacted with N-tosyl imine 125 to 
give racemic aziridine 127, with high diastereoselectivity for the aryl group cis to 
NO2 (Scheme 1.34).107 
 
Bull et al. reported the diastereoselective synthesis of aziridines with LiCHI2 
(129).108-109 They found that N-tosyl imine 128 could be reacted with in situ 
generated LiCHI2 to give racemic C-iodo cis-aziridine 130 (Scheme 1.35).109 
 
1.5.3 Addition to azirines 
 
Aziridine synthesis from azirines can proceed by three main pathways: by addition 
of nucleophiles, by addition of radicals, or by [4+2] cycloadditions with dienes. 
 
1.5.3.1 Addition of nucleophiles 
 
Using reagents such as LiAlH4 or NaBH4, it is possible to stereospecifically add 
hydride to the less hindered face of the azirine to give the cis-aziridine 
preferentially.110-112 For example, Hassner et al. reported that racemic azirine 131 
could be reduced with LiAlH4 to give cis-aziridine 132 in high yields (Scheme 
1.36).110  
 
Scheme 1.34. Yadav et al.’s racemic synthesis of aziridines with 1-bromoalkane 126. 
 
Scheme 1.35. Bull et al.’s synthesis of C-iodo cis-aziridines. 
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Additionally, using asymmetric transfer hydrogenation, Somfai et al. reported 
achiral azirine 133 can be hydrogenated to give chiral aziridine 135 in up to 72% 
ee using iPrOH as the hydrogen donor (Scheme 1.37).113 
 
Interestingly, when Grignard reagents are added to azirines bearing an ester group 
on the sp3 carbon, Davis et al. found that the reagent added from the more hindered 
face of 136, syn to the ester group (Scheme 1.38).114-115 They rationalized this was 
due to chelation of the organometallic reagent to the carbonyl oxygen. 
 
Palacios et al. found that when the ester group is replaced with a phosphonate 
group, Grignard reagents add from the less hindered face, away from the 
phosphonate group (Scheme 1.39).116 This is typical with most other nucleophiles, 
which usually add from the less hindered face of the azirine.117-118  
 
Scheme 1.36. Hassner et al.’s addition of hydride to azirines. 
 
Scheme 1.37. Somfai et al.’s asymmetric transfer hydrogenation of azirines. 
 
Scheme 1.38. Davis et al.’s addition of Grignard reagents to azirines. 
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Palacios et al. reported that azirine 140 could be acylated with subsequent 
addition of chloride from the less hindered face giving trans-aziridine 141 
(Scheme 1.40).119 
 
Alves et al. explored the addition of various nucleophiles to azirine 142 and found 
that sulfur, oxygen and nitrogen nucleophiles added from the less hindered face to 
give the trans-aziridine 143 (Scheme 1.41).120 They also explored the addition of 
nucleophiles to azirines containing a chiral auxiliary; however, diasteroselectivity 
was good only using aromatic thiols as nucleophiles.121 
  
 
Scheme 1.39. Palacios et al.’s addition of Grignards to azirines. 
 
Scheme 1.40. Palacios et al.’s addition of chloride to azirines. 
 
Scheme 1.41. Alves et al.’s synthesis of azirdines by addition of NuH. 
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1.5.3.2 Addition of radicals 
 
The addition of alkyl radicals to azirines is a useful way to synthesis aziridines. 
Alves et al. reported that alkyl radicals R· added to azirine 144 from the less 
hindered face with a high degree of stereoselectivity, giving aziridine 145 (Scheme 
1.42).122 Somfai et al. investigated the addition of various alkyl radicals to azirines 
with a chiral auxiliary, and found chiral azirines derived from 8-phenyl-menthol 
gave the best diastereoselectivities (Scheme 1.43).123-124 
 
 
1.5.3.3 Cycloaddition with dienes 
 
Azirines with a carboxyl substituent at the sp2 carbon of the azirine can undergo 
thermal [4+2] cycloadditions with dienes to give an aziridine. Interestingly, the 
acyl substituent ends up exo, with the aziridine ring endo. This is thought to be due 
to the preference for the lone pair on the azirine nitrogen to be exo in the transition 
state, minimizing lone-pair π interactions.125  
 
Scheme 1.42. Alves et al.’s addition of alkyl radicals to azirine 144. 
 
Scheme 1.43. Somfai et al.’s addition of alkyl radicals to chiral azirine 146. 
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For example, Alves et al. reported that azirine 148 could undergo cycloaddition 
with cyclopentadiene to give the aziridine 149 (Scheme 1.44).126-128 
 
 
However, in reactions where the diene is part of a furan ring, this selectivity is 
reversed.128 The isomer with the aziridine ring endo is thought to be formed first, 
but retro Diels-Alder reaction and re-addition eventually gives aziridine 151 
(Scheme 1.45).128 
 
Davis et al. reported that phosphonate substituted aziridine 154 could be 
produced stereospecifically starting from the chiral azirine 153 under thermal 
conditions.129  
 
Scheme 1.44. Cycloaddition of azirine with diene. 
 
Scheme 1.45. Cycloaddition with furan. 
 
Scheme 1.46. Davis et al.’s synthesis of chiral phosphonate aziridine 154. 
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Lewis acid catalyst such as that ZnCl2 or YbCl3 can also be used to accelerate the 
cycloaddition of azirines with dienes.130-133 This is useful in cases where the azirine 
does not have an activating carboxyl/phosphonyl group at the sp2 carbon. For 
example, Somfai et al. reported that YbCl3 catalysed the cycloaddition of diene 155 
with 3-alkyl/aryl azirine 156 to give aziridine 157 (Scheme 1.47).130-131 
 
1.5.4 Ring closure of 1,2-amino derivatives 
 
Ring closure of 1,2-amino derivatives is one of the oldest and most effective way 
to synthesize aziridines. Li et al. reported an adaptation of the Wenker synthesis 
to give various unprotected NH aziridines from the 1,2-amino alcohol (Scheme 
1.48).134 They first formed the sulfate 159 by reacting the 1,2-amino alcohol 158 
with ClSO3H, removed the solvent, then cyclized 159 to 160 by adding aq NaOH or 
aq Na2CO3. This is an improvement over the original Wenker synthesis which 
required extremely harsh conditions of 250 °C and concentrated H2SO4.135  
 
Scheme 1.47. YbCl3 catalysed cycloaddition of diene 155 with azirine 156. 
 
Scheme 1.48. Li et al.’s modified Wenker synthesis of aziridines. 
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Starting from epoxides, it is also possible to synthesize aziridines by first ring 
opening the epoxide with a nitrogen nucleophile, before effecting ring closure to 
give the aziridine. Blum et al. first reported reacting an epoxide with sodium azide, 
followed by treatment of the 2-azido alcohol 161 with PPh3, which gives aziridine 
165 with loss of O=PPh3 (Scheme 1.49).136 
 
The mechanism is thought to proceed via intermediate 162, which isomerizes to 
163 and then 164, before cyclization to give aziridine 165.137 If racemic epoxide is 
used, the reaction proceeds to give the aziridine with the same relative 
configuration as the epoxide, while if a chiral epoxide is used, the aziridine that is 
formed has the same relative configuration but with the opposite absolute 
configuration.138 
 
Other ring-openings of epoxides and subsequent ring closures to give aziridines 
have also been reported, but usually lead to aziridines that are N-protected. 
Jørgensen et al. reported a route similar to Blum et al., using ZnI2 catalysed addition 
of iminophosphoranes Ph3P=NPh or Ph3P=NiPr to epoxides to give the NPh or NiPr 
aziridine in one step (Scheme 1.50).139  
 
Scheme 1.49. Blum et al.’s conversion of epoxides to aziridines. 
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Other routes from epoxides to aziridine based on phosphorus140 and sulfur141 
chemistry have been reported; all of them involve cyclization of a 1,2-amino 
intermediate to give the aziridine. Using hydrolytic kinetic resolution of racemic 
epoxides with chiral catalysts, it is also possible to synthesize chiral aziridines.142 
 
Another way to make aziridines is by reduction of chiral amino acid derivatives, 
and cyclization of the 1,2-amino alcohol. Craig et al. reported that starting from 
chiral α-amino acid 168, reduction of the N-tosyl acid 169 with LiAlH4 gave the 
1,2-amino alcohol derivative 170, which was then cyclized to give N-Ts aziridine 
171 (Scheme 1.51).143 Other methods where the α-amino acid is first reduced 
before being tosylated have also been reported.144 
 
De Kimpe et al. reported that stereocontrolled reduction by NaBH4 of α-chloro N-
tert-butylsulfinyl imine 172 gives amine 173, which can be cyclized to aziridine 
174 in good yields using base (Scheme 1.52).145  
 
Scheme 1.50. Jørgensen et al.’s synthesis of aziridine from epoxide. 
 
Scheme 1.51. Craig et al.’s synthesis of N-Ts aziridines from α-amino acids. 
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1.6 Ring opening of aziridines 
 
The most common and useful reactions of aziridines are its ring openings.1, 4-5 The 
ring opening of aziridines can be broadly classified into two categories: ring 
opening of activated aziridines, and ring opening of unactivated aziridines.7 
Activated aziridines have an electron withdrawing group on the aziridine nitrogen, 
such as 175a – d, whereas unactivated aziridines have H (175e), alkyl (175f) or 
aryl (175g) substituents on the aziridine nitrogen (Figure 1.6). In the case of 2-
substituted aziridines 175, the regiochemical outcome of the ring opening can 
depend on whether the aziridine is activated or unactivated, the nucleophile used, 
as well as the reaction conditions.  
 
Scheme 1.52. De Kimpe et al.’s synthesis of aziridine from imine 172. 
 
Figure 1.6. Activated and unactivated aziridines. 
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Generally, with activated aziridines 175a – d, nucleophiles tend to attack at the 
less hindered 3-position of the aziridine; however, when the R’ substituent at the 
2 position of an activated aziridine 175a – d is an aromatic group, attack at the 2 
position can be favoured.7 With unactivated aziridines 175e – g, nucleophiles can 
attack at either the 2 or 3 position depending on the acid catalyst and nucleophile 
used.7 
 
There exists a large amount of literature on the ring opening of both activated and 
unactivated aziridines with carbon, nitrogen, sulfur, and halide nucleophiles; for 
every aziridine synthesized, a multitude of different nucleophiles can be used to 
ring open them.4 Here, we highlight pertinent examples. 
 
1.6.1 Ring opening of aziridines with nitrogen nucleophiles 
 
Some primary amines are known to ring open aziridines in the absence of Lewis 
acids.146 However, Lewis acids such as BF3·OEt2, BiCl3, B(C6F5)3, LiClO4, or InBr3 are 
more commonly used to add amines to aziridines.147-151 Yudin et al. reported that 
using B(C6F5)3 as Lewis acid, symmetrical N-alkyl aziridine 176 could be ring 
opened by amines such as BnNH2 and PhNH2 (Scheme 1.53).149 Similar results 
were reported by Singh et al. under solvent free conditions using silica gel.152  
 
Scheme 1.53. Yudin et al.’s B(C6F5)3 catalysed ring openings of aziridines with amines. 
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Using LiClO4 as Lewis acid, Yadav et al. reported that N-tosyl aziridines could be 
ring opened by ArNH2 giving 1,2-diamines.150 However, in cases of non-
symmetrical aziridines, regioselectivity was not complete (Scheme 1.54). With R1 
= aromatic, the amine attacked mostly at the benzylic position, but when R1 = alkyl, 
attack was mostly seen at the less hindered position. 
 
This preference for nucleophiles to attack at the less hindered end of 2-alkyl 
substituted activated aziridines, and at the benzylic position for 2-aromatic 
activated aziridines has been observed in a number of other reports.7, 151, 153 
 
A safer alternative to using LiClO4 is LiNTf2. Cossy et al. reported that LiNTf2 is an 
extremely efficient Lewis acid for the ring opening of N-tosyl, N-Boc and N-alkyl 
aziridines with primary and secondary amines (Scheme 1.55).154 
 
The ring opening of aziridines with azides is usually done with either NaN3 or 
Me3SiN3. In the absence of any Lewis acid, NaN3 is known to ring open activated N-
tosyl aziridines in MeCN/H2O with good yields quickly; however, the 
corresponding reaction with unactivated N-aryl aziridines is very sluggish with 
lower yields obtained.155  
 
Scheme 1.54. LiClO4 catalysed ring openings of aziridines with amines. 
 
Scheme 1.55. Cossy et al.’s LiNTf2 catalysed aziridine ring openings. 
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More commonly, reactions of aziridines with NaN3 are effected in the presence of 
Lewis acids such as CeIV(NH4)2(NO3)6 (Ceric ammonium nitrate, CAN), CeCl3·7H2O, 
LiClO4 or AlCl3.156-159 For example, Yadav et al. reported that CeCl3·7H2O was an 
extremely effective catalyst in the regioselective ring opening of N-tosyl aziridines 
with NaN3, giving product 181 (Scheme 1.56).157 
 
Me3SiN3 can also be used to ring open aziridines with azide (Scheme 1.57). 
Unactivated N-alkyl and N-aryl aziridines can be ring opened with Me3SiN3 in the 
absence160 of any external catalyst with good regioselectivity, but activated N-tosyl 
aziridines required nBu4NF as catalyst.161 Good yields were obtained in both cases. 
 
1.6.2 Ring opening of aziridines with oxygen nucleophiles 
 
The ring opening of both activated and unactivated aziridines by alcohols is often 
done by using the alcohol as a solvent, with an appropriate Lewis acid, such as 
CeIV(NH4)2(NO3)6, Sn(OTf)2 or BF3·OEt2.156, 162 Brønsted acids dissolved in the 
alcohol can also be used,163 and in the case of H2O as nucleophile, ring opening of 
activated aziridines can be achieved in the absence of any external Brønsted acid 
catalyst at elevated temperatures.164  
 
Scheme 1.56. CeCl3·7H2O catalysed ring openings of aziridines with NaN3. 
 
Scheme 1.57. Ring openings of aziridines with Me3SiN3. 
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For example, Singh et al.162 and Uneyama et al.163 respectively reported that 
BF3·OEt2 and H2SO4 catalyse the ring opening of N-alkyl, N-aryl and N-tosyl 
aziridines by alcohols (Scheme 1.58). 
 
Carboxylic acids can also ring open aziridines. N-Tosyl aziridines are ring opened 
by carboxylic acids using In(OTf)3 as Lewis acid catalyst,165 but unactivated N-alkyl 
aziridines react with carboxylic acids without the need for any external Lewis acid 
(Scheme 1.59).166-167 
 
1.6.3 Ring opening of aziridines with sulfur nucleophiles 
 
Thiols are sufficiently nucleophilic that they can ring open some aziridines in the 
absence of any acidic or basic catalyst.168 More commonly however, either Lewis 
or Brønsted acids are used to accelerate the ring opening of aziridines by thiols. 
Brønsted acids such as TfOH, and Lewis acids such as BF3·OEt2, ZnCl2 and Zn(OTf)2 
have been reported to catalyse the ring opening of N-alkyl, N-Boc and N-tosyl 
aziridines (Scheme 1.60).169-172  
 
Scheme 1.58. Ring openings of aziridines with ROH. 
 
Scheme 1.59. Ring openings of aziridines with carboxylic acids. 
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Aziridines can also be ring opened by thiols in the presence of bases such as 
NEt3.173-174 Hamzik et al. reported that N-sulfinyl aziridine 186 was ring opened by 
thiophenol to give 187 as the only regioisomer (Scheme 1.61).174 
 
Wu et al. reported that the tertiary amine DABCO was able to catalyse the ring 
opening of N-tosyl and N-benzyl aziridine 188 by thiols by acting as a nucleophilic 
“trigger” to produce intermediate 189, which was able to act as a base, eventually 
giving the ring opened product 192 (Scheme 1.62).175 Hou et al. reported that 
nBu3P was also able to promote this reaction.176  
 
Scheme 1.60. Literature ring openings of aziridines with thiols. 
 
Scheme 1.61. NEt3 catalysed ring opening of aziridine 186. 
 
Scheme 1.62. Wu et al.’s DABCO catalysed ring openings of aziridines. 
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Thiocyanate (NCS−) can also ring open aziridines. Yadav et al. reported KSCN ring 
opened N-tosyl aziridines in the presence of LiClO4 as Lewis acid, giving 193 after 
aqueous work-up (Scheme 1.63).177 
 
1.6.4 Ring opening of aziridines with halides 
 
Aziridines can be ring opened by chloride, bromide and iodide anions using metal 
halide salts, hydrogen halides, or trimethylsilyl halides. Various metal halides have 
been reported to ring open activated aziridines, such as MgBr2, InCl3, InBr3, InI3, 
LiCl, LiBr, LiI.178-182 However, the most general method appears to be use of zinc(II) 
halides ZnCl2, ZnBr2 and ZnI2, which give excellent regioselectivity with N-tosyl 
aziridines bearing an aromatic substituent (Scheme 1.64).181 
 
Me3SiCl, Me3SiBr and Me3SiI can ring open activated aziridines in the presence of 
a suitable Lewis base catalyst such as F− or TMEDA.161, 183-184 These authors 
proposed that the Lewis base first reacts with the trimethylsilyl halide to give the 
halide anion; the initially formed N-silyl 197 is hydrolysed upon aqueous work-up 
to give 198 (Scheme 1.65).161  
 
Scheme 1.63. Yadav et al.’s ring openings of N-tosyl aziridines with KSCN. 
 
Scheme 1.64. Ring openings of N-tosyl aziridines with zinc(II) halides. 
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Unactivated aziridines can be ring opened by halides by first converting them to 
the aziridinium cation, which then undergoes attack by the halide anion. De Kimpe 
et al. reported that unactivated aziridine 199 was ring opened by various acyl 
chlorides to give 201 (Scheme 1.66).185 
 
Alternatively, De Kimpe et al. reported that by methylating N-alkyl aziridine 202, 
the aziridinium triflate salt 203 could be ring opened by various tetra-butyl 
ammonium halides including fluoride with almost complete stereo and 
regioselectivity (Scheme 1.67).186 Attack of halide was at the more substituted end 
as the reaction was under thermodynamic control.  
 
Scheme 1.65. Wu et al.’s proposed catalytic cycle. 
 
Scheme 1.66. De Kimpe et al.’s acylation and ring openings of aziridines. 
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Another way to ring open aziridines with halide anions is to react the aziridine 
directly with the hydrogen halide.163, 187-188 However, this usually works only for 
HCl and HBr (Scheme 1.68). 
 
There are very few reports on ring openings of aziridines by fluoride due to the 
low nucleophilicity of F−. While HF can ring open aziridines, this method is not very 
popular because it is highly corrosive and can react with glass.189 Some metal 
fluoride salts such as KF·2H2O and NiF2 also ring open aziridines.190-191 Fan et al. 
reported that KF·2H2O ring opens N-tosyl, N-aryl and N-alkyl aziridines in the 
presence of nBu4NHSO4 to give 209, although the role nBu4NHSO4 of was not 
explained (Scheme1.69).190 Zhang et al. reported that partially hydrated NiF2 could 
effect the same transformation.191  
 
Scheme 1.67. De Kimpe et al.’s methylation and ring openings of aziridines. 
 
Scheme 1.68. Ring openings of aziridines with HCl or HBr. 
 
 
Scheme 1.69. Zhang et al.’s ring openings of aziridines with KF·2H2O. 
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Doyle et al. reported an interesting Lewis base catalysed in situ generation of 
amine-HF reagents which can ring open activated and unactivated aziridines 
(Scheme 1.70).192 Using 1,5-diazabicyclo[4.3.0]non-5-ene (210), benzoyl fluoride 
(211) and hexafluoroisopropanol (212), the amine-HF complex 213 was formed, 
which could ring open aziridine 214 to give 215. 
 
1.6.5 Ring opening of aziridines with carbon nucleophiles 
 
The simplest carbon nucleophile, the cyanide anion can ring open aziridines. If the 
aziridine is sufficiently activated, as in N-nosyl aziridines, CN− is sufficiently 
nucleophilic to attack the aziridine in the absence of any external Lewis acids. 
Farràs et al. reported that starting from chiral 2-alkyl, N-pNs aziridine 217, attack 
of NaCN from the less hindered carbon gave 218 as a single stereo and regioisomer 
(Scheme 1.71).193  
 
Scheme 1.70. Doyle et al.’s in situ generation of amine-HF complex 213. 
 
Scheme 1.71. Farràs et al.’s ring opening of aziridine 217 with NaCN. 
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However, with less activated N-tosyl aziridines, a Lewis acid such as LiClO4 is 
needed.158 Alternatively, Me3SiCN can be used to ring open N-tosyl aziridines with 
nBu4NF as catalyst.161 
 
Organometallic reagents can be used to ring open aziridines. While unactivated N-
alkyl aziridines can be ring opened by organometallic reagents, this method is not 
very popular.194-195 More commonly, organometallic reagents are used to ring open 
activated N-sulfonyl, N-sulfinyl and N-phosphonate aziridines (Scheme 1.72).174, 
196-199 The carbanion usually attacks the less hindered carbon with high 
regioselectivity, except with 2-aryl substituted activated aziridines.197 
 
Enolates and enolate equivalents have also been reported to ring open aziridines 
through carbon. Vicaro et al. showed that chiral enolate 220 ring opens various N-
tosyl aziridines at the less hindered carbon with high diastereoselectivity to give 
221 (Scheme 1.73).200 Interestingly, high regioselectivity was also observed even 
when there was a phenyl group at the 2-position of the aziridine.  
 
Scheme 1.72. Literature ring openings of aziridines with organometallic reagents. 
 
Scheme 1.73. Vicario et al.’s ring openings of aziridines with enolate 220. 
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Enders et al. reported ring openings of unsubstituted and 2-benzyl N-tosyl 
aziridines with SAMP hydrazone anion 222 to give 223 (Scheme 1.74).201 
 
Arenes and heteroaromatics can also ring open N-sulfonyl aziridines in the 
presence of a suitable Lewis acid, such as AlCl3, AuCl3, InCl3, In(OTf)3, AgPF6, or 
FeCl3.202-207 Most of these examples involved the ring opening of C-aryl, N-tosyl 
aziridines, such as that reported by Wu et al. with FeCl3 (Scheme 1.75).207 
 
 
 
 
Scheme 1.74. Enders et al.’s ring openings with SAMP hydrazone anion 222. 
 
Scheme 1.75. Wu et al.’s ring openings of aziridines with arenes. 
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2.1 Introduction to flow chemistry 
 
There have been a number of excellent reviews written on flow chemistry.208-214 
This short introduction does not aim to replicate these reports but to provide a 
brief summary on the principles of flow chemistry. 
 
Currently, the majority of synthetic organic chemistry in research and 
development settings is carried out in batch reactors, conventionally in a round 
bottom flask. However, a major problem faced by synthetic organic chemists is 
successful scaling up of reactions from laboratory conditions to mass 
production.208 One way to avoid the need to optimize reaction conditions each time 
a batch reaction is run on a bigger scale is to use flow chemistry.212 Flow chemistry 
is the continuous synthesis of chemicals in channels, tubes or pipes. Rather than 
scaling up a batch reaction by conducting the reaction on a larger scale in a bigger 
flask, flow chemistry aims to increase production by scaling out: the reaction is 
run under the same conditions, but in multiple parallel flow reactor systems.213 
 
Not having to optimize the conditions for chemical reactions at different scales is 
an attractive proposition in industrial processes.208 Thus, there has been growing 
interest in recent years in carrying out chemical reactions under continuous flow 
conditions. Furthermore, there are other inherent advantages to running a 
reaction using continuous flow methodology, which will be described later.  
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2.1.1 Types of flow reactors 
 
Flow reactors can be fabricated from various substrates such as glass, silicon, 
metal or polymers, with the exact substrate used dependent on chemical 
compatibility or cost.214 Flow reactors can be classed into two main categories: 
microfluidic flow reactors have reaction channels that are less than 500 μm; 
mesofluidic flow reactors have reaction channels larger than 500 μm but smaller 
than 3 mm.213 Microfluidic flow reactors have a larger surface area to volume ratio, 
and thus have better heat transfer characteristics, making microfluidic flow 
reactors better for exothermic reactions.211 
 
However, the smaller channel diameter of microfluidic flow reactors makes them 
much more prone to blockages. Mesofluidic flow reactors are less prone to 
blockages, and are thus more versatile for chemical reactions that are not highly 
exothermic. 
 
2.1.2 Mixing of reactants in a flow reactor 
 
In a batch reaction in a round bottom flask, mixing of two different miscible 
solutions is achieved by using a magnetic stirrer to effect mechanical agitation. In 
a flow reactor combining two reagent streams, mechanical agitation is not usually 
possible.212 The Reynolds number (Re) is a dimensionless number used to quantify 
the ratio between inertial and viscous forces within a stream of fluid.213 In a 
uniform tube, it is described by the equation: 
𝑅𝑒 =  
inertial forces
viscous forces
=  
𝜌𝑑𝑣
𝜇
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where 𝜌 is density in kgm−3, 𝑑 is the diameter of the channel in m, 𝑣 is the fluid 
velocity in ms−1, and 𝜇 the dynamic viscosity in Nsm−2. Fluid flow in microfluidic 
and mesofluidic flow reactors is characterized by low Reynolds numbers (usually 
below 250), which means that fluid flow is laminar, not turbulent.213 
 
An approximation212 for the time taken for reactants to diffuse in the channel of a 
flow reactor is given by Fick’s law of diffusion: 
𝑡𝑑 =  
𝐿2
𝐷
 
where 𝑡𝑑  is the diffusion time in s, 𝐿 is the diffusion distance in m, and 𝐷 is the 
diffusion coefficient in m2s−1. A consequence of Fick’s law and low Reynolds 
numbers in most flow reactors means that after a T-junction combining two 
reagent streams, complete mixing by only diffusion is usually not fast enough. 
 
Thus, rapid mixing is usually achieved by incorporation of a separate mixing unit 
after the T-junction of the flow reactor (the T-junction and the mixing unit is 
together refered to as the T-mixer), which combines the two reagent streams 
together. This can work by splitting the two reagent streams into many different 
‘laminae’ and recombining them, or by inducing turbulence in a small section of 
the flow reactor so that the two reagent streams are completely mixed.212  
Chapter 2: Flow Synthesis and Openings of Aziridines from 1,2-Amino Alcohols 
61 
 
2.1.3 Movement of fluid in a flow reactor 
 
Movement of fluids in a flow reactor is usually achieved using a mechanical pump, 
such as syringe pumps, or HPLC pumps. This is usually the most expensive part of 
a flow reactor. Non-mechanical pumping has also been used in flow reactors, such 
as electro-osmotic flow pumping, which is achieved by using an electric field to 
move various polar solvents such as water, methanol or acetonitrile; however, this 
method is not very versatile and the highest flow rate that can be achieved is 
around 5 μLmin−1.213 
 
How fast the reagents flow through the flow reactor of a given volume before 
heating is stopped or the reaction quenched affects the residence time, which 
corresponds to how long a reaction takes to occur under batch conditions. A brief 
schematic of the various variables in a flow reactor is given in Figure 2.1. 
 
The residence time, Rt (in min), is calculated by dividing the reactor volume, Vreactor 
(in mL), by the total flow rate, Frate (in mLmin−1): 
𝑅𝑡 =  
𝑉𝑟𝑒𝑎𝑐𝑡𝑜𝑟
𝐹𝑟𝑎𝑡𝑒
 
  
 
Figure 2.1. Schematic showing the various variables in a flow reactor. 
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2.1.4 Advantages of reactions in a flow reactor 
 
Running a reaction under continuous flow methodology in a flow reactor can give 
a number of direct benefits, which will be described with examples in this section. 
 
2.1.4.1 Better heat control 
 
Running a reaction in a microfluidic or mesofluidic flow reactor can offer a better 
heat dissipation rate of around 5000 – 25 000 Wm−2K−1, compared to a rate of 
around 2000 Wm−2K−1 under batch conditions.215 This can be extremely important 
in reactions that involve high exotherms, for both safety and product degradation 
reasons. For example, Pelleter et al. reported that the highly exothermic nitration 
of 3-alkylpyrazole 225 could be effected much more safely using continuous flow 
methodology (Scheme 2.1).215 This is important as local hot spots can cause 
explosive decomposition of the nitrated products 226, as well as causing 
unwanted side products. 
 
Better heat control can also improve the selectivity of products formed in a 
reaction. Roberge et al. reported that the DIBAL-H reduction of methylbutyrate 
(227) into butyraldehyde (228) could be effected with much higher selectivity 
against butyl alcohol (229) (89% aldehyde, only 11% alcohol) under continuous 
flow methodology at −55 °C (Scheme 2.2).216 The batch process at the same 
temperature gave 63% aldehyde with 27% alcohol.  
 
Scheme 2.1. Pelleter et al.’s nitration of 3-alkylpyrazole 225 in flow. 
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2.1.4.2 In situ generation of reactive or hazardous intermediates 
 
Running a reaction under continuous flow methodology can allow small quantities 
of highly reactive or hazardous intermediates to be generated in situ. This can be 
important for safety considerations, or avoiding the need to isolate a reactive 
intermediate which is prone to decomposition. Wirth et al. reported that highly 
reactive iodine azide (IN3) could be safely generated in situ from nbutylammonium 
azide and iodine-chloride. IN3 reacts with aldehyde 230 via a radical process to 
give acyl azide 231 which undergoes a Curtius rearrangement to give the 
isocyanate 232. 232 then reacts with excess azide to give the final product 233 
(Scheme 2.3).217  
 
Scheme 2.2. Roberge et al.’s reduction with DIBAL-H in flow. 
 
Scheme 2.3. Wirth et al.’s in situ generation of reactive IN3. 
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2.1.4.3 Rapid reactions at elevated temperatures and pressures 
 
Certain chemical reactions benefit from faster rates at elevated temperatures, but 
are limited by the boiling point of the solvent used. With the right flow reactor, 
reactions can be run under continuous flow methodology above the boiling point 
of the solvent at elevated pressures; this can speed up the rate of reaction.218 While 
running reactions in batch at high temperature and pressure is possible, elevated 
temperatures and pressures in a flow reactor are considered safer due to the lack 
of headspace in a flow reactor. 
 
2.1.4.4 Immobilized reagents reduce the need for purification 
 
The use of solid or polymer-supported reagents or catalysts can be combined with 
continuous flow methodology.219 By flowing a dissolved reactant in a solvent 
through the supported reagent or catalyst, the outlet would give a stream of 
product with lesser need for purification to remove the remaining reagent or 
catalyst. Supported scavengers can also be used to remove any remaining starting 
materials. 
 
Ley et al. has pioneered continuous flow methodology involving solid and 
polymer-supported reagents. In one example, polymer-supported base was used 
to induce cyclization of acyl chloride 234 and isocyanate 235 to give 4,5-
disubstituted oxazoles 237 (Scheme 2.4).220 A polymer supported scavenger was 
also used to remove unreacted starting material.  
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2.1.5 Disadvantages of running reactions in flow 
 
It should be pointed out running a reaction using continuous flow methodology 
has a number of disadvantages as well. Many chemical reactions which produce 
insoluble precipitates and by-products are unsuitable for flow methodology as this 
can clog up a flow reactor and cause blockages.213 Furthermore, chemistry run 
under continuous flow methodology should ideally involve homogenous solutions; 
while there have been examples of flow chemistry involving multiple phases such 
as gas and liquid, or biphasic mixtures, non-homogenous conditions in flow 
require special equipment. 
 
2.1.6 Flow chemistry of aziridines 
 
At the outset of my PhD studies in 2013, a literature search on aziridines in flow 
chemistry only yielded three papers. This included a single report on the synthesis 
of aziridines, and none on the ring opening reactions of aziridines 
 
Nagaki et al. generated N-(t-butylsulfonyl)aziridinyllithium 239 from N-(t-butyl 
sulfonyl)aziridine 238 and nBuLi or sBuLi in a microreactor, and subsequently 
reacted 239 with electrophiles in a telescoped process (Scheme 2.5).221  
 
Scheme 2.4. Ley et al.’s use of supported reagents and scavengers. 
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Nagaki et al. reported that the use of a microreactor allowed the effective 
generation of these reactive organolithiums at a higher temperature of −28 °C, 
compared to the much lower temperature of −78 °C needed for the batch reaction. 
 
Nagaki et al. further expanded on this flow chemistry.222 Aziridine 241 was 
deprotonated by sBuLi to give the organolithium 242, which isomerized via 243 to 
give the nucleophile 244. 244 was subsequently reacted with various 
electrophiles in a telescoped process to give 1,2,3,4-tetrahydroisoquinolines 245 
in overall moderate to good yields (Scheme 2.6). 
 
In 2013, the only report on the synthesis of aziridines in flow was that by Booker-
Milburn et al., in which they effected the photocycloaddition/rearrangement of 
pyrrole 246 to give aziridine 247 (Scheme 2.7).223 Whilst an impressive 
rearrangement, this method is not a general route to aziridines, and is limited to 
N-functionalized pyrroles.  
 
Scheme 2.5. Nagaki et al.’s generation and reactions of aziridinyllithiums in flow. 
 
Scheme 2.6. Nagaki et al.’s in flow synthesis of 1,2,3,4-tetrahydroisoquinolines. 
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One of the many advantages continuous flow methodology has over batch process 
is that flow chemistry can be used to generate and handle hazardous and reactive 
reagents in a safe way. Other than the literature just explored, there were no other 
reports on aziridines in flow. We were thus interested to investigate if continuous 
flow methodology could be applied to the synthesis of aziridines and their ring 
openings, and if these two processes could be combined. This would be attractive 
to industry, as a concern in the large scale manufacture of aziridines is its potential 
toxicity; avoiding the need to isolate an aziridine intermediate by directly reacting 
it in flow would be ideal. 
 
2.1.7 Related research on epoxides in flow chemistry 
 
Closely related to aziridines are epoxides. The synthesis and ring openings of 
epoxides under continuous flow methodology had received more attention at the 
time my PhD began. Schüth et al. reported in 2002 the gas phase oxidation of 
ethene by oxygen using silver catalysis to give ethylene oxide (248) using a 
specially constructed microreactor (Scheme 2.8).224  
 
Scheme 2.7. Booker-Milburn et al.’s in flow synthesis of aziridines. 
 
Scheme 2.8. Schüth et al.’s oxidation of ethene with oxygen. 
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Markowz et al. reported a similar gas phase oxidation of propene with H2O2 in a 
microreactor (Scheme 2.9), but the reaction conditions and yields were not 
disclosed; their results were used for scale up to pilot scale.225 
 
McPake et al. epoxidized a range of alkenes in a continuous flow reactor in 2009.226 
HOF·MeCN was generated in situ, which was used to epoxidize various alkenes 
(Scheme 2.10). The advantage of this method was that the highly oxidizing and 
corrosive HOF·MeCN did not need to be isolated, and could be used immediately. 
 
In 2009, Wiles et al. effected the epoxidation of a variety of alkenes using H2O2 by 
an immobilized enzyme, Novozym® 435 (Scheme 2.11).227 It is thought that the 
enzyme catalyzes the formation of peracetic acid from hydrolysis of the EtOAc 
solvent which then epoxidizes the alkene. Wiles et al. reported the advantage of 
carrying out the chemo-enzymatic epoxidation of alkenes under continuous flow 
compared to in batch was that reaction times were reduced.  
 
Scheme 2.9. Markowz et al.’s oxidation of propene with H2O2. 
 
Scheme 2.10. McPake et al.’s epoxidation of alkenes with HOF·MeCN. 
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Munirathinam et al.228 and Bedore et al.229 managed to effect the ring opening of 
epoxides using continuous flow methodology, using sodium azide and various 
amines respectively (Scheme 2.12). Bedore et al. reported that by using a 
microreactor, higher temperatures above the boiling point of the solvent and/or 
amines could be reached, allowing faster reaction. 
 
2.2 Research hypothesis and aims 
 
Based on the successes achieved with epoxides, and the importance of aziridines 
in synthesis,1 we felt that it would be of interest to develop flow methods for the 
generation and ring opening reactions of aziridines. The application of continuous 
flow methodology with aziridines would potentially have a number of benefits, 
such as improved safety and faster reaction times.208-213 Furthermore, we hoped to 
couple the synthesis of aziridines with subsequent cascade ring openings. This 
would allow the opportunity to make libraries of compounds by systematic 
variation of the starting materials used.230  
 
Scheme 2.11. Wiles et al.’s enzyme catalysed epoxidation of alkenes. 
 
Scheme 2.12. Literature ring openings of epoxides under continuous flow. 
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2.3 Initial attempts to synthesize aziridines from alkenes 
 
Our initial goal was the continuous flow synthesis of N-sulfonyl 2-phenylaziridines. 
These molecules are sufficiently activated towards ring opening by nucleophiles 
that they are useful intermediates, but are also stable enough to be isolated, 
characterized, and stored for long periods of time. The phenyl group increases the 
rate of nucleophilic attack as well as improves regioselectivity due to a SN1/loose 
SN2 transition state.231-232 
 
Initially, we explored the aziridination of styrene. The eventual goal was to adapt 
the procedure to a wider range of alkene substrates. The direct aziridination of 
alkenes is well studied, and offers the most attractive way of making aziridines due 
to the wide variety of alkenes that are commercially available and its directness. 
 
One of the most important considerations when adapting batch processes for use 
under continuous flow methodology is solubility. This is to avoid blocking the 
channels of the microreactor. The solutions should be homogeneous as biphasic 
mixtures are not normally suitable for continuous flow methodology. In the 
context of alkene aziridinations, these limitations initially proved quite difficult to 
overcome. When we adapted the literature aziridination233 of styrene, TsNH2 and 
hypochlorite by adding H2O to solubilize the NaCl by-product, the reaction failed 
(Scheme 2.13).  
 
Scheme 2.13. Trial reaction with TsNH2 under homogeneous conditions. 
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Similarly, attempts to avoid the biphasic CH2Cl2/H2O mixture used in the literature 
aziridination234 of styrene with NaNTsCl·3H2O (254) by switching CH2Cl2 to MeCN 
also did not work; the reaction remained heterogeneous with brown precipitates 
and no aziridine was detected (Scheme 2.14). 
 
2.4 Use of 1,2-amino alcohols 
 
Disappointed with these early findings, we sought an alternative strategy based on 
ring closure. We will return to direct alkene aziridinations in Chapter 3, where a 
successful solution to this problem was developed. We were attracted to Vicario et 
al.’s one step synthesis of 2-phenyl-1-tosylaziridine (253), from 2-amino-2-
phenylethan-1-ol (255), as the reaction is not biphasic, and the reactants are all 
soluble in CH2Cl2 (Scheme 2.15).235 
 
The synthesis of aziridines via ring closure of 1,2-amino alcohols also had a 
number of other benefits, such as the easy synthesis of 1,2-amino alcohols from α-
amino acids.236 Furthermore, if the 1,2-amino alcohol is chiral, ring closure readily 
gives a single enantiomer of the aziridine.237  
 
Scheme 2.14. Trial reaction with NaNTsCl·3H2O under homogeneous conditions. 
 
Scheme 2.15. Vicario et al.’s synthesis of 2-phenyl-1-tosylaziridine. 
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A B Out (a) (b) 
While the batch reaction of 2-amino-2-phenylethan-1-ol (255) with TsCl worked 
in our hands, the rate of product formation was extremely slow and produced 
insoluble Et3NHCl as a by-product. It was hoped that the rate of reaction could be 
improved by using increased amounts of DMAP, and that a change of solvent used 
would dissolve the Et3NHCl formed. Pleasingly, when the amount of DMAP was 
increased to stoichiometric quantities (0.5 – 1 eq), and the solvent changed to 
CHCl3, the trial reaction in batch was homogeneous and went to completion within 
one hour.  
 
2.5 Optimization of the flow synthesis of 2-phenyl-1-tosylaziridine (253) 
 
Since the trial batch reaction was successful, we carried out the same reaction 
under continuous flow. Two microreactors, a mixer module (LTF-MX) and a 
reaction module (LTF-V) were connected in series (Figure 2.2). The combined 
volume of the microreactors together with connecting tubes was 2.0 cm3. The two 
inputs of the mixer module were connected to two computer controlled syringe 
pumps. Above atmosphere pressure was achieved with a back pressure regulator, 
and heating was achieved by immersing the connected microreactors in a silicone 
oil bath. To prevent further reaction after leaving the microreactor, the mixture 
was quenched into a stirred solution of saturated aq NH4Cl.  
 
Figure 2.2. (a) Drawing; (b) schematic of the microreactor. 
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Table 2.1. Optimization of synthesis of 2-phenyl-1-tosylaziridine (253) in flow. 
 
Entry T (°C) DMAP (eq) Base (eq) TsCl (eq) Rt (min) Yieldb (%) 
1 21 0.5 Et3N (4.5) 2.0 8 30 
2 21 0.5 Et3N (4.5) 2.5 8 51 
3 21 0.5 Et3N (4.5) 2.5 13 53 
4 21 0.5 Et3N (4.5) 2.5 40 67 
5 30 0.5 Et3N (3.8) 2.5 40 53 
6 30 0.5 Et3N (4.5) 2.5 40 73 
7 30 0.5 Et3N (5.3) 2.5 40 74 
8 30 0.5 DBU (4.5) 2.5 40 trace 
9 30 0 Et3N (4.5) 2.5 40 trace 
10 30 0.3 Et3N (4.5) 2.5 40 70 
11 30 1.0 Et3N (4.5) 2.5 40 70 
12 30 1.0 Et3N (4.5) 3.0 40 77 
13 35 0.5 Et3N (4.5) 2.5 40 70 
14 30 0.3 Et3N (4.5) 2.3 40 61 
15 50 0.5 Et3N (4.5) 2.5 8 60 
16 80 0.5 Et3N (4.5) 2.5 8 47 
17 80 0.5 Et3N (4.5) 2.5 4 52 
a 2-amino-2-phenylethan-1-ol (1 eq), DMAP (eq) and base (eq) were dissolved in CHCl3; 
TsCl (eq) was dissolved in CHCl3. b Isolated yield after chromatography. 
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The results of the optimization are shown in Table 2.1. As entries 1 and 2 show, 
increasing the number of equivalents of TsCl from 2.0 eq to 2.5 eq increased the 
yield. Attempts to further increase the equivalents of TsCl under more optimized 
conditions (entry 12 compared with entry 6) did not improve the yield by much. 
Furthermore, the increase in concentration of TsCl posed technical problems for 
the syringe pumps, causing TsCl precipitation around the syringe pump seals 
which would damage the syringe pumps. 
 
As entries 2, 3 and 4 show, increasing the residence time Rt increased the isolated 
yield. The residence time is the average amount of time a single molecule spends 
in the microreactor before quenching. It was not readily possible to alter the 
residence time beyond 40 min, due to the limitations of the pumps used. 
 
Increasing the temperature from 21 °C (entry 4) to 30 °C (entry 6) increased the 
yield, but further temperature rises (entry 13) did not further improve the yield. 
In fact, when the temperature was further increased, the reaction did occur faster, 
but the aziridine began to decompose, necessitating a concurrent reduction in the 
residence time (entries 15, 16 and 17). 
 
The reaction did not work in the absence of DMAP (entry 9), and decreasing the 
amount of DMAP and TsCl together lead to lower yields (entry 14). It was found 
necessary to keep the quantities of TsCl and DMAP in careful balance. Ideally, (2+x) 
equivalents of TsCl required x equivalents of DMAP to be present in order to avoid 
any remaining TsCl after quenching. When only the amount of equivalents of 
DMAP was reduced (entry 10), the yield was affected slightly, but purification 
became much more difficult due to remaining TsCl even after quenching.  
Chapter 2: Flow Synthesis and Openings of Aziridines from 1,2-Amino Alcohols 
75 
 
Decreasing the number of equivalents of NEt3 lowered the yield (entry 5), but 
increasing the number of equivalents of NEt3 beyond 4.5 eq (entry 7) did not 
improve the yield significantly. Changing the base from NEt3 to DBU caused the 
reaction not to work (entry 8). Preliminary studies using other bases such as 
pyridine, 2,4,6-collidine, 2,6-lutidine and piperidine were also unproductive 
(details not shown). 
 
Thus, the optimal conditions for the synthesis of aziridine 253 from 1,2-amino 
alcohol 255 was found to be at 30 °C, with 0.5 eq of DMAP, 4.5 eq of NEt3, 2.5 eq of 
TsCl, with a residence time of 40 min (entry 6). 
 
A possible mechanism for the synthesis of aziridine 253 is shown in Scheme 2.16. 
DMAP first reacts with TsCl to form an active tosylating intermediate 256, which 
then further reacts with the 1,2-amino alcohol. Some evidence in support of this 
mechanism is that the [DMAPTs]+Cl− complex 256 can be isolated, and this 
complex has been shown to tosylate amines and alcohols efficiently.238  
 
Scheme 2.16. Proposed mechanism in the synthesis of aziridine 253. 
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2.6 Continuous flow synthesis of other aziridines from 1,2-amino alcohols 
 
Next, we attempted the continuous flow synthesis of other aziridines from 1,2-
amino alcohols using the optimized conditions detailed in section 2.5. Gratifyingly, 
it was possible to vary both the sulfonyl protecting group on the aziridine nitrogen, 
as well as the type of 1,2-amino alcohol used (Table 2.2). 
 
The best yields were achieved with 1,2-amino alcohols that had an amine flanked 
by a non-bulky aromatic group (R1 = Ar; R2 = R3 = H; entries 1, 2, 5 – 8). 1,2-amino 
alcohols with R1 = alkyl, R2 = R3 = H, gave moderate yields (entries 13 and 14). 
Attempts to synthesize aziridines 274 and 279 were unsuccessful, with only trace 
product observed (entries 10 and 15).  
 
When the synthesis of 1-mesyl-2-phenylaziridine (269) was attempted using 
MsCl, a moderate yield of 54% was obtained (entry 3). Switching from MsCl to 
Ms2O did not improve the yield (entry 4), but when the base was changed from 
NEt3 to DBU, a significantly higher yield of 74% was obtained (entry 5). This 
combination of Ms2O and DBU gave much higher yields compared to MsCl / NEt3 
in the synthesis of a range of mesyl protected aziridines (see also section 2.10). 
However, it was necessary to use a mixed solvent system (CH2Cl2:CHCl3, 1:1) to 
keep Ms2O in solution. Unfortunately, Ts2O and pNs2O were too insoluble in all 
solvent systems tried to explore (ArSO2)2O / DBU more generally. 
 
When chiral (S)-phenylglycinol (S)-(255) was used to make chiral (S)-253, no 
detectable racemization could be observed; only the S-enantiomer was formed as 
indicated by chiral HPLC. The absolute configuration was confirmed by comparing 
the sign and magnitude of the optical rotation to literature values.239  
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Table 2.2. Synthesis of various aziridines from 1,2-amino alcohols. 
 
Entry   1,2-amino alcohol RSO2X            Aziridine 
Yieldb 
(%) 
1    73 
2    59 
3    54 
4    50 
5    74c 
6    73 
7    71c 
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Table 2.2. Synthesis of various aziridines from 1,2-amino alcohols (continued). 
Entry   1,2-amino alcohol    RSO2X             Aziridine 
Yieldb 
(%) 
8 
 
  77 
9    39 
10    trace 
11    68 
12    30 
13    42 
14    51 
15    trace 
a 1,2-amino alcohol (1 eq), DMAP (0.5 eq) and NEt3 (4.5 eq) were dissolved in CHCl3; RSO2Cl 
(2.5 eq) was dissolved in CHCl3; Ms2O was dissolved in CH2Cl2 / CHCl3 1:1. b Isolated yield 
after chromatography. c DBU (4.5 eq) was used as base. 
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An attempt to synthesize gem-dimethyl aziridines where R1 = R2 = Me was made 
using this continuous flow methodology, but this was not particularly successful. 
However, it was found that the product could be obtained if the sulfonylation of 
the 1,2-amino alcohol and the subsequent ring closure were separated into 2 
operations using a three input, two stage reactor (Table 2.3). This was achieved 
using 2.1 equivalents of DMAP with 2.1 equivalents of TsCl to first disulfonylate 2-
amino-2-methyl propan-1-ol (280) in the first section of the reactor. Ring closure 
of 281 was then effected with DBU in the second section of the reactor. In the 
absence of DBU, very little ring closure product was observed by mass 
spectrometry. Whilst the Thorpe-Ingold effect240 might have been expected to 
improve yields in synthesis of gem-dimethyl aziridines due to angle compression 
and the reduction in the number of degrees of freedom, this was not the case. This 
perhaps suggests that N-tosylation is the rate determing step, not ring closure.  
Table 2.3. Synthesis of 2,2-dimethylaziridines with a three input, two stage microreactor. 
 
Entry RSO2X Aziridine Yieldc (%) 
1   36 
2   34 
a 2-amino-2-methylpropan-1-ol (1 eq) and DMAP (2.1 eq) were dissolved in CHCl3; TsCl 
(2.1 eq) was dissolved in CHCl3; Ms2O (2.1 eq) was dissolved in CH2Cl2 / CHCl3 1:1. b DBU 
(4.5 eq) in CHCl3. c Isolated yield after chromatography. 
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2.7 Ring opening reactions of aziridines 
 
Next, we explored the ring opening reactions of these aziridines with a range of 
potential nucleophiles. Our ultimate aim was to telescope the aziridine formation 
with such ring opening processes (section 2.10). 
 
First, we synthesized multi-gram quantities of both the non-symmetrical 2-phenyl-
1-tosylaziridine (253) and the symmetrical 7-tosyl-7-azabicyclo[4.1.0] heptane 
(274). For convenience, we chose to synthesize these aziridines under batch 
conditions33, 234 (Schemes 2.17 and 2.18), in part because styrene and cyclohexene 
were much cheaper than the corresponding 1,2-amino alcohols. It should be noted 
that these reactions produced precipitates, were biphasic, and hence were 
unsuitable for carrying out under continuous flow methodology. 
 
This iodine-catalysed aziridination of alkenes proceeds by a different mechanism 
(Scheme 2.19). Iodine first forms an iodonium cation 284 with the alkene, which 
then is attacked by NaNTsCl, before further cyclization.  
 
Scheme 2.17. Synthesis of 2-phenyl-1-tosylaziridine (253) in batch. 
 
Scheme 2.18. Synthesis of 7-tosyl-7-azabicyclo[4.1.0]heptane (274) in batch. 
Chapter 2: Flow Synthesis and Openings of Aziridines from 1,2-Amino Alcohols 
81 
 
 
 
With large quantities of aziridine 253 in hand, we screened ring opening with a 
variety of nucleophiles under batch conditions163, 183, 187-188 (Table 2.4). A key aim 
was to identify conditions to achieve good regiocontrol. Surprisingly, when we 
repeated work by Wu et al.183, we obtained low conversion, as well as a mixture of 
regioisomers resulting from predominant attack at the less hindered carbon (entry 
1). Wu et al. had reported high yields with predominant attack at the more 
hindered benzylic position. Regioisomers A and B were assigned using COSY and 
HMBC experiments.  
 
Scheme 2.19. Mechanism for the aziridination of cyclohexene with NaNTsCl. 
Table 2.4. Screening of ring opening of 253 with various nucleophiles. 
 
Entry Nu Conditions Conversion (%)a 
1 Cl 12 eq Me3SiCl; DMF; 40 °C; 24 h. 37 (A/B = 1/9). 
2 Cl 1.1 eq tBuMe2SiCl; DMF; 40 °C; 24 h. 70 (only A observed). 
3 Cl HCl (2M in Et2O); 40 °C; 1h. 94 (only A observed). 
4 N3 12 eq Me3SiN3; DMF; 40 °C; 24 h. 35 (A/B = 7/3). 
5 OH 3 eq H2SO4; 22 eq H2O; acetone; 40 °C; 1 h. 92 (only A observed). 
6 OMe 3 eq H2SO4; MeOH; 40 °C; 1 h. 97 (only A observed). 
7 OMe 3 eq AcOH; MeOH; 40 °C; 1h. 0 
a Conversion into A + B determined by 1H NMR spectroscopy. 
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As the actual nucleophile in ring openings of aziridines with Me3SiNu is thought to 
be a DMF/Me3SiNu complex183, 241 287 (Scheme 2.20), we wondered if changing 
the chloride source from Me3SiCl to the bulkier tBuMe2SiCl would alter the 
regioselectivity of the ring opening. Interestingly, we obtained attack only at the 
benzylic position under these conditions (entry 2). With Me3SiN3, we obtained the 
same mixture of regioisomers (A/B = 7/3) as reported by Wu, but the reaction did 
not go to completion even after 24 h with an excess of reagent (entry 4). This 
perhaps suggests that with Me3SiNu (Nu = Cl or N3), there is a competition between 
two reaction pathways which can favour either the A or B regioisomer with 
incomplete regioselectivity. With tBuMe2SiCl, the nitrogen on the aziridine might 
first complex with the silicon to give a positive charge, which favours nucleophilic 
attack at the benzylic position with complete regioselectivity. 
 
Complete regioselectivity for attack at the benzylic position was achieved under 
strong acid catalysis, with the additional benefit that reactions were all much 
quicker (entries 3, 5 and 6). Using a weaker acid such as AcOH lead to no product 
formation (entry 7). The regioselectivity of the H+ catalysed ring openings can be 
rationalized either by a SN1 process, or by a loose SN2 process (Scheme 2.21). No 
attempts to open aziridines with N3− in the presence of acid were made, as HN3 is 
both extremely toxic as well as potentially explosive. However, convenient 
conditions for the complete regioselective ring opening at the benzylic position of 
253 by chloride, water and methanol were identified through this study.  
 
Scheme 2.20. Formation of DMF/Me3SiNu complex. 
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2.8 Ring opening reactions of aziridines under continuous flow 
 
Next, we attempted to apply continuous flow methodology to the ring opening of 
aziridines (Table 2.5). In order to get complete conversion with a residence time 
of 40 min, we had to increase the temperature to 70 °C for N-tosyl aziridines 253 
and 274 (entries 1 – 7). Interestingly, N-mesyl aziridine 269 was much more 
reactive, undergoing complete conversion within 40 min at 21 °C (entries 9 – 12). 
 
Oxygen and carbon nucleophile ring openings could be effected under Brønsted 
acid catalysis with strong acids having non-nucleophilic counterions such as H2SO4 
and MsOH (entries 2, 3, 4, 6, 7, 9, 10 for oxygen nucleophiles; entries 11, 12 for 
carbon nucleophiles). Chloride ring openings were effected using HCl in diethyl 
ether / chloroform as both acid catalyst and nucleophile source (entries 1, 5). 
Fluoride ring opening of N-pnosyl aziridine 275 could also be achieved within 40 
min at 21 °C (entry 8), using an adaptation of the BF3·OEt2 / iPrOH protocol 
developed by Ding et al..242 The yield of 63% for this example (entry 8) is closely 
comparable to Ding et al.’s yield of 68% for the fluoride ring opening of the N-Bs 
derivative under batch conditions.  
 
Scheme 2.21. Rationalization for complete regioselectivity. 
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Table 2.5. Ring-opening of aziridines in flow. 
 
Entry Aziridine HNu Catalyst T (°C) Product 
Yieldb 
(%) 
1  HCl − 70  69 
2  HOMe H2SO4 70  97 
3  HOEt MsOH 70  39 
4  HOH H2SO4 70  98 
5  HCl − 70  98 
6  HOMe H2SO4 70  72 
7  HOH H2SO4 70  75 
8  “HF” 
Et2O·BF3 
iPrOH 
21  63 
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Unfortunately, Ding et al.’s protocol did not work in the fluoride ring opening of 
aromatic aziridines such as 253 or 269, which is not surprising considering they 
only reported it working for aziridines with alkyl (or benzyl) groups at the 2-
position of the aziridine.242 
 
With unsymmetrical 2-phenyl aziridines 253 and 269, only the regioisomer 
formed from attack at the benzylic position was observed. This was confirmed in 
all cases by 2D NMR experiments including 1H COSY and 1H – 13C HMBC.  
Table 2.5. Ring-opening of aziridines in flow (continued). 
Entry Aziridine HNu Catalyst T (°C) Product 
Yieldb 
(%) 
9 
 
HOMe H2SO4 21  73 
10  HOPh MsOH 21  53 
11   MsOH 21  51 
12   MsOH 21  14 
a For ring openings with HCl: aziridine was dissolved in CHCl3; HCl in Et2O / CHCl3. For ring 
openings with MeOH or EtOH: aziridine in CHCl3; H2SO4 in MeOH or EtOH. For ring 
openings with H2O: aziridine in acetone; H2O and H2SO4 in acetone. For ring openings with 
“HF”: aziridine in CHCl3; iPrOH and BF3·OEt2 in CHCl3. For ring openings with ArOH or ArH: 
aziridine was dissolved in CHCl3; ArOH or ArH and MsOH in CHCl3. b Isolated yield after 
chromatography. 
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All ring-opened products formed from 2-phenyl aziridines showed a three bond 
coupling between the NH and the CH2N in the 1H COSY spectrum. In the case of ring 
openings with alcohols such as MeOH, a three bond coupling between the OCH2R 
and PhCH could be detected in the 1H–13C HMBC spectrum. An example is given in 
Figure 2.3, where the spectra of 299 in CDCl3 is given; the MeO and MeSO2 methyl 
groups were distinguished by chemical shift and 1H–13C HMBC experiments.  
(a) 
 
(b) 
Figure 2.3. Illustrative 2D NMR spectra of 299 in CDCl3. (a) 1H COSY. (b) 1H–13C HMBC. 
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For the Brønsted acid catalysed Friedel-Crafts alkylation with 1,3,5-trimethoxy 
benzene (289), the regiochemical outcome in 301 was confirmed by X-ray 
crystallography (Figure 2.4). While the Friedel-Crafts alkylation of aziridines with 
arenes is known, most of these processes involve the use of Lewis acids.207 
 
 
Only the trans stereoisomer was observed in ring opening of the symmetrical 
aziridines 274 and 275. Mechanistically, a trans stereochemical outcome would be 
expected due to SN2 attack of the nucleophile from opposite the aziridine ring.243 
The trans-stereochemistry of ring opened products 295, 296, 297, and 298 were 
confirmed by the large 3JHH coupling constants between the diaxial hydrogens 
attached to the carbons bearing the diequatorial substituents.  
 
Figure 2.4. X-ray crystal structure of 301 showing regiochemical outcome. 
 
 
Figure 2.5. X-ray crystal structure of 298 showing trans-stereochemistry. 
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The NMRs of these compounds matched data given in literature where the 
stereochemistry was assigned as trans.183, 244 In the case of 298, this was further 
confirmed by X-ray crystallography (Figure 2.5). 
 
2.9 Formal [3+2] cycloaddition of 2-arylaziridines with nitriles in flow 
 
The Lewis acid catalysed formal [3+2] cycloaddition of N-tosyl 2-arylaziridines 
with nitriles was previously reported by Singh et al. (Scheme 2.22).245 As their 
reaction conditions were extremely mild and rapid, with reaction at room 
temperature in less than 5 min, we wondered if we could adapt their protocol to 
flow. This offers an attractive route to these imidazolines. 
 
When we effected the formal [3+2] cycloaddition of a range of N-sulfonyl 2-
arylaziridines with a variety of nitriles at room temperature using a 5 min 
residence time, we obtained imidazolines in moderate to good yields (Table 2.6). 
A single regioisomer was seen in all cases. However, it was not possible to assign 
the regiochemistry of the imidazolines by 2D NMR experiments such as 1H COSY 
and 1H–13C HMBC; three bond couplings in imidazolines obtained from attack at 
either carbon of the aziridine would be expected to be very similar.  
 
Scheme 2.22. Singh et al.’s formal [3+2] cycloaddition of N-tosyl aziridines with nitriles. 
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Table 2.6. Formal [3+2] cycloaddition of aziridines with nitriles in flow. 
 
Entry Aziridine R’CN Product 
Yieldb 
(%) 
1    73 
2    71 
3    58 
4    48 
5    68 
6    81 
7    53 
a Aziridine (1 eq) was dissolved in CH2Cl2; Et2O·BF3 (5.0 eq) and R’CN (5.0 eq) was dissolved 
in CH2Cl2. b Isolated yield after chromatography. 
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Attempted NOESY experiments were also inconclusive. However, the mechanism 
through which the formal [3+2] cycloaddition occurs likely involves attack of the 
nitrile nitrogen at the benzylic carbon (Scheme 2.23). 
 
This mechanism is supported by studies done by Singh et al.245, in which the 
chirality of (R)-2-phenyl-1-tosylaziridine (253) was lost leading to a racemic 
imidazoline. Furthermore, we obtained X-ray crystal structures of 305 (Figure 2.6) 
and 306 (Figure 2.7), which confirm the regiochemical outcome in these cases. 
Since the 1H NMR spectra of all imidazolines were similar, with a characteristic 
peak for ArCH at around 5 ppm and two peaks for CHH and CHH at 3 – 4 ppm, we 
were confident that nitrile attack occurred at the benzylic carbon in all cases.  
 
Scheme 2.23. Proposed mechanism for the formal [3+2] cycloaddition. 
 
Figure 2.6. X-ray crystal structure of 305. 
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2.10 Continuous flow cascade reactions involving aziridine intermediates 
 
With the synthesis of various aziridines achieved in flow (section 2.6), and ring 
opening and cycloaddition chemistries under continuous flow methodology 
developed (sections 2.8 and 2.9), we set about combining these methods using a 
two stage, three-input glass microreactor (Figure 2.8). 
 
This proved more problematic than we initially envisaged. Attempts to use RSO2X 
= TsCl, pNsCl or MsCl as the sulfonylating agent produced large amounts of chloride 
anion which competed in the subsequent ring opening step. This resulted in a large 
amount of chloride ring opened product regardless of nucleophile used in the 
subsequent cascade step.  
 
Figure 2.7. X-ray crystal structure of 306. 
 
Figure 2.8. Two stage, three input microreactor. (a) drawing (b) schematic 
A 
B 
C 
Out 
(a) (b) 
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To overcome these problems, we switched to a different activator that would 
produce a much weaker nucleophile as by product. Ms2O was the only reagent 
which produced acceptable yields in these cascade processes (Table 2.7).  
Table 2.7. Cascade reactions involving aziridine intermediates. 
 
Entry 1,2-amino alcohol Nu Catalyst Product 
Yieldc 
(%) 
1  MeOH  MsOH  61 
2  HCl  −  58 
3  MeCN  BF3  42 
4  MeOH  MsOH  57 
5  HCl  −  53 
a 1,2-amino alcohol (1 eq), DMAP (0.5 eq) and DBU (4.5 eq) were dissolved in CHCl3; Ms2O 
was dissolved in CH2Cl2/CHCl3 1:1. b Nucleophile (and catalyst if necessary) were dissolved 
in the appropriate solvent. c Isolated yield after chromatography. 
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Other sulfonyl anhydrides were tried, such as pNs2O, oNs2O and Ts2O, but these 
sulfonyl anhydrides were too insoluble in all solvent systems tested to be suitable 
for flow chemistry. A further limitation with this chemistry was the requirement 
to use large amounts of acid catalyst (8 eq), since there was 4.5 equivalents of base 
from the ring closure step which had to be neutralized before Brønsted acid 
activation could occur. 
 
Despite these problems, we managed to explore a number of examples of 
nucleophilic ring opening of aziridine intermediates generated from 1,2-amino 
alcohols 255 and 260 under continuous flow methodology (Table 2.7). The best 
yield was achieved when the nucleophile was used as a solvent (entries 1 and 4). 
Moderate yields were achieved with HCl (entries 2 and 5). 
 
Other 1,2-amino alcohols were tried using this telescoped flow methodology, but 
it was not possible to isolate and purify the ring opened products from the reaction 
mixture by column chromatography. These limitations in the cascade ring opening 
of aziridines generated from 1,2-amino alcohols led to the direction of studies 
detailed in Chapter 3.  
 
2.11 Conclusions 
 
We have achieved a rapid and general route to aziridines through ring closure of 
the corresponding 1,2-amino alcohols using continuous flow methodology. Using 
this method, a range of substitution patterns are accessible, with 13 examples of 
aziridines synthesized in flow with moderate to good yields.  
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We also explored various reactions of aziridines under continuous flow 
methodology. Ring opening of aziridines with various oxygen, carbon and halide 
nucleophiles was successful in flow, with 12 examples of ring opened products. 
Formal [3+2] cycloadditions with a variety of nitriles in flow was also possible, 
with 7 examples of imidazolines synthesized. Under the developed conditions, 
complete regiocontrol in the reactions of 2-arylaziridines was seen, and complete 
stereocontrol witnessed in ring openings of 7-azabicyclo[4.1.0]heptane aziridine 
derivatives. 
 
The synthesis of aziridines from 1,2-amino alcohols and its subsequent ring 
opening can be telescoped in flow, limiting exposure to this potentially hazardous 
class of electrophilic reagents. Using this new flow methodology, the rapid 
synthesis of 5 ring opened products directly from the 1,2-amino alcohol was 
achieved, without having to isolate and purify the intermediate aziridine. 
 
The work discussed in this chapter was published in Organic Letters in 2015.246 
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3.1 Introduction 
 
After our paper on the generation and ring opening of aziridines in telescoped 
continuous flow processes was published in July 2015, a number of other papers 
emerged on the continuous flow synthesis of aziridines. Booker-Milburn et al. 
conducted further investigation into the flow synthesis of tricyclic aziridines by 
the rearrangement of N-functionalized pyrroles (Scheme 2.7).247 
 
Baumann et al. effected the synthesis of 2H-azirine 317 from the Neber 
rearrangement of oxime 316 in flow, and subsequently reacted the 2H-azirine in a 
telescoped process with nucleophiles to give aziridine 318 (Scheme 3.1).248 
 
 
Yoon et al. aziridinated cyclohexene with 2,2,2-trichloroethyl azidoformate (319) 
to give the aziridine using photochemical catalysis in a flow reactor (Scheme 3.2). 
Interestingly, they found that the reduced dimensionality of a flow reactor 
increased the photon flux and increased efficiencies, leading to a shorter reaction 
time; the residence time was shortened from 4 h in batch to 2.3 h in flow.249  
 
Scheme 3.1. Baumann et al.’s in flow synthesis of aziridines. 
 
Scheme 3.2. Yoon et al.’s in flow aziridination of cyclohexene. 
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Similarly, Puglisi et al. aziridinated aromatic alkenes with a range of arylazides to 
give N-aryl aziridine 321 (Scheme 3.3).250 However, their procedure required the 
use of the alkene as solvent, as well as high temperatures. 
 
The approaches above did not seem suitable for us to try and improve cascade type 
processes in which the aziridine is generated and further reacted in situ. Moreover, 
we did not have access to flow equipment which could withstand high 
temperatures or allow photoirradiation. 
 
We remained interested in the direct aziridination of alkenes using continuous 
flow methodology, with a view to coupling it with ring opening reactions to 
provide telescoped, cascade processes to give functionalized products directly 
from the alkenes. One of the key challenges is that we must use soluble 
aziridinating agents, some of which are described in the following section. 
 
3.2 Soluble aryliminobromane and aryliminoiodanes 
 
In 2007, Ochiai et al. prepared a soluble aryliminobromane that attracted our 
interest. Starting from trimethyl(4-(trifluoromethyl)phenyl)silane (322), reaction 
with bromine trifluoride at −78 °C gave the hypervalent ArBrF2 323 and 
subsequent exchange with CF3SO2NH2 gave the aryliminobromane 324 (Scheme 
3.4).251  
 
Scheme 3.3. Puglisi et al.’s in flow synthesis of aziridines using arylazides. 
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Interestingly, the aryliminobromane 324 was capable of aziridinating a wide 
variety of alkenes without any metal catalysis at room temperature (Scheme 3.5). 
Good yields were obtained with both aliphatic and styrenic alkenes across a range 
of substitution patterns. 
 
Starting from thiophenol (Scheme 3.6), Protasiewicz et al. prepared an o-tert-
butylsulfonylphenyliminoiodane 328 which had increased solubility relative to 
PhI=NTs due to the oxygen of the sulfone coordinating to the iodine centre.252  
 
Protasiewicz et al. also prepared another soluble aryliminoiodane from 4-tert-
butylbromo benzene (329) (Scheme 3.7).253 In this case, the intermediate 
diacetate was not isolated.  
 
Scheme 3.4. Ochiai et al.’s preparation of a soluble aryliminobromane 324. 
 
Scheme 3.5. Ochiai et al.’s aziridination of alkenes with aryliminobromane 324. 
 
Scheme 3.6. Protasiewicz et al.’s synthesis of a soluble derivative of PhI=NTs. 
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Protasiewicz et al.’s soluble aryliminoiodanes 328 and 331 were able to 
aziridinate a range of aromatic alkenes using transition metal catalysts such as 
CuOTf and MnIII(TPFC) (Scheme 3.8).252-254 Both these aryliminoiodanes 328 and 
331 gave similar yields, and could be run with either the aryliminoiodane or 
alkene as the limiting reagent. 
 
Yoshimura et al. prepared a range of soluble o-alkoxyphenyliminoiodanes, starting 
from 2-iodophenol (333) (Scheme 3.9).255 Again, the oxygen atom in these soluble 
o-alkoxyphenyliminoiodanes contributed to the solubility of the molecules by 
coordinating to the iodine centre.  
 
Scheme 3.7. Protasiewicz et al.’s synthesis of a soluble derivative of PhI=NTs. 
 
Scheme 3.8. Aziridinations with Protasiewicz et al.’s soluble aryliminoiodanes. 
 
Scheme 3.9. Yoshimura et al.’s soluble o-alkoxyphenyliminoiodanes. 
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Yoshimura reported the Cu(OTf)2 catalysed aziridination of a variety of both 
aromatic and aliphatic alkenes using these o-alkoxyphenyliminoiodanes in 
moderate to high yields (Scheme 3.10). Interestingly, they reported that their o-
alkoxyphenyliminoiodanes were more reactive compared to Protasiewicz et al.’s 
soluble aryliminoiodanes. 
 
3.3 Synthesis of o-propoxyaryliminoiodanes 
 
As the synthesis of Ochiai et al.’s soluble aryliminobromane required special 
precautions due to the highly corrosive bromine trifluoride (BrF3), and 
Protasiewicz et al.’s soluble aryliminoiodanes required many steps to synthesize, 
we decided to investigate use of Yoshimura et al.’s o-alkoxyphenyliminoiodanes in 
flow aziridinations. Not only was their synthesis straightforward, these 
aryliminioiodanes were reported to be highly reactive. 
 
2-Iodophenol (333) was alkylated with 1-iodopropane to give 1-iodo-2-
propoxybenzene (338) (Scheme 3.11). We chose to synthesize the n-propoxy 
derivative as Yoshimura et al. reported the best yields in aziridinations with the 
aryliminoiodane derived from it.  
 
Scheme 3.10. Aziridination of alkenes with o-alkoxyphenyliminoiodanes. 
 
Scheme 3.11. Synthesis of ArI(OAc)2 339 from 2-iodophenol. 
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ArI 338 was then oxidized with commercially available 39% AcOOH in AcOH to 
give ArI(OAc)2 339. The use of H2O2 / Ac2O as reported in Yoshimura et al.’s 
original procedure was avoided as it was potentially more hazardous;256 this 
change led to a small reduction in yield. We managed to grow a single crystal of 
ArI(OAc)2 339, which confirms its structure (Figure 3.1); while Yoshimura et al. 
had reported the X- ray crystal structures of the other derivatives, they did not 
report one for 339. 
 
ArI(OAc)2 339 was reacted with a variety of sulfonamides RSO2NH2 to give a range 
of aryliminoiodanes ArI=NSO2R 340 – 343 (Scheme 3.12). 340 was previously 
synthesized by Yoshimura et al., but 341 – 343 are novel compounds.  
 
Figure 3.1. X-ray crystal structure of ArI(OAc)2 339. 
 
 
Scheme 3.12. Synthesis of ArI=NSO2R 340 – 343 from ArI(OAc)2 339. 
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Aryliminoiodanes 341 – 343 bear N-sulfonyl groups which should be easier to 
remove than tosyl groups from nitrogen.197, 257 The structure of 343 was confirmed 
by X-ray crystallography (Figure 3.2). 
 
PhI=NTs is insoluble in most organic solvents due to strong secondary 
intermolecular I···N interactions that gives rise to a polymeric structure.258-261 
Other than 341 which was only slightly soluble in CHCl3, all the iminioiodanes 
proved to be very soluble (Table 3.1). This is due to the interaction between the 
iodine centre and the alkoxy oxygen, which disrupts intermolecular interactions. 
The solubility of 343 is further enhanced by the additional intramolecular 
interaction between the pyridine nitrogen and the iodine centre.  
 
Figure 3.2. X-ray crystal structure of 343. 
Table 3.1. Solubilities of the aryliminoiodanes 340 – 343. 
    
250 mg cm−3 
(CH2Cl2) 
5 mg cm−3 
(CHCl3) 
22 mg cm−3 
(CH2Cl2) 
270 mg cm−3 
(CH2Cl2) 
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3.4 Optimization of conditions for aziridination of styrene with 340 
 
Our studies began with an investigation into the aziridination of styrene with 
ArI=NTs 340. The procedure reported by Yoshimura et al. involved use of Cu(OTf)2 
in a minimum volume of acetonitrile.255 However, this was found to be unsuitable 
for adapting to flow, as 340 has a low solubility in acetonitrile. Trial reactions were 
run under a variety of conditions and monitored by 1H NMR (Table 3.2). 
 
It was found that while the aziridination did not work in the absence of acetonitrile, 
340 could first be dissolved in CH2Cl2 before adding to a solution of styrene and 
catalyst in CD3CN. In the absence of catalyst, the aziridination did not work (entry 
1). Instead, 340 decomposed to give the sulfonamide, with about 10% of TsNH2 
formed (<90% 340 remaining) after 1 hour.  
Table 3.2. Optimization of conditions for aziridination of styrene by 340. 
 
Entry Catalyst (eq) Styrene (eq) 
Conversiona 
(%) 
1 − 10 0 
2 Cu(OTf)2 (0.1 eq) 10 76 
3 (pyr)4Cu(OTf)2 (0.1 eq) 10 85 
4 (pyr)4Cu(OTf)2 (0.1 eq) 2 63 
5 (pyr)4Cu(OTf)2 (0.1 eq) 5 79 
6 (pyr)4Cu(OTf)2 (0.05 eq) 10 61 
7 (pyr)4Cu(OTf)2 (0.2 eq) 10 86 
a Catalyst and styrene were dissolved in CD3CN; 1 eq of 340 was dissolved in CH2Cl2; the 
two solutions were mixed in a NMR tube; conversion was determined after 10 min by 1H 
NMR spectroscopy. 
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Cu(OTf)2 (0.1 eq) catalyzed the aziridination of styrene with 340 efficiently (entry 
2), but (pyr)4Cu(OTf)2 proved even better (entry 3). The optimum number of 
equivalents of styrene was 10 eq (entry 3), as decreasing it led to lower 
conversions (entries 4 and 5). Decreasing the number of equivalents of 
(pyr)4Cu(OTf)2 led to lower conversions (entry 6) but increasing it led to little 
improvement (entry 7). The optimized conditions for the aziridination of styrene 
with ArI=NTs 340 was 0.1 eq (pyr)4Cu(OTf)2, and 10 eq styrene (entry 3). 
 
3.5 Investigation into scope of alkene aziridination with aryliminoiodanes. 
 
With suitable conditions for the ArI=NTs 340 aziridination of styrene identified, 
we decided to test the aziridination of a range of alkenes with aryliminoiodanes 
340, 342, and 343 again under batch conditions before moving to flow (Table 3.3). 
 
When styrene was aziridinated with aryliminoiodanes 340, 342 and 343, 1H NMR 
indicated the corresponding aziridines were produced with good conversions 
within 10 min (entries 1 – 3). As the literature with PhI=NTs indicated that styrenic 
substrates tended to have similar reactivities, we focused our studies on aliphatic 
alkenes, which tended to be much more difficult to aziridinate.262-264 
 
Unfortunately, the results for the aziridination of aliphatic alkenes with 
aryliminoiodanes 340, 342 and 343 under our conditions were not especially 
encouraging. Our data revealed that 340 and 342 can aziridinate the extremely 
reactive norbornene within 10 min (entries 4 and 5), but 343 was ineffective 
(entry 6). This led us to focus our efforts into the aziridination of aliphatic alkenes 
with iminoiodanes 340 and 342.  
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Table 3.3. Batch aziridination of alkenes. 
 
Entry Alkene (eq) R Catalyst Conversion 
1  Ts (pyr)4Cu(OTf)2 84%; reaction complete. 
2  oNs (pyr)4Cu(OTf)2 81%; reaction complete. 
3  Xsa (pyr)4Cu(OTf)2 82%; reaction complete. 
4  Ts (pyr)4Cu(OTf)2 73%; reaction complete. 
5  oNs (pyr)4Cu(OTf)2 69%; reaction complete. 
6  Xsa (pyr)4Cu(OTf)2 
No reaction; ArI=NXs 343 
slowly decomposes. 
7  Ts (pyr)4Cu(OTf)2 
No reaction; ArI=NTs 340 
slowly decomposes. 
8  Ts Cu(OTf)2 
No reaction; ArI=NTs 340 
slowly decomposes. 
9  oNs (pyr)4Cu(OTf)2 
35% after 10 min, with 
ArI=NoNs 342 remaining. 
10  oNs Cu(OTf)2 
24% after 10 min, with 
ArI=NoNs 342 remaining. 
11  oNs (pyr)4Cu(OTf)2 47%; reaction complete. 
12  oNs (pyr)4Cu(OTf)2 
6% after 10 min, with 
ArI=NoNs 342 remaining. 
13  oNs (pyr)4Cu(OTf)2 
11% after 10 min, with 
ArI=NoNs 342 remaining. 
14  oNs (pyr)4Cu(OTf)2 
No reaction; ArI=NoNs 342 
slowly decomposes. 
15  oNs (pyr)4Cu(OTf)2 
No reaction; ArI=NoNs 342 
slowly decomposes. 
a Xs is 2-sulfonyl-5-methylpyridine. b Alkene and 0.1 eq catalyst were dissolved in CD3CN; 
arylimimoiodane was dissolved in CH2Cl2, and the two solutions mixed. c Measured by 1H 
NMR spectroscopy. 
Chapter 3: Aziridination of Alkenes and Subsequent Cascade Reactions in Flow 
106 
 
When the aziridination of cycloheptene with 340 was examined, there was no 
evidence for production of aziridine (entry 7). As Yoshimura et al. reported that 
cycloheptene could be aziridinated with ArI=NTs 340, we wondered if this could 
be because Cu(OTf)2 was better than (pyr)4Cu(OTf)2 at aziridinating aliphatic 
alkenes. Unfortunately, the aziridination still did not work with Cu(OTf)2 as 
catalyst under our conditions (entry 8). 
 
However, the aziridination of cycloheptene with ArI=NoNs 342 was more 
successful, with NMR indicating 35% conversion after 10 min with ArI=NoNs 342 
remaining (entry 9). When the number of equivalents of cycloheptene was 
increased to 20 equivalents (entry 11), the aziridination was complete, with 47% 
conversion into aziridine. Aziridination of cycloheptene with Cu(OTf)2 was less 
effective (entry 10). 
 
While NMR indicated traces of aziridine were formed in the aziridination of trans-
4-octene, we were unable to get acceptable yields even by increasing the number 
of equivalents of alkene (entries 12 and 13). The aziridination of 1-octene and 
allylacetate were unsuccessful using 20 equivalents of alkene with ArI=NoNs 342 
(entries 14 and 15). 
 
3.6 Continuous flow aziridination of alkenes 
 
Having identified the scope of these aziridinations in batch, we next applied the 
optimized conditions to the continuous flow aziridination of substituted styrenes, 
norbornene, and cycloheptene (Table 3.4). A modification of the glass micro-
reactor described in Chapter 2, Figure 2.7, was used; input C was blocked off to 
convert the three-input microreactor into a two-input microreactor.  
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Table 3.4. Aziridination of alkenes under continuous flow. 
 
Entry Alkene   ArI=NSO2R      Aziridine 
Yieldb 
(%) 
1    82 
2    70 (73c) 
3    68 
4    68 (68c) 
5    71 
6    77 
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Table 3.4. Aziridination of alkenes under continuous flow (continued). 
Entry Alkene ArI=NSO2R   Aziridine 
Yieldb 
(%) 
7 
 
  70 
8    46d 
9    79 
10    73 
11    76 
12    82 
a 1 eq ArI=NSO2R in CH2Cl2; 10 eq alkene and 0.1 eq (pyr)4Cu(OTf)2 in MeCN; the two-
input microreactor was used. b Isolated yields after chromatography. c The PTFE tubing 
flow reactor was used. d 20 eq of cycloheptene was used. 
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A custom built flow reactor constructed out of PTFE tubing could also be used 
instead of the glass microreactor, with similar yields obtained. A residence time of 
Rt = 10 min was appropriate, as prior NMR studies indicated that the reaction was 
complete in this timeframe. ArI=pNs 341 was not soluble enough to be used for 
aziridinations under continuous flow. 
 
ArI=NTs 340 was capable of aziridinating styrene (entry 1), 2-vinylnaphthalene 
(entry 2), 4-methylstyrene (entry 3), 3-methylstyrene (entry 4) and norbornene 
(entry 5) in good yields; all the products from the aziridination with 340 could 
easily be isolated by column chromatography without decomposition. 
 
Unfortunately for ArI=NoNs 342, we were unable to isolate the aziridines derived 
from aromatic alkenes other than 348 (entry 6). 1H NMR of these reaction mixtures 
indicated the formation of aziridine, but attempts to isolate and purify the 
aziridines by column chromatography were not successful. This leads us to 
conclude these aziridines are quite reactive, being unstable to column 
chromatography. However, this proved to be useful for the telescoped ring 
opening processes described in section 3.7, where these reactive aziridines 
derived from ArI=NoNs 342 and aromatic alkenes were directly ring opened in a 
cascade sequence. However, the aziridines derived from ArI=NoNs 342 and 
norbornene (entry 7) or cycloheptene (entry 8), were stable enough to be isolated 
by column chromatography. 
 
Aryliminoiodane 343 was capable of aziridinating aromatic alkenes effectively, 
and the aziridines derived from it could be isolated without decomposition in good 
yields (entries 9 – 12).  
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Through the use of aryliminoiodanes 340, 342, and 343, we have successfully 
achieved the flow aziridination of a range of alkenes in good yields (46 – 82%), 
through application of copper catalysis. Our flow processes are faster than those 
reported for related batch processes,58, 255 and proceed under very mild conditions. 
We think it is a significant advance on other flow aziridinations, being 
operationally straightforward, quick and rather general. 
 
3.7 Aziridination of alkenes and subsequent cascade reactions  
 
Next, we set about ascertaining if telescoped reactions could be undertaken in 
which the aziridine generated from the alkene could be directly ring opened 
without recourse to handling or isolation. We anticipated that this approach would 
be more general than our studies detailed in Chapter 2, as the alkene starting 
material and the iodoarene by-product would be rather inert and should not 
interfere in the subsequent telescoped step. This would be extremely useful in the 
case of aziridination of styrene derivatives with ArI=NoNs 342 as the o-nosyl 
protecting group makes the aziridine extremely reactive toward ring openings. 
 
For these cascade reactions, we used a custom built flow reactor constructed out 
of PTFE tubing; details of its construction are given in section 6.15. We used a 
residence time of 10 min for both the aziridination and ring opening steps, with 
the temperature at 21 °C. 5 equivalents of alkene were used in the telescoped 
process in order to reduce side reactions such as the polymerization by the acid 
catalyst (1.5 – 5.1 eq). Further optimization of the cascade process was not carried 
out as the reaction conditions were mild and rapid. Using these telescoped 
reactions, nucleophiles such as methanol, ethanol, benzyl alcohol, hydrogen 
chloride and acetonitrile could be used to ring open the aziridines (Table 3.5).  
Chapter 3: Aziridination of Alkenes and Subsequent Cascade Reactions in Flow 
111 
 
  
Table 3.5. Aziridination of alkenes and subsequent ring opening in flow. 
 
Entry Alkene ArI=NSO2R Nucleophileb Product 
Yieldc 
(%) 
1   MeOH  73 
2   BnOH  55 
3   HCl  55 
4   MeOH  64 
5   MeCN  71 
6   MeOH  67 
7   EtOH  56 
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Table 3.5. Aziridination of alkenes and subsequent ring opening in flow (continued). 
Entry Alkene    ArI=NSO2R Nucleophileb Product 
Yieldc 
(%) 
8 
 
 MeOH  71 
9   HCl  49 
10   MeOH  76 
11   EtOH  78 
12   MeCN  77 
13   MeOH  73 
14   HCl  58 
15   MeOH  48 
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Table 3.5. Aziridination of alkenes and subsequent ring opening in flow (continued). 
Entry Alkene ArI=NSO2R Nucleophileb Product 
Yieldc 
(%) 
16 
 
 MeOH  79 
17   BnOH  61 
18   MeCN  70 
19   MeOH  77 
20   HCl  52 
21   EtOH  61 
22   MeCN  74 
a 1 eq ArI=NSO2R in CH2Cl2; 5 eq alkene and 0.1 eq (pyr)4Cu(OTf)2 in MeCN. b H2SO4 in MeOH 
or EtOH; MsOH in BnOH; HCl in Et2O/CH2Cl2; BF3 in MeCN. c Isolated yields after 
chromatography. 
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Alcohols generally ring opened the aziridines derived from ArI=NoNs 342 in the 
telescoped flow process in high yields (entries 1, 2, 6 – 8, 10, 11, 13, 15 – 17, 19). 
The telescoped alcohol ring openings of aziridines derived from 343 had moderate 
yields (entries 4 and 21), perhaps because the pyridine nitrogen competes for the 
protonation, disfavouring activation of the aziridine nitrogen. Chloride ring 
openings gave moderate yields with the aziridines formed from both 
aryliminoiodanes 342 and 343 (entries 3, 9, 14, 20). 
 
Formal cycloadditions with acetonitrile were possible with in situ aziridines 
derived from 343 in good yields in general (entries 5, 12, 18, 22). Attempts to do 
the same chemistry using ArI=NoNs 342 were unsuccessful, possibly due to the 
imidazolines being more susceptible to hydrolysis due to the o-nosyl group, 
although this was not examined further. When nitriles other than MeCN were used 
as the solvent in the second step of the telescoped process to try and vary the C-2 
substituent, a mixture of imidazolines was obtained arising from presence of 
MeCN. Replacing acetonitrile with other nitriles in the initial aziridination step 
caused the aziridination to fail. 
 
The N-tosyl aziridines formed in situ from ArI=NTs 340 were not sufficiently 
reactive to undergo alcohol ring openings under our telescoped process (21 °C, Rt 
= 10 min, 1.5 – 5.1 eq H2SO4). Increasing the residence time for the ring opening 
step to 20 min did not lead to any improvement. Increasing the number of 
equivalents of H2SO4 (more than 20 eq) such that there was no more N-tosyl 
aziridine detected did not work either, as no ring opened product could be isolated. 
Increasing the temperature of the cascade process to 30 °C caused problems due 
to the boiling of CH2Cl2.  
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When the cascade sequence involving BF3/MeCN was tried with aziridines derived 
from ArI=NTs 340, no imidazolines were isolated. 
 
A range of nitrogen nucleophiles such as ammonia in methanol, hydroxylamine, 
benzylamine, dimethylamine, diethylamine, and aniline were tried in the cascade 
process with ArI=NoNs 342 and ArI=NSO2R 343, but it was not possible to isolate 
any ring opened product from the reaction mixture. 
 
Complete regioselectivity was observed in all products by analysis of the crude 1H 
NMR spectra. In the case of the alcohol ring openings, attack of the alcohol at the 
benzylic position was confirmed by HMBC three-bond couplings, as described in 
section 2.8. Alcohol and chloride ring openings showed COSY three-bond couplings 
between the NH and NCH2. Additionally, the X-ray crystal structure of 363 
provided further evidence for the observed regiochemistry (Figure 3.3). 
 
In the case of formal [3+2] cycloadducts with acetonitrile, the regioselectivity 
proposed is consistent with the NMR data presented in section 2.9. In particular, 
the 1H NMR spectra of products 359, 366, 372 and 376 had characteristic ArCH 
peaks at around 5 ppm and two signals for CHH and CHH at 3 – 4 ppm.  
 
Figure 3.3. X-ray crystal structure of 363. 
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3.8 Conclusions 
 
We have synthesized a series of aryliminoiodanes 340 – 343 in 3 steps from 2-
iodophenol. Of these, ArI=NTs 340 is known, while ArI=NSO2R 341 – 343 are 
novel. Using these aryliminoiodanes, we identified efficient conditions for the 
aziridination of a wide range of alkenes. The high solubility of these 
aryliminoiodanes enabled them to be successfully used in flow for the first time, 
and 12 aziridines were synthesized under continuous flow with good yields. 
 
The mild and clean conditions for these aziridinations with few side products 
enabled them to be combined with further ring opening or formal cycloadditions. 
A variety of alkenes were aziridinated and the in situ aziridines directly reacted 
with various nucleophiles, in telescoped flow processes. This telescoped flow 
process enabled the synthesis of a range of nitrogen containing molecules (22 
examples) directly from the alkene, without having to isolate and purify the 
intermediate aziridine. This is very useful in cases where the aziridines formed are 
highly reactive and difficult to isolate, such as 2-aryl N-oNs aziridines, or are 
potentially hazardous. 
 
The work discussed in this chapter was published in Organic Letters in 2016.265 
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4.1 Introduction 
 
The use of phenyliminoiodanes PhI=NSO2R in asymmetric aziridinations with 
transition metal catalysts and chiral ligands has been thoroughly investigated over 
the past two decades60-63, 266 as detailed in Chapter 1. 
 
Whilst there have been a number of studies exploring variation in the R group of 
PhI=NSO2R in asymmetric aziridinations,59, 267 fewer studies have examined the 
impact of changing the aryl group of N-tosyl aryliminoiodanes ArI=NTs. This is 
because it is widely believed that the nitrene source is fully dissociated from the 
iodoarene in the transition state.268-269 One study by Jacobsen et al. showed that ee 
was unchanged if the aryl group was changed (Scheme 4.1).270 
 
Evidence for a fully dissociated nitrene intermediate was provided by Au et al., in 
which the bis(tosyl)imidoruthenium (VI) porphyrin complex 377 was shown to 
effect the stoichiometric aziridination of various alkenes.268-269  
 
Scheme 4.1. Asymmetric aziridination with different N-tosyl aryliminoiodanes. 
 
Figure 4.1. Bis(tosyl)imidoruthenium (VI) porphyrin complex 377. 
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In 2006, Zdilla et al. reported that in aziridinations catalysed by MnIII(TPFC), the 
MnIII(nitrenoid) complex was still associated with the iodoarene, as evidenced by 
double labelling experiments (Scheme 4.2).254 MnIII(TPFC) was reacted with 
aryliminoiodane 378 to give the MnV(imido) complex 379. 379 was not able to act 
as a stoichiometric reagent in the aziridination of styrene, but was able to catalyse 
aziridination of styrene with aryliminoiodanes. 379 was reacted with a different 
aryliminoiodane ArI=NTs 328, and then reacted with styrene, giving only aziridine 
253. This strongly suggests that the nitrenoid intermediate 382 was still bound to 
the iodoarene. If the iodoarene was fully dissociated, as in 380, a 1:1 mixture of 
381 and 253 would have been expected. Crucially, when the order of arylimino-
iodanes 328 and 378 was switched, only 381 was formed, which further confirms 
that the iodoarene is still attached to the nitrenoid during aziridination.  
 
Scheme 4.2 Zdilla et al.’s double labelling experiment. 
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Thus, with some evidence that the iodoarene is still attached to the nitrenoid in 
MnIII(TPFC) catalysed aziridinations, we were interested to see if the o-propoxy 
substituent of ArI=NTs 340 would lead to any difference in asymmetric or 
diastereoselective aziridinations compared to PhI=NTs. The increased solubility of 
ArI=NTs 340 compared with PhI=NTs might also have an impact in the selectivity 
of such stereocontrolled aziridinations. 
 
4.2 Enantioselective aziridination of styrene 
 
PhI=NTs was synthesized from PhI(OAc)2 according to the published method 
(Scheme 4.3).55 Jacobsen’s chiral ligand 67 was synthesized from (1R,2R)-
cyclohexane-1,2-diamine, using Jacobsen et al.’s procedure (Scheme 4.4).60 
 
Using PhI=NTs, ArI=NTs 340, Jacobsen’s chiral diimine ligand 67, and 
commercially available Evan’s chiral bis(oxazoline) ligand 383, the asymmetric 
aziridination of styrene was investigated under a range of different batch 
conditions (Table 4.1). Most of the reactions were run in acetonitrile as solvent. 
Enantiomeric excess (ee) was determined by chiral HPLC.246  
 
Scheme 4.3. Synthesis of PhI=NTs 
 
Scheme 4.4. Synthesis of Jacobsen’s chiral diimine ligand. 
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Using Evan’s chiral bis(oxazoline) ligand 383, CuII(OTf)2 and PhI=NTs at 0 °C, the 
reaction was complete within 1.5 h, with 73% yield and 10% ee (entry 1). Changing 
the catalyst from CuII to CuI did not make much difference to the rate, yield or 
enantioselectivity (entry 2). Changing the aryliminoiodane from PhI=NTs to 
ArI=NTs 340 increased the rate of reaction (complete within 0.5 h) with a similar 
yield, but the ee was increased to 30% (entry 3).  
Table 4.1. Investigation into enantioselective aziridinations with styrene. 
 
Entry ArI=NTs Catalyst Ligand 
Temperature 
(°C) 
Reaction timea 
(h) 
Yieldb and ee 
1 PhI=NTs Cu(OTf)2 383 0 1.5 73%; 10% ee 
2 PhI=NTs Cu(OTf) 383 0 1.5 72%; 10% ee 
3 340 Cu(OTf)2 383 0 0.5 76%; 30% ee 
4 340 Cu(OTf) 383 0 0.5 74%; 29% ee 
5 340 Cu(OTf)2 383 −40 → 0 2 54%; 30% ee 
6c PhI=NTs Cu(OTf)2 383 0 3 67%; 9% ee 
7c 340 Cu(OTf)2 383 0 1 68%; 9% ee 
8 PhI=NTs Cu(OTf)2 67 0 2 77%; 38% ee 
9 PhI=NTs Cu(OTf) 67 0 2 75%; 37% ee 
10 340 Cu(OTf)2 67 0 0.5 73%; 37% ee 
11 340 Cu(OTf) 67 0 0.5 75%; 37% ee 
a Time taken for all the ArI=NTs to dissolve. b Isolated yield after chromatography. c Reaction was run 
in styrene as solvent. 
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When CuII was changed to CuI with aryliminoiodane 340, there was no significant 
change to rate, yield or ee (entry 4). 
 
The lack of difference in asymmetric induction (ee) between CuII and CuI is 
consistent with the literature for asymmetric aziridinations suggesting the 
oxidation state of the copper is the same in the transition state.62 However, the 
difference in ee between PhI=NTs and ArI=NTs 340 was encouraging, and suggests 
that the active nitrene species is at least partially bound to the iodoarene in the 
transition state. As the difference in ee was counter to the findings of Jacobsen et 
al., albeit with different catalyst (Scheme 4.1), entries 1 and 3 were run multiple 
times, with ArI=NTs 340 giving a consistently higher ee (29 – 30%) compared to 
PhI=NTs (9 – 10%). 
 
Unfortunately, attempts to improve the enantioselectivity were unsuccessful with 
Cu(OTf)2 and Evans’ bis(oxazoline) ligand 383. Decreasing the temperature to −40 
°C with ArI=NTs 340 caused the reaction to slow down drastically, and the 
aziridination only occurred upon warming to 0 °C, with a lower yield but similar 
ee (entry 5). Using styrene as solvent, slightly lower yields were obtained with 
both PhI=NTs and ArI=NTs 340, but the ee for both iminoiodanes were now the 
same (9%) (entries 6 and 7). We were unable to achieve enantioselectivies as high 
as that reported in the literature with ligand 383 (lit. 63% ee).59, 62 This might be 
due to trace contaminants in ligand 383 or copper catalysts.  
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However, when the chiral ligand was changed to Jacobsen’s chiral diimine ligand 
67, similar yields and ee were obtained for both PhI=NTs and ArI=NTs 340 
(entries 8 – 11). These results suggest that with Jacobsen’s diimine ligand 67, the 
iodoarene is completely dissociated from the active nitrene species. Jacobsen et 
al.270 obtained 39 – 43% ee for the asymmetric aziridination of styrene with N-
tosyl aryliminoiodanes, which is similar to the values we obtained (37 – 38%). 
 
The initial results obtained with 383 are interesting from a mechanistic point of 
view, as copper-nitrene intermediates have been thought to be totally dissociated 
from the iodoarene species. Unfortunately, due to time constraints, we were 
unable to investigate other chiral ligands and transition metal catalysts to explore 
these findings further. 
 
4.3 Diastereoselective aziridination of 2-phenyl-2H-chromene 
 
As the copper catalyzed enantioselective aziridinations of styrene with PhI=NTs 
and ArI=NTs 340 were inconclusive, we decided to investigate diastereoselective 
aziridinations with Mn(TPFC). Zdilla et al. had shown that with Mn(TPFC), the 
iodoarene is still attached to the nitrene source.254 It was hoped that by using an 
alkene with a chiral centre, aziridination would be favoured from the less hindered 
face of the alkene, and that interactions from the bulkier iodoarene in ArI=NTs 340 
would enhance this selectivity. A further advantage of exploring diastereocontrol 
is that the catalyst system is more straightforward to assemble, with fewer 
experimental variables.  
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Mn(TPFC) is known to be an effective catalyst in the aziridination of aromatic but 
not aliphatic alkenes.254 As there were not many reports on diastereoselective 
aziridinations of aromatic alkenes, we explored the literature on diastereo-
selective epoxidations of aromatic alkenes. Day et al. reported that various 2-
substituted 2H-chromenes could be diastereoselectively epoxidized from the less 
hindered face.271 Of the various 2H-chromenes epoxidized, 2-phenyl-2H-chromene 
was the most shelf-stable and straightforward to synthesize. Thus, we choose to 
investigate the diastereoselective aziridination of 2-phenyl-2H-chromene (386). 
 
2-Phenyl-2H-chromene (386) was synthesized by adaptation of a literature 
method.272 Chalcone 384 was reduced with NaBH4 to give alcohol 385, which was 
then immediately cyclized to give chromene 386 (Scheme 4.5). 
 
Mn(TPFC) was synthesized by a modification of a literature procedure.273-275 
Pentafluorobenzaldehyde and pyrrole were first reacted with TfOH and DDQ to 
give tris(pentafluorophenyl)corrole 387, which was reacted directly with 
Mn(OAc)2 to give MnIII(TPFC) (Scheme 4.6).  
 
Scheme 4.5. Synthesis of 2-phenyl-2H-chromene. 
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A number of different conditions were examined for the aziridination of chromene 
386 with PhI=NTs and ArI=NTs 340 (Table 4.2). Unfortunately, the highest yield 
was only 5%, and was obtained with Cu(OTf)2 and PhI=NTs in acetonitrile (entry 
1). The rest of the reaction mixture consisted of TsNH2 and unidentifiable 
compounds. 
 
Use of ArI=NTs 340 increased the rate of reaction but the yield was similar to 
PhI=NTs (entry 2). Lowering the temperature from 0 °C to −20 °C with ArI=NTs 
340 caused the reaction to slow down and the yield to drop (entry 3). 
Unfortunately, it was not possible to accurately determine the diastereoselectivity 
of these reactions as the crude 1H NMR spectra were extremely complex. 
 
When 0.01 eq of Mn(TPFC) was used, no aziridine was formed with either PhI=NTs 
(entry 4) or ArI=NTs 340 (entry 5). Increasing the amount of Mn(TPFC) to 0.04 eq 
did not make any difference (entry 6). Changing the solvent to chlorobenzene, 
benzene, or chloroform also did not work (entries 7 – 9).  
 
Scheme 4.6. Synthesis of Mn(TPFC). 
Chapter 4: Stereocontrolled Aziridinations with N-tosyl Aryliminoiodanes 
126 
 
  
Table 4.2. Aziridination of 2-phenyl-2H-chromene (386). 
 
Entry ArI=NTs Catalyst (eq) Solvent Yielda; reaction timeb 
1 PhI=NTs CuII(OTf)2 (0.1 eq) MeCN 5%; 3 h. 
2 340 CuII(OTf)2 (0.1 eq) MeCN 4%; 0.5 h. 
3c 340 CuII(OTf)2 (0.1 eq) MeCN 2%; 3 h. 
4 PhI=NTs MnIII(TPFC) (0.01 eq) MeCN −d 
5 340 MnIII(TPFC) (0.01 eq) MeCN −d 
6 340 MnIII(TPFC) (0.04 eq) MeCN −d 
7 PhI=NTs MnIII(TPFC) (0.01 eq) PhCl −d 
8 PhI=NTs MnIII(TPFC) (0.01 eq) PhH −d 
9 PhI=NTs MnIII(TPFC) (0.01 eq) CHCl3 −d 
10e PhI=NTs MnIII(TPFC) (0.04 eq) 386 −d 
11e 340 MnIII(TPFC) (0.04 eq) 386 −d 
12 PhI=NTs CuICl(NHC) 388 (0.1 eq) PhCl −d 
13 PhI=NTs CuICl(NHC) 388 (0.1 eq) MeCN −d 
14 PhI=NTs (pyr)4CuII(OTf)2 (0.1 eq) MeCN 1%; 5 h. 
15e PhI=NTs MnII(TPP)Cl (0.04 eq) 386 −d 
a Isolated yield after chromatography. b Time taken for ArI=NTs to complete dissolve. c Run 
at −20 °C. d No aziridine was detected; TsNH2 was formed. e Excess chromene 386 was used 
as solvent; 1 eq of ArI=NTs was used. 
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Using chromene 386 as solvent in the presence of 0.04 eq of Mn(TPFC) did not 
work with both PhI=NTs (entry 10) and ArI=NTs 340 (entry 11). 
 
CuICl(NHC) catalyst 388 has been shown by Xu et al. to be an effective catalyst in 
aryliminoiodane aziridinations for both aliphatic and aromatic alkenes.264 
However, CuICl(NHC) 388 was not able to effect the aziridination of chromene 386 
with PhI=NTs in chlorobenzene or acetonitrile (entries 12, 13). When 
(pyr)4Cu(OTf)2 was used, the reaction was complete in 5 h, but the yield obtained 
was very low (entry 14). MnII(TPP)Cl was also unsuccessful in effecting 
aziridination of chromene 386 (entry 15). 
 
The results in Table 4.2 suggest that 2-phenyl-2H-chromene (386) is not a good 
substrate for aziridination, which might be due to the steric bulk of the phenyl 
substituent. Moreover, the hydrogen at the 2-position of the chromene 386 is also 
both allylic and benzylic, making 386 prone to decomposition pathways involving 
hydrogen atom abstraction.276 In most cases, the N-tosyl aryliminoiodanes and 
386 decomposed to give TsNH2 and unidentified substances (black tar). However, 
sufficient amount of aziridine 389 was obtained in order to grow a single crystal 
suitable for X-ray diffraction, which confirmed the relative trans geometry 
between the aziridine ring and the phenyl substituent (Figure 4.2). Due to time 
constraints, we were unable to investigate the diastereoselective aziridination of 
other alkenes with Mn(TPFC).  
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4.4 Conclusions 
 
Stereocontrolled aziridinations with PhI=NTs and ArI=NTs 340 were attempted. 
With styrene, asymmetric reactions catalysed by copper and Evans’ chiral 
bis(oxazoline) ligand 383 in MeCN showed higher enantioselectivity (29 – 30% ee) 
with ArI=NTs 340 compared to PhI=NTs (9 – 10%). However, upon changing to 
Jacobsen’s chiral diimine ligand 67, both aryliminoiodanes gave the same 
enantioselectivity (37 – 38% ee). This might suggest that depending on conditions, 
the active nitrene intermediate may or may not be bound to the iodoarene. 
 
Attempts to use Mn(TPFC) to see if the iodoarene of the aryliminoiodane had any 
influence on diastereoselective aziridination of 2-phenyl-2H-chromene (386) 
proved unsuccessful. However, a small amount of aziridine 389 was obtained from 
the Cu(OTf)2 catalysed aziridination of 2-phenyl-2H-chromene with PhI=NTs, from 
which a single crystal was grown. X-ray diffraction of 389 showed that the phenyl 
substituent was trans to the aziridine ring. 
 
Figure 4.2. X-ray crystal structure of aziridine 389. 
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5.1 Key findings 
 
This chapter gives a summary of the key findings from Chapters 2 – 4. Using 
continuous flow methodology, aziridine 392 can be synthesized in moderate to 
good yield from 1,2-amino alcohol 390 and a suitable sulfonylating agent 391 
(Scheme 5.1). Alternatively, aziridination of alkene 393 with soluble o-
propoxyaryliminoiodane 394 under continuous flow can also give similar 
aziridine 392 (Scheme 5.2). Both these methods have their own unique 
advantages. The synthesis of aziridines from 1,2-amino alcohols allows chiral 
aziridines to be synthesized if the 1,2-amino alcohol itself is chiral; the 
aziridination of alkenes has a shorter residence time with higher yields, and the 
starting alkenes are more readily available.  
 
Scheme 5.1. Continuous flow synthesis of aziridines from 1,2-amino alcohols. 
 
Scheme 5.2 Continuous flow synthesis of aziridines from alkenes. 
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The ring opening reactions of aziridines using continuous flow methodology was 
also explored. Various nucleophiles such as alcohols, halides, and arenes can be 
used to ring open aziridine 392 with excellent regioselectivity and good yields 
(Scheme 5.3). 
 
2-Aryl aziridine 396 can also undergo BF3 catalysed formal [3+2] cycloadditions 
with nitriles to give the imidazoline 397 under continuous flow conditions 
(Scheme 5.4). This method gives moderate to high yields with complete 
regioselectivity. 
 
The continuous flow processes in Schemes 5.1 and 5.2 could be directly coupled 
together with those in Schemes 5.3 or 5.4. This allows the aziridine to be directly 
reacted with nucleophiles without having to isolate the aziridine intermediate. 
Starting from 1,2-amino alcohol 398, the aziridine intermediate 399 was directly 
reacted with various nucleophiles to give 400 or 401 (Scheme 5.5). Ms2O is 
required to prevent competitive ring opening by chloride anion from RSO2Cl.  
 
Scheme 5.3. Continuous flow ring opening of aziridines. 
 
Scheme 5.4. Continuous flow [3+2] cycloadditions with 2-arylaziridines. 
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Alternatively, alkene 402 can be aziridinated by ArI=NSO2R 394 to give in situ 
aziridine 403, which can then be directly reacted with various nucleophiles 
(Scheme 5.6). This method gives higher yields and has a broader substrate scope 
compared to the method in Scheme 5.5. It was shown that aziridines that are 
difficult to isolate, such as highly reactive N-oNs aziridines, can be used in this 
chemistry. 
 
We believe that the methods outlined above provide the most general routes 
currently available to the generation and ring opening reactions of aziridines 
under continuous flow conditions.  
 
Scheme 5.5. Continuous flow telescoped process from 1,2-amino alcohols. 
 
Scheme 5.6. Continuous flow telescoped process from alkenes. 
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The asymmetric aziridination of styrene with chiral ligands 67 and 383 was 
investigated with aryliminoiodanes PhI=NTs and 340 (Scheme 5.7). Interestingly, 
chiral ligand 383 gave higher enantioselectivity with ArI=NTs 340 (30% ee) 
compared with PhI=NTs. However, using chiral ligand 67, the enantioselectivity 
for both aryliminoiodanes PhI=NTs and 340 was very similar (37 – 38% ee). This 
suggests that depending on the chiral ligand, the aryl group may still be associated 
with the active nitrene intermediate. 
 
We also attempted the diastereoselective aziridination of 2-phenyl-2H-chromene 
(386) with different aryliminoiodanes PhI=NTs and 340. Unfortunately, this was 
unsuccessful, and we only managed to obtain a small amount of aziridine 389 
using PhI=NTs and Cu(OTf)2 (Scheme 5.8). Diastereoselectivity could not be 
accurately determined due to the low yield, as well as large amounts of TsNH2 and 
unidentified compounds produced in the reaction mixture.  
 
Scheme 5.7. Asymmetric aziridination of styrene under different conditions. 
 
Scheme 5.8. Aziridination of 2-phenyl-2H-chromene. 
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5.2 Future work 
 
The synthesis of aziridines from 1,2-amino alcohols under continuous flow 
conditions could be further improved by moving to supported reagents. For 
example, 1,2-amino alcohol 390 and sulfonylating agent 391 could be flowed 
through polymer supported DMAP and NEt3 to give aziridine 392 with less need 
for purification219 (Scheme 5.9). The process described in Scheme 5.9 could be 
directly linked to a further ring opening step. This would have a benefit over the 
process in Scheme 5.5 as less acid is needed in the ring opening step as there would 
be no free NEt3 in solution. 
 
Supported reagents can also be applied to the aziridination of alkenes. The use of 
supported copper catalysts would be an obvious extension.277 For example, if 
chiral ligand 67 could be immobilized, it would be capable of chelating Cu(OTf)2 
catalyst, and would enable asymmetric aziridinations in flow (Scheme 5.10).  
 
Scheme 5.9. Future work involving polymer supported DMAP and NEt3. 
 
Scheme 5.10. Future work with polymer supported copper catalysts. 
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Investigation into the diastereoselective aziridinations of other chromenes 406 
could be carried out, in which the allylic and benzylic H has been replaced with a 
methyl group (Scheme 5.11). This should hopefully improve the yield of aziridine 
407 formed, and enable us to probe the impact of iodoarene structure on 
stereoselectivity. 
 
 
 
 
 
Scheme 5.11. Future work into diastereoselective aziridinations. 
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6.1 General Information. 
All batch reactions were performed under an atmosphere of dry nitrogen in oven 
dried glassware unless otherwise stated. Anhydrous solvents were purchased 
from Sigma-Aldrich in Sure/Seal™ bottles. All other solvents used were reagent 
grade and used as received. Commercially available starting materials were used 
without further purification unless otherwise stated. Column chromatography was 
carried out using Sigma-Aldrich 60 Å pore size, 40 – 64 μm particle size silica gel.  
 
Melting points were recorded on a Gallenkamp MPD350 apparatus. Infrared 
spectra were recorded on a Bruker Alpha Platinum ATR spectrometer. Low 
resolution mass spectra were recorded on an Agilent 6130B platform with 
electrospray ionization. High resolution mass spectra were obtained on a Bruker 
MicroTOF spectrometer. Optical rotations were measured on an Optical Activity 
AA-1000 Polarimeter. Enantiomeric excess (ee) was determined by chiral HPLC on 
an Agilent 1260 Infinity system. Single crystal X-ray diffraction data were obtained 
by Dr Guy Clarkson on an Oxford Diffraction Gemini XRD system. 
 
Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker 
Spectrospin DPX300 or HD300 (1H at 300 MHz and 13C at 75 MHz); Bruker 
Spectrospin DPX400 or HD400 (1H at 400 MHz and 13C at 100 MHz); or a Bruker 
Spectrospin HD500 (1H at 500 MHz and 13C at 125 MHz). Chemical shifts are 
reported in ppm using TMS as internal standard. Structures were assigned using 
COSY, HMQC and HMBC experiments. Peak multiplicities were recorded as singlet 
(s), doublet (d), triplet (t), quartet (q), quintet (quint), multiplet (m), and coupling 
constants (J) are reported in Hertz.  
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6.2 Experimental set-up of flow reactors used in 6.3 – 6.10. 
A custom flow system was assembled by connecting computer controlled 
Tricontinent C3000 syringe pumps278 to borosilicate glass microreactor modules 
purchased from Little Things Factory.279 Two different set-ups were used 
depending on whether the two-input or three-input configuration was required. 
The two-input microreactor was assembled from LTF-MX and LTF-V modules 
(total reaction volume = 2.0 cm3). The three-input reactor was a XXL-S-01 module 
(1.0 cm3 for first stage; 2.0 cm3 for second stage inclusive of extra tubing). For 
reactions performed above room temperature, the microreactor assembly was 
maintained at a constant temperature by immersion in a silicone oil bath heated 
on a hot plate stirrer (two-input configuration), or heated directly on the hotplate 
(three-input configuration).  
 
Figure 6.1: Two input microreactor setup. 
 
Figure 6.2: Three input microreactor setup. 
A B Out 
B A C 
out 
tubing 
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6.3 General method for the flow synthesis of aziridines from 1,2-amino 
alcohols. 
The 1,2-amino alcohol (0.50 mmol, 1 eq), base (NEt3 for reactions involving 
RSO2Cl; DBU for reactions involving Ms2O; 2.25 mmol, 4.5 eq) and DMAP (0.25 
mmol, 0.5 eq) were dissolved in CHCl3 (2.0 cm3) to produce solution A. RSO2Cl 
(1.25 mmol, 2.5 eq) was dissolved in CHCl3 (2.0 cm3), or Ms2O (1.25 mmol, 2.5 eq) 
in CHCl3/CH2Cl2 (1:1, 2.0 cm3), to give solution B. Solutions A and B were combined 
in the two-input microreactor (Figure 6.1.) maintained at 30°C using a 40 min 
residence time. 
 
The outlet stream was quenched into a stirred solution of saturated aq NH4Cl for 
reactions involving RSO2Cl, or cooled with liquid nitrogen for reactions involving 
Ms2O. Upon completion of the run, additional quantities of CHCl3 were passed 
through the microreactor to ensure all the product was collected. For reactions 
involving RSO2Cl, the crude mixture was first extracted with CH2Cl2 (5 × 5 cm3), 
dried over MgSO4 and concentrated in vacuo. For reactions involving Ms2O, the 
frozen mixture was allowed to warm to room temperature and then concentrated 
in vacuo. The crude mixture was then purified by column chromatography (3:1; 
nhexane:EtOAc) to give: 
 
2-Phenyl-1-tosylaziridine, 253. Using 2-amino-2-
phenylethan-1-ol (69 mg, 0.50 mmol), Et3N (228 mg, 
2.25 mmol), DMAP (31 mg, 0.25 mmol) and TsCl (238 
mg, 1.25 mmol), 253 (100 mg, 73%) was produced as a clear oil. IR (film): 1596 
(C=C), 1323 (S=O), 1160 (S=O) cm−1; δH (500 MHz, CDCl3): 7.87 (2H, d, J = 8.3 Hz, 
ArH), 7.33 (2H, d, J = 8.3 Hz, ArH), 7.32 – 7.27 (3H, m, ArH), 7.24 – 7.20 (2H, m, 
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ArH), 3.78 (1H, dd, J = 4.5, 7.2 Hz, PhCH), 2.99 (1H, d, J = 7.2 Hz, CHH), 2.43 (3H, s, 
ArCH3), 2.39 (1H, d, J = 4.5 Hz, CHH); δC (125 MHz, CDCl3): 144.7 (C), 135.1 (C), 
135.0 (C), 129.8 (CH), 128.6 (CH), 128.3 (CH), 128.0 (CH), 126.6 (CH), 41.1 (CH), 
36.0 (CH2), 21.7 (CH3); m/z (ES+) 296 [MNa]+; HRMS (ES+) calcd. for C15H15NNaO2S 
[MNa]+: 296.0716, found: 296.0726. Using (S)-2-amino-2-phenylethan-1-ol, (S)-
253 is produced in >99% ee (Daicel Chiralcel OJ, hexane:iPrOH 7:3, 0.70 cm3/min, 
254 nm, 30°C), [𝛼]𝐷
27 +115.6 (c 0.106, CHCl3); literature value of [𝛼]𝐷
25 −108.6 (c 
0.950, CHCl3) for the (R) enantiomer.239 Data consistent with that reported in 
literature.19 
 
1-[(4-Nitrophenyl)sulfonyl]-2-phenyl aziridine, 
268. Using 2-amino-2-phenylethan-1-ol (69 mg, 
0.50 mmol), Et3N (228 mg, 2.25 mmol), DMAP (31 
mg, 0.25 mmol) and pNsCl (277 mg, 1.25 mmol), 268 (90 mg, 59%) was produced 
as a clear oil. IR (film): 1521 (C=C), 1350 (S=O), 1158 (S=O) cm−1; δH (300 MHz, 
CDCl3): 8.32 (2H, d, J = 8.9 Hz, ArH), 8.13 (2H, d, J = 8.9 Hz, ArH), 7.28 – 7.11 (5H, 
m, ArH), 3.84 (1H, dd, J = 4.6, 7.2 Hz, PhCH), 3.05 (1H, d, J = 7.2 Hz, CHH), 2.45 (1H, 
d, J = 4.6 Hz, CHH); δC (75 MHz, CDCl3): 150.1 (C), 143.3 (C), 133.5 (C), 128.6 (CH), 
128.2 (CH), 128.2 (CH), 125.9 (CH), 123.8 (CH), 41.3 (CH), 36.0 (CH2); m/z (ES+) 
327 [MNa]+; HRMS (ES+) calcd. for C14H12N2NaO4S+ [MNa]+: 327.0410, found: 
327.0410. Data consistent with that reported in literature.19 
 
1-Mesyl-2-phenylaziridine, 269. Using 2-amino-2-
phenylethan-1-ol (69 mg, 0.50 mmol), DBU (343 mg, 2.25 
mmol), DMAP (31 mg, 0.25 mmol) and Ms2O (218 mg, 1.25 
mmol), 269 (73 mg, 74%) was produced as a clear oil. IR (film): 1463 (C=C), 1302  
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(S=O), 1140 (S=O) cm−1; δH (300 MHz, CDCl3): 7.40 – 7.27 (5H, m, ArH), 3.72 (1H, 
dd, J = 4.4, 7.3 Hz, PhCH), 3.10 (3H, s, CH3), 2.98 (1H, d, J = 7.3 Hz, CHH), 2.44 (1H, 
d, J = 4.4 Hz, CHH); δC (75 MHz, CDCl3): 134.9 (C), 128.8 (CH), 128.6 (CH), 126.5 
(CH), 40.8 (CH), 39.8 (CH3), 35.5 (CH2); m/z (ES+) 220 [MNa]+; HRMS (ES+) calcd. 
for C9H11NNaO2S [MNa]+: 220.0403, found: 220.0400. Data consistent with that 
reported in literature.33 
 
2-(4-Chlorophenyl)-1-tosylaziridine, 270. 
Using 2-amino-2-(4-chlorophenyl) ethan-1-ol (86 
mg, 0.50 mmol), Et3N (228 mg, 2.25 mmol), DMAP 
(31 mg, 0.25 mmol) and TsCl (238 mg, 1.25 mmol), 
270 (112 mg, 73%) was produced as a clear oil. IR (film): 1594 (C=C), 1321 (S=O), 
1158 (S=O) cm−1; δH (300 MHz, CDCl3): 7.88 (2H, d, J = 8.3 Hz, ArH), 7.35 (2H, d, J = 
8.3 Hz, ArH), 7.28 (2H, d, J = 8.4 Hz, ArH), 7.17 (2H, d, J = 8.4 Hz, ArH), 3.75 (1H, dd, 
J = 4.4, 7.2 Hz, ArCH), 3.00 (1H, d, J = 7.2 Hz, CHH), 2.45 (3H, s, ArCH3), 2.36 (1H, d, 
J = 4.4 Hz, CHH); δC (75 MHz, CDCl3): 144.8 (C), 134.8 (C), 134.2 (C), 133.7 (C), 129.8 
(CH), 128.8 (CH), 128.0 (CH), 127.9 (CH), 40.3 (CH), 36.1 (CH2), 21.7 (CH3); m/z 
(ES+) 330 [MNa]+; HRMS (ES+) calcd. for C15H14ClNNaO2S [MNa]+: 330.0326, found: 
330.0322. Data consistent with that reported in literature.28 
 
2-(4-Chlorophenyl)-1-mesylaziridine, 271. Using 2-
amino-2-(4-chlorophenyl) ethan-1-ol (86 mg, 0.50 
mmol), DBU (343 mg, 2.25 mmol), DMAP (31 mg, 0.25 
mmol) and Ms2O (218 mg, 1.25 mmol), 271 (82 mg, 71%) 
was produced as a clear oil. IR (film): 1495 (C=C), 1149 (S=O) cm−1; δH (300 MHz, 
CDCl3): 7.32 (2H, d, J = 8.5 Hz, ArH), 7.23 (2H, d, J = 8.5 Hz, ArH), 3.68 (1H, dd, J = 
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4.4, 7.2 Hz, ArCH), 3.09 (3H, s, CH3), 2.95 (1H, d, J = 7.2 Hz, CHH), 2.38 (1H, d, J = 4.4 
Hz, CHH); δC (75 MHz, CDCl3): 134.5 (CCl), 133.5 (C), 129.0 (CH), 127.9 (CH), 39.9 
(CH or CH3), 39.8 (CH or CH3), 35.7 (CH2); m/z (ES+) 254 [MNa]+; HRMS (ES+) calcd. 
for C9H10ClNNaO2S [MNa]+: 254.0013, found: 254.0013. 
 
2-(Pentafluorophenyl)-1-tosylaziridine, 272. 
Using 2-amino-2-(pentafluorophenyl) ethan-1-ol 
(114 mg, 0.50 mmol), Et3N (228 mg, 2.25 mmol), 
DMAP (31 mg, 0.25 mmol) and TsCl (238 mg, 1.25 
mmol), 272 (140 mg, 77%) was produced as a clear oil. IR (film): 1501 (C=C), 1331 
(S=O), 1162 (S=O) cm−1; δH (500 MHz, CD2Cl2): 7.85 (2H, d, J = 8.3 Hz, ArH), 7.36 
(2H, d, J = 8.3 Hz, ArH), 3.79 (1H, dd, J = 4.5, 7.2 Hz, ArCH), 3.04 (1H, d, J = 7.2 Hz, 
CHH), 2.80 (1H, d, J = 4.5 Hz, CHH), 2.46 (3H, s, ArCH3); δC (75 MHz, CDCl3): 146.1 
(d, J = 247.7 Hz, CF), 145.3 (C), 141.3 (d, J = 250.7 Hz, CF), 137.6 (d, J = 252.9 Hz, 
CF), 134.1 (C), 129.9 (CH), 128.3 (CH), 108.9 (C), 32.5 (CH2), 31.9 (CH), 21.7 (CH3); 
m/z (ES+) 386 [MNa]+; HRMS (ES+) calcd. for C15H10F5NNaO2S [MNa]+: 386.0245, 
found: 386.0246. Data consistent with that reported in literature.28 
 
2-Mesityl-1-tosylaziridine, 273. Using 2-amino-2-
mesitylethan-1-ol (90 mg, 0.50 mmol), Et3N (228 
mg, 2.25 mmol), DMAP (31 mg, 0.25 mmol) and TsCl 
(238 mg, 1.25 mmol), 273 (62 mg, 39%) was 
produced as a clear oil. IR (film): 1598 (C=C), 1327 (S=O), 1156 (S=O) cm−1; δH (300 
MHz, CDCl3): 7.87 (2H, d, J = 8.3 Hz, ArH), 7.34 (2H, d, J = 8.3 Hz, ArH), 6.78 (2H, s, 
ArH), 3.85 (1H, dd, J = 4.7, 7.2 Hz, ArCH), 2.92 (1H, d, J = 7.2 Hz, CHH), 2.44 (3H, s, 
ArCH3), 2.30 (6H, s, ArCH3), 2.22 (3H, s, ArCH3), 2.15 (1H, d, J = 4.7 Hz, CHH); δC (75  
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MHz, CDCl3): 144.7 (C), 137.5 (C), 137.4 (C), 135.1 (C), 129.7 (CH), 129.2 (CH), 
128.4 (C), 128.3 (CH), 39.5 (CH), 35.5 (CH2), 21.7 (CH3), 20.8 (CH3), 20.1 (CH3); m/z 
(ES+) 338 [MNa]+; HRMS (ES+) calcd. for C18H21NNaO2S [MNa]+: 338.1185, found: 
338.1181. Data consistent with that reported in literature.28 
 
7 – [(4 – Nitrophenyl)sulfonyl] – 7 – azabicyclo[4.1.0] 
heptane, 275. Using trans-2-aminocyclohexan-1-ol (58 
mg, 0.50 mmol), Et3N (228 mg, 2.25 mmol), DMAP (31 
mg, 0.25 mmol) and pNsCl (277 mg, 1.25 mmol), 275 (96 
mg, 68%) was produced as a clear oil. IR (film): 1607 (C=C), 1346 (S=O), 1167 
(S=O) cm−1; δH (300 MHz, CDCl3): 8.39 (2H, d, J = 8.5 Hz, ArH), 8.15 (2H, d, J = 8.5 
Hz, ArH), 3.17 – 3.10 (2H, m, NCH), 1.90 – 1.75 (4H, m, CH2), 1.47 – 1.35 (2H, m, 
CH2), 1.31 – 1.20 (2H, m, CH2); δC (75 MHz, CDCl3): 150.5 (C), 144.9 (C), 128.9 (CH), 
124.3 (CH), 41.0 (CH), 22.7 (CH2), 19.3 (CH2); m/z (ES+) 305 [MNa]+; HRMS (ES+) 
calcd. for C12H14N2NaO4S [MNa]+: 305.0566, found: 305.0570. Data consistent with 
that reported in literature.280 
 
7–[(4–Chlorophenyl)sulfonyl]–7–azabicyclo[4.1.0] 
heptane, 276. Using trans-2-aminocyclohexan-1-ol 
(58 mg, 0.50 mmol), Et3N (228 mg, 2.25 mmol), DMAP 
(31 mg, 0.25 mmol) and 4-chlorobenzenesulfonyl chloride (264 mg, 1.25 mmol), 
276 (41 mg, 30%) was produced as a clear oil. IR (film): 2931 (C–H), 1332 (S=O), 
1158 (S=O) cm−1; δH (300 MHz, CDCl3): 7.89 (2H, d, J = 8.4 Hz, ArH), 7.52 (2H, d, J = 
8.4 Hz, ArH), 3.05 – 3.01 (2H, m, NCH), 1.84 – 1.76 (4H, m, CH2), 1.49 – 1.35 (2H, m, 
CH2), 1.30 – 1.17 (2H, m, CH2); δC (75 MHz, CDCl3): 139.1 (C), 136.9 (C), 128.7 (CH), 
128.4 (CH), 39.7 (CH), 22.1 (CH2), 18.7 (CH2); m/z (ES+) 294, 296 [MNa]+; HRMS 
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(ES+) calcd. for C12H14ClNNaO2S [MNa]+: 294.0326, found: 294.0331. Data 
consistent with that reported in literature.281 
 
2-Benzyl-1-tosylaziridine, 277. Using 2-amino-3-
phenylpropan-1-ol (76 mg, 0.50 mmol), Et3N (228 
mg, 2.25 mmol), DMAP (31 mg, 0.25 mmol) and TsCl 
(238 mg, 1.25 mmol), 277 (60 mg, 42%) was produced as a clear oil. IR (film): 
1595 (C=C), 1315 (S=O), 1156 (S=O) cm−1; δH (300 MHz, CDCl3): 7.60 (2H, d, J = 8.3 
Hz, ArH), 7.13 (2H, d, J = 8.3 Hz, ArH), 7.10 – 6.92 (5H, m, ArH), 2.91 – 2.82 (1H, m, 
BnCH), 2.73 (1H, dd, J = 5.1, 14.3 Hz, PhCHH), 2.63 (1H, d, J = 7.0 Hz, NCHH), 2.60 
(1H, dd, J = 7.3, 14.8 Hz, PhCHH), 2.34 (3H, s, ArCH3), 2.08 (1H, J = 4.4 Hz, NCHH); 
δC (75 MHz, CDCl3): 143.7 (C), 136.4 (C), 134.2 (C), 129.0 (CH), 128.1 (CH), 127.8 
(CH), 127.3 (CH), 125.9 (CH), 40.6 (CH), 36.9 (CH2), 32.2 (CH2), 21.0 (CH3); m/z 
(ES+) 310 [MNa]+; HRMS (ES+) calcd. for C16H17NNaO2S [MNa]+: 310.0872, found: 
310.0877. Data consistent with that reported in literature.282 
 
2-Methyl-1-tosylaziridine, 278. Using 2-aminopropan-1-
ol (38 mg, 0.51 mmol), Et3N (228 mg, 2.25 mmol), DMAP (31 
mg, 0.25 mmol) and TsCl (238 mg, 1.25 mmol), 278 (55 mg, 
51%) was produced as a clear oil. IR (film): 1317 (S=O), 1156 (S=O) cm−1; δH (300 
MHz, CDCl3): 7.82 (2H, d, J = 8.3 Hz, ArH), 7.34 (2H, d, J = 8.3 Hz, ArH), 2.88 – 2.77 
(1H, m, CHMe), 2.61 (1H, d, J = 7.0 Hz, CHH), 2.44 (3H, s, ArCH3), 2.03 (1H, d, J = 4.6 
Hz, CHH), 1.25 (3H, d, J = 5.6 Hz, CH3); δC (75 MHz, CDCl3): 144.7 (C), 135.5 (C), 
129.9 (CH), 128.0 (CH), 36.1 (CH), 35.0 (CH2), 21.9 (CH3), 17.0 (CH3); m/z (ES+) 234 
[MNa]+; HRMS (ES+) calcd. for C10H13NNaO2S [MNa]+: 234.0559, found: 234.0565. 
Data consistent with that reported in literature.282  
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6.4 Flow synthesis of 2,2-dimethyl-1-tosylaziridine, 282. 
2-Amino-2-methylpropan-1-ol (45 mg, 0.50 mmol, 1 eq) 
and DMAP (128 mg, 1.05 mmol, 2.1 eq) were dissolved in 
CHCl3 (2.0 cm3) to give solution A. TsCl (200 mg, 1.05 mmol, 
2.1 eq) was dissolved in CHCl3 (2.0 cm3) to give solution B. DBU (343 mg, 2.25 
mmol, 4.5 eq) was dissolved in CHCl3 (4.0 cm3) to give solution C. These solutions 
were combined in the three-input microreactor (Figure 6.2). The syringe pump 
additions were adjusted to give a 15 min residence time for the initial combination 
of solutions A and B; and a further 15 min residence time upon addition of solution 
C. The outlet stream was quenched into a stirred solution of saturated aq NH4Cl. 
Upon completion of the run, additional quantities of CHCl3 were passed through 
the microreactor to ensure all the product was collected. The resulting mixture 
was extracted with CH2Cl2 (5 × 5 cm3), the combined organic extracts dried over 
MgSO4, and solvent removed in vacuo. Purification by column chromatography 
(3:1; nhexane:EtOAc) gave 282 (41 mg, 36%) as a clear oil. IR (film): 1596 (C=C), 
1302 (S=O), 1155 (S=O) cm−1; δH (500 MHz, CDCl3): 7.83 (2H, d, J = 8.3 Hz, ArH), 
7.31 (2H, d, J = 8.3 Hz, ArH), 2.44 – 2.42 (5H, m, ArCH3 and CH2), 1.54 (6H, s, CH3); 
δC (125 MHz, CDCl3): 143.8 (C), 138.1 (C), 129.5 (CH), 127.3 (CH), 47.9 (C), 42.0 
(CH2), 22.9 (CH3), 21.6 (CH3); m/z (ES+) 226 [MH]+; HRMS (ES+) calcd. for 
C11H16NO2S [MH]+: 226.0896, found: 226.0894.  
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6.5 Flow synthesis of 2,2-dimethyl-1-(mesyl)aziridine, 283. 
2-Amino-2-methylpropan-1-ol (45 mg, 0.50 mmol, 1 eq) and 
DMAP (128 mg, 1.05 mmol, 2.1 eq) were dissolved in CHCl3 (2.0 
cm3) to give solution A. Ms2O (183 mg, 1.05 mmol, 2.1 eq) was 
dissolved in CHCl3/CH2Cl2 (1:1, 2.0 cm3) to give solution B. DBU (343 mg, 2.25 
mmol, 4.5 eq) was dissolved in CHCl3 (4.0 cm3) to give solution C. These solutions 
were combined in the three-input microreactor (Figure 6.2). The syringe pump 
additions were adjusted to give a 15 min residence time for the initial combination 
of solutions A and B; and a further 15 min residence time upon addition of solution 
C. The outlet stream was cooled with liquid N2 to inhibit further reaction. Upon 
completion of the run, additional quantities of CHCl3 were passed through the 
microreactor to ensure all the product was collected. The crude mixture was 
purified by column chromatography (3:1; nhexane:EtOAc) to give 283 (25 mg, 
34%) as a clear oil. IR (film): 1304 (S=O), 1149 (S=O) cm−1; δH (500 MHz, CDCl3): 
3.06 (3H, s, SO2CH3), 2.44 (2H, s, CH2), 1.53 (6H, s, C(CH3)2); δC (125 MHz, CDCl3): 
47.0 (C), 42.2 (CH3), 42.0 (CH2), 22.8 (CH3); m/z (ES+) 172 [MNa]+; HRMS (ES+) 
calcd. for C5H11NNaO2S [MNa]+: 172.0403, found: 172.0403.  
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6.6 Large scale batch synthesis of 2-phenyl-1-tosylaziridine, 253. 
NaNTsCl·3H2O (16.5 g, 58.6 mmol, 1.2 eq) and nBu4NBr 
(1.59 g, 4.93 mmol, 0.1 eq) were dissolved in H2O (75 
cm3). CH2Cl2 (100 cm3) was then added, and to this 
mixture was added styrene (5.09 g, 48.9 mmol, 1 eq) 
and I2 (1.25 g, 4.92 mmol, 0.1 eq). The mixture was stirred for 24 h at r.t. An orange-
brown mixture/ emulsion was obtained immediately. After 24 h, Na2S2O3 (2.50 g, 
15.8 mmol, 0.3 eq) was added. After 15 min, the mixture was extracted with CH2Cl2 
(4 × 100 cm3). The combined organic layers were washed with saturated aq NaCl 
(200 cm3), dried with MgSO4, filtered, and the solvent removed in vacuo to give a 
yellow oil. Recrystallization from nhexane gave 253 (6.37 g, 48%) as off-white 
crystals. M.p. 90 – 93 °C. Other data as previously reported.33 
 
6.7 Large scale batch synthesis of 7-tosyl-7-azabicyclo[4.1.0]heptane, 274. 
Cyclohexene (4.06 g, 49.4 mmol, 1 eq) was dissolved in 
CH2Cl2 (25 cm3). To the solution was added H2O (75 cm3). 
NaNTsCl·3H2O (16.7 g, 59.3 mmol, 1.2 eq), I2 (1.25 g, 4.92 
mmol, 0.1 eq), and nBu4NBr (1.59 g, 4.93 mmol, 0.1 eq) were added, and the 
mixture stirred for 24 h at r.t. A brownish-orange suspension formed immediately. 
After 24 h, the mixture was extracted with CH2Cl2 (4 × 100 cm3). The combined 
organic layers were washed with saturated aq Na2S2O3 (200 cm3), then saturated 
aq NaCl (200 cm3), dried with MgSO4, filtered and the solvent removed in vacuo. 
The resulting oil was purified by column chromatography (5:1 nhexane:EtOAc), 
then recrystallized (nhexane) to give 274 (4.48 g, 36%) as pure white crystals. M.p. 
57 – 58 °C. IR (film): 2939 (C–H), 1597 (C=C), 1320 (S=O), 1156 (S=O) cm−1; δH 
(300 MHz, CDCl3): 7.82 (2H, d, J = 8.3 Hz, ArH), 7.33 (2H, d, J = 8.3 Hz, ArH), 2.97 
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(2H, t, J = 1.3 Hz, NCH), 2.44 (3H, s, ArCH3), 1.85 – 1.76 (4H, m, CH2), 1.44 – 1.17 
(4H, m, CH2); δC (75 MHz, CDCl3): 144.0 (C), 135.8 (C), 129.6 (CH), 127.6 (CH), 39.8 
(CH), 22.8 (CH2), 21.6 (CH3), 19.4 (CH2); m/z (ES+) 274 [MNa]+; HRMS (ES+) calcd. 
for C13H17NNaO2S [MNa]+: 274.0872, found: 274.0874. Data consistent with that 
reported in literature.281 
 
6.8 General method for the ring opening of aziridines in flow. 
The aziridine (0.50 mmol, 1 eq) in solvent A (2.0 cm3) was reacted with the 
nucleophile and catalyst dissolved in solvent B (2.0 cm3) using the two-input 
microreactor (Figure 6.1) maintained at the stated temperature with a 40 min 
residence time. The outlet stream was quenched into saturated aq NaHCO3 
solution. Upon completion of the run, additional quantities of the solvents were 
passed through the microreactor to ensure all the product was collected. The 
mixture was extracted with CH2Cl2 (5 × 5 cm3), the combined organic extracts dried 
over MgSO4, and solvent removed in vacuo. Purification by column 
chromatography gave the following products: 
 
N-(2 –Chloro - 2- phenylethyl)-4-methylbenzene 
sulfonamide, 291. Aziridine 253 (137 mg, 0.50 
mmol) in CHCl3 (2.0 cm3) was combined with a 
solution of HCl (2M in Et2O, 1.0 cm3) in CHCl3 (1.0 cm3) at 70 °C as described above. 
After work-up and chromatography (3:1; nhexane:EtOAc), 291 (107 mg, 69%) was 
obtained as a clear oil. IR (film): 3256 (N−H), 1596 (C=C), 1156 (S=O) cm−1; δH (300 
MHz, CDCl3): 7.73 (2H, d, J = 8.4 Hz, ArH), 7.38 – 7.26 (7H, m, ArH), 4.87 (1H, dd, J 
= 6.0, 8.2 Hz, PhCH), 4.78 (1H, t, J = 6.4 Hz, NH), 3.53 – 3.37 (2H, m, CH2), 2.45 (3H, 
s, ArCH3); δC (75 MHz, CDCl3): 143.3 (C), 137.2 (C), 136.3 (C), 129.3 (CH), 128.5 
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(CH), 128.3 (CH), 126.6 (CH), 126.4 (CH), 61.1 (CH), 49.8 (CH2), 21.0 (CH3); m/z 
(ES+) 332, 334 [MNa]+; HRMS (ES+) calcd. for C15H16ClNNaO2S [MNa]+: 332.0482, 
found: 332.0488. Data consistent with that reported in literature.232 
 
N-(2-Methoxy-2-phenylethyl)-4-methylbenzene 
sulfonamide, 292. Aziridine 253 (137 mg, 0.50 
mmol) in CHCl3 (2.0 cm3) was combined with H2SO4 
(147 mg, 1.50 mmol) in MeOH (2.0 cm3) at 70 °C as described above. After work-
up and chromatography (3:1; nhexane:EtOAc), 292 (148 mg, 97%) was obtained 
as a clear oil. IR (film): 3282 (N−H), 1601 (C=C), 1159 (S=O) cm−1; δH (300 MHz, 
CDCl3): 7.73 (2H, d, J = 8.3 Hz, ArH), 7.35 – 7.18 (7H, m, ArH), 5.15 (1H, dd, J = 2.9, 
9.3 Hz, NH), 4.20 (1H, dd, J = 3.6, 9.3 Hz, PhCH), 3.26 – 3.17 (1H, m, CHH), 3.16 (3H, 
s, OCH3), 3.01 – 2.91 (1H, m, CHH), 2.42 (3H, s, ArCH3); δC (75 MHz, CDCl3): 143.5 
(C), 138.3 (C), 137.0 (C), 129.8 (CH), 128.7 (CH), 128.4 (CH), 127.1 (CH), 126.6 
(CH), 82.1 (CH), 56.8 (CH3), 49.4 (CH2), 21.6 (CH3); m/z (ES+) 328 [MNa]+; HRMS 
(ES+) calcd. for C16H19NNaO3S [MNa]+: 328.0978, found: 328.0979. Data consistent 
with that reported in literature.244 
 
N-(2– Ethoxy - 2-phenylethyl)-4-methylbenzene 
sulfonamide, 293. Aziridine 253 (137 mg, 0.50 
mmol) in CHCl3 (2.0 cm3) was combined with H2SO4 
(147 mg, 1.50 mmol) in EtOH (2.0 cm3) at 70 °C as described above. After work-up 
and chromatography (3:1; nhexane:EtOAc), 293 (62 mg, 39%) was obtained as a 
clear oil. IR (film): 3284 (N−H), 1597 (C=C), 1164 (S=O) cm−1; δH (500 MHz, CDCl3): 
7.72 (2H, d, J = 8.3 Hz, ArH), 7.35 – 7.18 (7H, m, ArH), 4.96 (1H, dd, J = 2.7, 9.4 Hz, 
NH), 4.31 (1H, dd, J = 3.7, 9.4 Hz, PhCH), 3.41 – 3.19 (2H, m, OCH2CH3), 3.25 – 3.15  
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(1H, m, CHH), 2.98 – 2.90 (1H, m, CHH), 2.42 (3H, s, ArCH3), 1.14 (3H, t, J = 7.0 Hz, 
OCH2CH3); δC (125 MHz, CDCl3): 143.5 (C), 139.0 (C), 137.0 (C), 129.7 (CH), 128.6 
(CH), 128.3 (CH), 127.1 (CH), 126.5 (CH), 80.2 (CH), 64.4 (CH2), 49.4 (CH2), 21.5 
(CH3), 15.2 (CH3); m/z (ES+) 342 [MNa]+; HRMS (ES+) calcd. for 
C17H21NNaO3S[MNa]+: 342.1134, found: 342.1143. Data consistent with that 
reported in literature.244 
 
2-(Tosylamino)-1-phenylethan-1-ol, 294. 
Aziridine 253 (137 mg, 0.50 mmol) in acetone (2.0 
cm3) was combined with H2SO4 (147 mg, 1.50 
mmol) and H2O (200 mg, 11.1 mmol) in acetone (2.0 cm3) at 70 °C as described 
above. After work-up and chromatography (3:1; nhexane:EtOAc), 294 (143 mg, 
98%) was obtained as a clear oil. IR (film): 3398, 3147, 1598 (C=C), 1146 (S=O) 
cm−1; δH (300 MHz, CDCl3): 7.73 (2H, d, J = 8.1 Hz, ArH), 7.38 – 7.26 (7H, m, ArH), 
5.03 (1H, dd, J = 4.5, 7.7 Hz, NH), 4.85 – 4.75 (1H, m, PhCH), 3.32 – 3.18 (1H, m, 
CHH), 3.10 – 2.96 (1H, m, CHH), 2.54 (1H, d, J = 3.5 Hz, OH), 2.42 (3H, s, ArCH3); δC 
(75 MHz, CDCl3): 143.6 (C), 140.8 (C), 136.7 (C), 129.8 (CH), 128.7 (CH), 128.2 (CH), 
127.1 (CH), 125.9 (CH), 72.8 (CH), 50.2 (CH2), 21.6 (CH3); m/z (ES+) 314 [MNa]+; 
HRMS (ES+) calcd. for C15H17NNaO3S [MNa]+: 314.0821, found: 314.0820. Data 
consistent with that reported in literature.164 
 
trans- N -(2 - Chlorocyclohexyl)- 4 -methylbenzenesulfon 
amide, 295. Aziridine 274 (126 mg, 0.50 mmol) in CHCl3 
(2.0 cm3) was combined with a solution of HCl (2M in Et2O, 
1.0 cm3) in CHCl3 (1.0 cm3) at 70 °C as described above. After 
work-up and chromatography (1:1; nhexane:EtOAc), 295 (141 mg, 98%) was 
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obtained as a clear oil. IR (film): 3250 (N−H), 1594 (C=C), 1152 (S=O) cm−1; δH (300 
MHz, CDCl3): 7.78 (2H, d, J = 8.3 Hz, ArH), 7.30 (2H, d, J = 8.3 Hz, ArH), 5.07 (1H, d, 
J = 5.4 Hz, NH), 3.71 (1H, td, J = 4.2, 9.6 Hz, ClCH), 3.18 – 3.01 (1H, m, NCH), 2.43 
(3H, s, ArCH3), 2.28 – 2.12 (2H, m, CH2), 1.76 – 1.56 (3H, m, CH2), 1.35 – 1.21 (3H, 
m, CH2); δC (75 MHz, CDCl3): 143.1 (C), 136.7 (C), 129.1 (CH), 126.9 (CH), 61.9 (CH), 
58.2 (CH), 34.4 (CH2), 31.9 (CH2), 23.8 (CH2), 22.8 (CH2), 21.0 (CH3); m/z (ES+) 310, 
312 [MNa]+; HRMS (ES+) calcd. for C13H18ClNNaO2S [MNa]+: 310.0639, found: 
310.0640. Data consistent with that reported in literature.232 
 
trans-N-(2-Methoxycyclohexyl)-4-methylbenzenesulfon 
amide, 296. Aziridine 274 (126 mg, 0.50 mmol) in CHCl3 
(2.0 cm3) was combined with H2SO4 (147 mg, 1.50 mmol) in 
MeOH (2.0 cm3) at 70 °C as described above. After work-up 
and chromatography (3:1; nhexane:EtOAc), 296 (102 mg, 
72%) was obtained as a clear oil. IR (film): 3277 (N−H), 1598 (C=C), 1155 (S=O) 
cm−1; δH (300 MHz, CDCl3): 7.78 (2H, d, J = 8.3 Hz, ArH), 7.30 (2H, d, J = 8.3 Hz, ArH), 
5.37 – 5.31 (1H, m, NH), 3.18 (3H, s, OCH3), 2.98 – 2.81 (2H, m, NCH and (MeO)CH), 
2.42 (3H, s, ArCH3), 2.20 – 1.90 (2H, m, CH2), 1.71 – 1.53 (2H, m, CH2), 1.30 – 1.01 
(4H, m, CH2); δC (75 MHz, CDCl3): 142.4 (C), 136.9 (C), 128.9 (CH), 126.6 (CH), 80.7 
(CH), 56.3 (CH), 55.3 (CH3), 30.6 (CH2), 28.0 (CH2), 23.0 (CH2), 22.7 (CH2), 20.9 
(CH3); m/z (ES+) 306 [MNa]+; HRMS (ES+) calcd. for C14H21NNaO3S [MNa]+: 
306.1134, found: 306.1143. Data consistent with that reported in literature.244  
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trans-N-(2-Hydroxycyclohexyl)-4-methylbenzenesulfon 
amide, 297. Aziridine 274 (126 mg, 0.50 mmol) in acetone 
(2.0 cm3) was combined with H2SO4 (147 mg, 1.50 mmol) and 
H2O (200 mg, 11.1 mmol) in acetone (2.0 cm3) at 70 °C as 
described above. After work-up and chromatography (3:1; nhexane:EtOAc), 297 
(101 mg, 75%) was obtained as a clear oil. IR (film): 3541, 3259, 1597 (C=C), 1149 
(S=O) cm−1; δH (300 MHz, CDCl3): 7.82 (2H, d, J = 8.3 Hz, ArH), 7.31 (2H, d, J = 8.3 
Hz, ArH), 5.62 (1H, d, J = 6.7 Hz, NH), 3.34 (1H, td, J = 4.2, 9.7 Hz, (HO)CH), 3.22 (1H, 
s, OH), 2.94 – 2.82 (1H, m, NCH), 2.42 (3H, s, ArCH3), 2.05 – 1.96 (1H, m, CH2), 1.71 
– 1.50 (3H, m, CH2), 1.30 – 1.08 (4H, m, CH2); δC (75 MHz, CDCl3): 143.5 (C), 137.6 
(C), 129.8 (CH), 127.1 (CH), 73.1 (CH), 59.7 (CH), 33.4 (CH2), 31.6 (CH2), 24.7 (CH2), 
23.9 (CH2), 21.6 (CH3); m/z (ES+) 292 [MNa]+; HRMS (ES+) calcd. for C13H19NNaO3S 
[MNa]+: 292.0978, found: 292.0980. Data consistent with that reported in 
literature.244 
 
trans - N -(2-Fluorocyclohexyl)-4-nitrobenzenesulfon 
amide, 298. Aziridine 275 (142 mg, 0.50 mmol) in CHCl3 
(2.0 cm3) was combined with BF3.OEt2 (213 mg, 1.50 
mmol) and iPrOH (90 mg, 1.50 mmol) in CHCl3 (2.0 cm3) 
at 21 °C as described above. After work-up and chromatography (3:1; 
nhexane:EtOAc), 298 (95 mg, 63%) was obtained as a crystalline solid. M.p. 174 – 
175 °C. IR (film): 3345 (N−H), 1603 (C=C), 1163 (S=O) cm−1; δH (500 MHz, CD2Cl2): 
8.32 (2H, d, J = 8.9 Hz, ArH), 8.05 (2H, d, J = 8.9 Hz, ArH), 4.92 (1H, d, J = 6.8 Hz, NH), 
4.22 – 4.04 (1H, dm, J = 50.2 Hz, FCH), 3.31 – 3.22 (1H, m, NCH), 2.09 – 1.99 (2H, m, 
CH2), 1.75 – 1.59 (2H, m, CH2), 1.45 – 1.34 (1H, m, CH2), 1.30 – 1.15 (3H, m, CH2); δC 
(125  MHz, CD2Cl2):  150.1 (C), 146.8 (C), 128.4 (CH), 124.3 (CH), 93.6 (d, J = 179.2  
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Hz, CH), 57.5 (d, J = 17.5 Hz, CH), 32.2 (CH2), 31.2 (CH2), 23.9 (CH2), 23.0 (CH2); m/z 
(ES+) 325 [MNa]+; HRMS (ES+) calcd. for C12H15N2FNaO4S [MNa]+: 325.0629, found: 
325.0626. 
 
N - (2 – Methoxy - 2-phenylethyl)methanesulfonamide, 
299. Aziridine 269 (99 mg, 0.50 mmol) in CHCl3 (2.0 cm3) 
was combined with H2SO4 (147 mg, 1.50 mmol) in MeOH 
(2.0 cm3) at 70 °C as described above. After work-up and chromatography (1:1; 
nhexane:EtOAc), 299 (84 mg, 73%) was obtained as a clear oil. IR (film): 3278 
(N−H), 1453 (C=C), 1147 (S=O) cm−1; δH (500 MHz, CDCl3): 7.42 – 7.29 (5H, m, ArH), 
4.92 – 4.87 (1H, m, NH), 4.34 (1H, dd, J = 3.7, 8.5 Hz, PhCH), 3.39 – 3.32 (1H, m, 
CHH), 3.28 (3H, s, OCH3), 3.26 – 3.20 (1H, m, CHH), 2.90 (3H, s, SO2CH3); δC (125 
MHz, CDCl3): 138.3 (C), 128.8 (CH), 128.5 (CH), 126.7 (CH), 82.5 (CH), 56.9 (CH3), 
49.4 (CH2), 40.4 (CH3); m/z (ES+) 252 [MNa]+; HRMS (ES+) calcd. for C10H15NNaO3S 
[MNa]+: 252.0665, found: 252.0661. 
 
N - (2 – Phenoxy - 2-phenylethyl)methanesulfonamide, 
300. Aziridine 269 (99 mg, 0.50 mmol) in CHCl3 (2.0 cm3) 
was combined with PhOH (235 mg, 2.50 mmol) and MsOH 
(240 mg, 2.50 mmol) in CHCl3 (2.0 cm3) at 21 °C as 
described above. After work-up and chromatography (1:1; nhexane:EtOAc), 300 
(77 mg, 53%) was obtained as a clear oil. IR (film): 3286 (N−H), 1596 (C=C), 1144 
(S=O) cm−1; δH (300 MHz, CDCl3): 7.29 – 7.15 (5H, m, ArH), 7.11 – 7.03 (2H, m, ArH), 
6.81 – 6.68 (3H, m, ArH), 5.24 – 5.14 (1H, m, PhCH), 4.84 (1H, dd, J = 5.0, 7.4 Hz, 
NH), 3.50 – 3.30 (2H, m, CH2), 2.76 (3H, s, CH3); δC (75 MHz, CDCl3): 156.6 (C), 137.3 
(C), 128.9 (CH), 128.3 (CH), 127.9 (CH), 125.6 (CH), 120.9 (CH), 115.2 (CH), 78.4 
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(CH), 49.0 (CH2), 40.2 (CH3); m/z (ES+) 314 [MNa]+; HRMS (ES+) calcd. for 
C15H17NNaO3S [MNa]+: 314.0821, found: 314.0828. 
 
N–[2–Phenyl–2–(2,4,6–trimethoxyphenyl)ethyl]methane 
sulfonamide, 301. Aziridine 269 (99 mg, 0.50 mmol) in CHCl3 
(2.0 cm3) was combined with 1,3,5-trimethoxybenzene (420 
mg, 2.50 mmol) and MsOH (240 mg, 2.50 mmol) in CHCl3 (2.0 
cm3) at 21 °C as described above. After work-up and 
chromatography (1:1; nhexane:EtOAc), 301 (93 mg, 51%) was obtained as a 
crystalline solid. M.p. 158 – 159 °C. IR (film): 3313 (N−H), 1587 (C=C), 1145 (S=O) 
cm−1; δH (500 MHz, CDCl3): 7.28 – 7.22 (4H, m, ArH), 7.18 – 7.13 (1H, m, ArH), 6.13 
(2H, s, ArH), 4.80 (1H, dd, J = 6.9, 9.4 Hz, PhCH), 4.32 – 4.25 (1H, m, NH), 3.98 – 3.85 
(2H, m, CH2), 3.80 (3H, s, OCH3), 3.74 (6H, s, OCH3), 2.78 (3H, s, SO2CH3); δC (125 
MHz, CDCl3): 160.5 (C), 159.4 (C), 141.9 (C), 128.1 (CH), 127.8 (CH), 126.2 (CH), 
109.3 (C), 91.3 (CH), 55.7 (CH3), 55.3 (CH3), 45.6 (CH2), 40.3 (CH or CH3), 40.2 (CH 
or CH3); m/z (ES+) 388 [MNa]+; HRMS (ES+) calcd. for C18H23NNaO5S [MNa]+: 
388.1189, found: 388.1190. 
 
N-[2 - (6-Bromo-2,3,4-trimethoxyphenyl)-2-phenylethyl] 
methanesulfonamide, 302. Aziridine 269 (99 mg, 0.50 
mmol) in CHCl3 (2.0 cm3) was combined with 5-bromo-1,2,3-
trimethoxybenzene (618 mg, 2.50 mmol) and MsOH (240 mg, 
2.50 mmol) in CHCl3 (2.0 cm3) at 21 °C as described above. 
After work-up and chromatography (1:1; nhexane:EtOAc), 302 (31 mg, 14%) was 
obtained as an oil. IR (film): 3277 (N−H), 1585 (C=C), 1117 (S=O) cm−1; δH (500 
MHz, CDCl3): 7.33 – 7.18 (5H, m, ArH), 6.94 (1H, s, ArH), 4.84 (1H, t, J = 7.5 Hz, 
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PhCH), 4.50 – 4.40 (1H, m, NH), 4.03 – 3.97 (2H, m, CH2), 3.86 (3H, s, OCH3), 3.78 
(3H, s, OCH3), 3.27 (3H, s, OCH3), 2.82 (3H, s, SO2CH3); δC (125 MHz, CDCl3): 153.4 
(C), 153.2 (C), 142.4 (C), 140.8 (C), 128.4 (CH), 127.3 (CH), 127.1 (C), 126.6 (CH), 
119.3 (C), 111.9 (CH), 60.6 (CH3), 60.4 (CH3), 56.2 (CH3), 47.7 (CH), 44.7 (CH2), 40.3 
(CH3); m/z (ES+) 466 [MNa]+; HRMS (ES+) calcd. for C18H22BrNNaO5S [MNa]+: 
466.0294, found: 466.0294.  
 
6.9 General flow procedure for ring expansion of aziridines to imidazolines. 
The aziridine (0.50 mmol, 1 eq) was dissolved in CH2Cl2 (2.0 cm3) to give solution 
A. Et2O·BF3 (2.50 mmol, 5.0 eq) and the appropriate nitrile (2.50 mmol, 5.0 eq) 
were dissolved in CH2Cl2 (2.0 cm3) to give solution B. These two solutions were 
combined in the two-input microreactor (Figure 6.1) at 21°C using a 5 min 
residence time. The outlet stream was quenched into saturated aq NaHCO3. Upon 
completion of the run, additional quantities of CH2Cl2 were passed through the 
microreactor to ensure all the product was collected. The resulting mixture was 
extracted with CH2Cl2 (5 × 5 cm3), the combined organic extracts dried over MgSO4, 
and solvent removed in vacuo. Purification by column chromatography (EtOAc) 
gave the following products: 
 
2-Methyl-4-phenyl-1-(4-methylbenzenesulfonyl)-4,5 
-dihydro-1H-imidazole, 304. Using aziridine 253 (137 
mg, 0.50 mmol), BF3.OEt2 (309 μL, 2.50 mmol), MeCN 
(131 μL, 2.51 mmol), imidazoline 304 (115 mg, 73%) was 
produced as a clear oil. IR (film): 1645, 1356 (S=O), 1165 (S=O) cm−1; δH (300 MHz, 
CDCl3): 7.77 (2H, d, J = 8.3 Hz, ArH), 7.36 (2H, d, J = 8.3 Hz, ArH), 7.32 – 7.24 (3H, 
m, ArH), 7.10 – 7.03 (2H, m, ArH), 5.04 – 4.97 (1H, m, PhCH), 4.19 (1H, t, J = 10.0 
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Hz, CHH), 3.64 (1H, dd, J = 8.0, 10.0 Hz, CHH), 2.47 (3H, s, ArCH3), 2.43 – 2.41 (3H, 
m, CH3); δC (75 MHz, CDCl3): 156.3 (C), 144.8 (C), 141.6 (C), 135.2 (C), 130.2 (CH), 
128.7 (CH), 127.7 (CH), 127.3 (CH), 126.4 (CH), 66.7 (CH), 55.5 (CH2), 21.6 (CH3), 
16.9 (CH3); m/z (ES+) 315 [MH]+; HRMS (ES+) calcd. for C17H19N2O2S [MH]+: 
315.1162, found: 315.1162. Data consistent with that reported in literature.283 
 
2-Methyl-1-methylsulfonyl-4-phenyl-4,5-dihydro-1H-
imidazole, 305. Using aziridine 269 (99 mg, 0.50 mmol), 
BF3.OEt2 (309 μL, 2.50 mmol), MeCN (131 μL, 2.51 mmol), 
imidazoline 305 (85 mg, 71%) was produced as a crystalline solid. M.p. 97 – 100 
°C. IR (film): 1646, 1348 (S=O), 1161 (S=O) cm−1; δH (500 MHz, CDCl3): 7.39 – 7.24 
(5H, m, ArH), 5.16 – 5.10 (1H, m, PhCH), 4.25 (1H, t, J = 9.8 Hz, CHH), 3.70 (1H, dd, 
J = 8.2, 9.8 Hz, CHH), 3.04 (3H, s, SO2CH3), 2.39 – 2.34 (3H, m, CH3); δC (125 MHz, 
CDCl3): 156.0 (C), 141.5 (C), 128.9 (CH), 127.9 (CH), 126.4 (CH), 66.7 (CH), 55.7 
(CH2), 39.2 (CH3), 16.7 (CH3); m/z (ES+) 239 [MH]+; HRMS (ES+) calcd. for 
C11H15N2O2S [MH]+: 239.0849, found: 239.0854. 
 
1 – (Methylsulfonyl) –2, 4 – diphenyl – 4, 5 –dihydro–1H-
imidazole, 306. Using aziridine 269 (99 mg, 0.50 mmol), 
BF3.OEt2 (309 μL, 2.50 mmol), PhCN (258 mg, 2.50 mmol), 
imidazoline 306 (87 mg, 58%) was produced as a 
crystalline solid. M.p. 131 – 132 °C. IR (film): 1621, 1346 (S=O), 1155 (S=O) cm−1; 
δH (500 MHz, CDCl3): 7.79 (2H, d, J = 7.3 Hz, ArH), 7.51 (1H, t, J = 7.3 Hz, ArH), 7.44 
(2H, t, J = 7.3 Hz, ArH), 7.41 – 7.30 (5H, m, ArH), 5.37 (1H, dd, J = 8.2, 9.8 Hz, PhCH), 
4.50 (1H, dd, J = 9.8, 11.0 Hz, CHH), 3.95 (1H, dd, J = 8.2, 11.0 Hz, CHH), 2.84 (3H, s, 
CH3);  δC (125 MHz, CDCl3): 159.4 (C), 141.5 (C), 131.3 (CH), 129.8 (C), 129.5 (CH),  
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128.9 (CH), 128.1 (CH), 127.9 (CH), 126.5 (CH), 68.0 (CH), 58.0 (CH2), 40.0 (CH3); 
m/z (ES+) 301 [MH]+; HRMS (ES+) calcd. for C16H17N2O2S [MH]+: 301.1005, found: 
301.1009. 
 
2-(tert-Butyl)-1-(methylsulfonyl)-4-phenyl-4,5-dihydro 
-1H-imidazole, 307. Using aziridine 269 (99 mg, 0.50 
mmol), BF3.OEt2 (309 μL, 2.50 mmol), tBuCN (208 mg, 2.50 
mmol), imidazoline 307 (67 mg, 48%) was produced as a 
clear oil. IR (film): 1621, 1347 (S=O), 1168 (S=O) cm−1; δH (500 MHz, CDCl3): 7.36 
(2H, t, J = 7.5 Hz, ArH), 7.29 (1H, t, J = 7.5 Hz, ArH), 7.22 (2H, d, J = 7.5 Hz, ArH), 5.10 
(1H, dd, J = 7.5, 9.7 Hz, PhCH), 4.31 (1H, dd, J = 9.7, 10.7 Hz, CHH), 3.74 (1H, dd, J = 
7.5, 10.7 Hz, CHH), 2.94 (3H, s, SO2CH3), 1.49 (9H, s, C(CH3)3); δC (125 MHz, CDCl3): 
166.7 (C), 141.8 (C), 128.8 (CH), 127.8 (CH), 126.3 (CH), 65.9 (CH), 58.8 (CH2), 39.5 
(CH3), 36.5 (C), 29.0 (CH3); m/z (ES+) 281 [MH]+; HRMS (ES+) calcd. for C14H21N2O2S 
[MH]+: 281.1318, found: 281.1321. 
 
2–Methyl–1–(4–nitrobenzenesulfonyl)–4–phenyl-
4,5–dihydro–1H–imidazole, 308. Using aziridine 
268 (152 mg, 0.50 mmol), BF3.OEt2 (309 μL, 2.50 
mmol), MeCN (131 μL, 2.51 mmol), imidazoline 308 
(117 mg, 68%) was synthesized as a clear oil. IR (film): 1651, 1531 (C=C), 1350 
(S=O), 1171 (S=O) cm−1; δH (500 MHz, CDCl3): 8.38 (2H, d, J = 8.9 Hz, ArH), 8.04 
(2H, d, J = 8.9 Hz, ArH), 7.29 – 7.23 (3H, m, ArH), 7.08 – 7.03 (2H, m, ArH), 5.09 – 
5.03 (1H, m, PhCH), 4.22 (1H, t, J = 10.0 Hz, CHH), 3.66 (1H, dd, J = 7.6, 10.0 Hz, 
CHH), 2.43 – 2.41 (3H, m, CH3); δC (125 MHz, CDCl3): 155.3 (C), 150.6 (C), 143.9 (C), 
141.1 (C), 128.9 (CH), 128.4 (CH), 127.9 (CH), 126.2 (CH), 124.8 (CH), 66.8 (CH), 
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55.7 (CH2), 17.0 (CH3); m/z (ES+) 346 [MH]+; HRMS (ES+) calcd. for C16H16N3O4S 
[MH]+: 346.0856, found: 346.0856. Data consistent with that reported in 
literature.284 
 
2-Isopropyl-1-(4-nitrobenzenesulfonyl)-4-
phenyl-4,5-dihydro-1H-imidazole, 309. 
Using aziridine 268 (152 mg, 0.50 mmol), 
BF3.OEt2 (309 μL, 2.50 mmol), iPrCN (173 mg, 
2.50 mmol), imidazoline 309 (151 mg, 81%) was synthesized as a clear oil. IR 
(film): 1642, 1531 (C=C), 1350 (S=O), 1171 (S=O) cm−1; δH (500 MHz, CDCl3): 8.32 
(2H, d, J = 8.9 Hz, ArH), 7.96 (2H, d, J = 8.9 Hz, ArH), 7.24 – 7.20 (3H, m, ArH), 7.00 
– 6.94 (2H, m, ArH), 5.03 (1H, dd, J = 6.7, 10.2 Hz, PhCH), 4.19 (1H, t, J = 10.2 Hz, 
CHH), 3.65 (1H, dd, J = 6.7, 10.2 Hz, CHH), 3.38 (1H, sep, J = 6.5 Hz, CHMe2), 1.35 
(3H, d, J = 6.5 Hz, CH3), 1.33 (3H, d, J = 6.5 Hz, CH3); δC (125 MHz, CDCl3): 164.5 (C), 
150.5 (C), 143.8 (C), 141.7 (C), 128.7 (CH), 128.3 (CH), 127.7 (CH), 126.0 (CH), 
124.7 (CH), 66.4 (CH), 56.3 (CH2), 28.9 (CH), 21.4 (CH3), 21.2 (CH3); m/z (ES+) 374 
[MH]+; HRMS (ES+) calcd. for C18H20N3O4S [MH]+: 374.1169, found: 374.1173. 
 
4-Mesityl-2-methyl-1-(4-methylbenzenesulfonyl)-
4,5-dihydro-1H-imidazole, 310. Using aziridine 273 
(158 mg, 0.50 mmol), BF3.OEt2 (309 μL, 2.50 mmol), 
MeCN (131 μL, 2.51 mmol), imidazoline 310 (94 mg, 
53%) was synthesized as a clear oil. IR (film): 2916 (C−H) 1648, 1355 (S=O), 1163 
(S=O) cm−1; δH (500 MHz, CDCl3): 7.79 (2H, d, J = 8.4 Hz, ArH), 7.36 (2H, d, J = 8.4 
Hz, ArH), 6.75 (2H, s, ArH), 5.43 – 5.35 (1H, m, ArCH), 4.11 (1H, dd, J = 9.6, 11.2 Hz, 
CHH), 3.54 (1H, dd, J = 9.6, 10.6 Hz, CHH), 2.46 (3H, s, ArCH3), 2.39 – 2.36 (3H, m, 
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CH3), 2.21 (3H, s, ArCH3), 2.04 (6H, s, ArCH3); δC (125 MHz, CDCl3): 155.4 (C), 144.7 
(C), 137.1 (C), 136.7 (C), 135.5 (C), 132.8 (C), 130.2 (CH), 130.1 (CH), 127.4 (CH), 
63.3 (CH), 52.9 (CH2), 21.6 (CH3), 20.7 (CH3), 20.3 (CH3), 16.8 (CH3); m/z (ES+) 357 
[MH]+; HRMS (ES+) calcd. for C20H25N2O2S [MH]+: 357.1631, found: 357.1639. 
 
6.10 General method for cascade reactions involving aziridine intermediates 
from 1,2-amino alcohols. 
The 1,2-amino alcohol (0.50 mmol, 1 eq), DBU (2.25 mmol, 4.5 eq) and DMAP (0.25 
mmol, 0.5 eq) were dissolved in CHCl3 (2.0 cm3) to give solution A. Ms2O (1.25 
mmol, 2.5 eq) was dissolved in CHCl3/CH2Cl2 (1:1, 2.0 cm3) to give solution B. 
Solution C was made by dissolving the nucleophile and catalyst in a suitable 
solvent (4.0 cm3); details are given for each entry. These solutions were combined 
in the three-input microreactor (Figure 6.2). The syringe pump additions were 
adjusted to give a 16 min residence time for the initial combination of solutions A 
and B; and a further 12 min residence time upon addition of solution C. The outlet 
stream was quenched into a stirred solution of saturated aq NaHCO3. Upon 
completion of the run, additional quantities of CHCl3 were passed through the 
microreactor to ensure all the product was collected. The resulting mixture was 
extracted with CH2Cl2 (5 × 5 cm3), the combined organic extracts dried over MgSO4, 
and solvent removed in vacuo. Purification by column chromatography gave the 
following products:  
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N-(2-Methoxy-2-phenylethyl)methanesulfonamide, 
299. Using 2-amino-2-phenylethan-1-ol (69 mg, 0.50 
mmol), DBU (343 mg, 2.25 mmol), DMAP (31 mg, 0.25 
mmol) to make solution A; Ms2O (218 mg, 1.25 mmol) to generate solution B; and 
MsOH (384 mg, 4.0 mmol) in MeOH (4.0 cm3) to produce solution C, 299 (70 mg, 
61%) was produced as a clear oil after work-up and chromatography (1:1 
nhexane:EtOAc). Data as previously described. 
 
N-(2-Chloro-2-phenylethyl)methanesulfonamide, 313. 
Using 2-amino-2-phenylethan-1-ol (69 mg, 0.50 mmol), 
DBU (343 mg, 2.25 mmol), DMAP (31 mg, 0.25 mmol) to 
make solution A; Ms2O (218 mg, 1.25 mmol) to generate solution B; and HCl (2M 
in Et2O, 2.0 cm3) in CHCl3 (2.0 cm3) to produce solution C, 313 (68 mg, 58%) was 
produced as a clear oil after work-up and chromatography (1:1; nhexane:EtOAc). 
IR (film): 3287 (N−H), 1454 (C=C), 1319 (S=O), 1149 (S=O) cm−1; δH (500 MHz, 
CDCl3): 7.43 – 7.34 (5H, m, ArH), 5.03 (1H, dd, J = 5.9, 7.8 Hz, PhCH), 4.73 – 4.65 
(1H, m, NH), 3.69 – 3.58 (2H, m, CH2), 2.91 (3H, s, CH3); δC (125 MHz, CDCl3): 137.8 
(C), 129.2 (CH), 129.0 (CH), 127.3 (CH), 62.2 (CH), 50.6 (CH2), 41.3 (CH3); m/z (ES+) 
256, 258 [MNa]+; HRMS (ES+) calcd. for C9H12ClNNaO2S 256.0169, found: 256.0170. 
 
2-Methyl-1-methylsulfonyl-4-phenyl-4,5-dihydro-1H-
imidazole, 305. Using 2-amino-2-phenylethan-1-ol (69 
mg, 0.50 mmol), DBU (343 mg, 2.25 mmol), DMAP (31 mg, 
0.25 mmol) to make solution A; Ms2O (218 mg, 1.25 mmol) to generate solution B; 
a solution of 15.2% BF3 in MeCN solution (1.78 g, 4.0 mmol) was diluted with MeCN 
to produce  4.0 cm3 of solution C,  305 (50 mg, 42%) was synthesized as a clear oil  
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was produced as a clear oil after work-up and chromatography (EtOAc). Data as 
previously described. 
 
N-[2-(4-Chlorophenyl)-2-methoxyethyl]methane 
sulfonamide, 314. Using 2-amino-2-(4-chloro 
phenyl)ethan-1-ol (86 mg, 0.50 mmol), DBU (343 mg, 
2.25 mmol), DMAP (31 mg, 0.25 mmol) to make solution A; Ms2O (218 mg, 1.25 
mmol) to generate solution B; and MsOH (384 mg, 4.0 mmol) in MeOH (4.0 cm3) to 
produce solution C, 314 (75 mg, 57%) was produced as a clear oil after work-up 
and chromatography (1:1; nhexane:EtOAc). IR (film): 3284 (N−H), 1489 (C=C), 
1316 (S=O), 1147 (S=O) cm−1; δH (500 MHz, CDCl3): 7.36 (2H, d, J = 8.5 Hz, ArH), 
7.26 (2H, d, J = 8.5 Hz, ArH), 4.84 – 4.77 (1H, m, ArCH), 4.33 (1H, dd, J = 3.8, 8.7 Hz, 
NH), 3.36 – 3.30 (1H, m, CHH), 3.27 (3H, s, OCH3), 3.21 – 3.15 (1H, m, CHH), 2.93 
(3H, s, SO2CH3); δC (125 MHz, CDCl3): 136.8 (C), 134.3 (C), 129.0 (CH), 128.1 (CH), 
82.0 (CH), 57.0 (CH3), 49.3 (CH2), 40.6 (CH3); m/z (ES+) 286, 288 [MNa]+; HRMS 
(ES+) calcd. for C10H14ClNNaO3S [MNa]+: 286.0275, found : 286.0278. 
 
N-[2-Chloro-2-(4-chlorophenyl)ethyl]methane 
sulfonamide, 315. Using 2-amino-2-(4-chloro 
phenyl)ethan-1-ol (86 mg, 0.50 mmol), DBU (343 
mg, 2.25 mmol), DMAP (31 mg, 0.25 mmol) to make solution A; Ms2O (218 mg, 1.25 
mmol) to generate solution B; and HCl (2M in Et2O, 2.0 cm3) in CHCl3 (2.0 cm3) to 
produce solution C, 315 (71 mg, 53%) was produced as a clear oil after work-up 
and chromatography (1:1; nhexane:EtOAc). IR (film): 3264 (N−H), 1493 (C=C), 
1147 (S=O) cm−1; δH (500 MHz, CDCl3): 7.40 – 7.33 (4H, m, ArH), 5.01 (1H, dd, J = 
5.9, 7.9 Hz, ArCH); 4.75 (1H, t, J = 6.3 Hz, NH), 3.65 – 3.54 (2H, m, CH2), 2.94 (3H, s,  
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CH3); δC (125 MHz, CDCl3): 136.3 (C), 135.1 (C), 129.2 (CH), 128.7 (CH), 61.4 (CH), 
50.5 (CH2), 41.3 (CH3); m/z (ES+) 290, 292 [MNa]+; HRMS (ES+) calcd. for 
C9H11Cl2NNaO2S [MNa]+: 289.9780, found: 289.9783. 
 
6.11 Synthesis of 1-iodo-2-propoxybenzene, 338. 
2-iodophenol (2.31 g, 10.5 mmol, 1 eq) was dissolved in DMF 
(20 cm3). K2CO3 (7.78 g, 56.3 mmol, 5.4 eq) was added, and the 
mixture stirred for 10 min. 1-iodopropane (2.57 g, 15.1 mmol, 
1.4 eq) was added, and the mixture stirred at 50°C for 5 h, at which point, a yellow 
solution containing solids was obtained. The solvent was removed under high 
vacuum on a rotary evaporator, saturated aq NaCl (50 cm3) was added, and the 
mixture extracted with EtOAc (5 × 10 cm3). The organic extracts were combined, 
dried with MgSO4, filtered and the solvent removed in vacuo. Column 
chromatography (5:1 nhexane:EtOAc) gave 338 (2.20 g, 80%). IR (film): 2963 
(C−H), 2935 (C−H), 2875 (C−H), 1580 (C=C) cm−1. δH (500 MHz, CDCl3): 7.79 – 7.74 
(1H, m, ArH), 7.31 – 7.25 (1H, m, ArH), 6.82 – 6.78 (1H, m, ArH), 6.72 – 6.67 (1H, m, 
ArH), 3.98 (2H, t, J = 7.0 Hz, OCH2CH2CH3), 1.87 (2H, sextuplet, J = 7.0 Hz, 
OCH2CH2CH3), 1.10 (3H, t, J = 7.0 Hz, OCH2CH2CH3); δC (125 MHz, CDCl3): 157.6 (C), 
139.4 (CH), 129.4 (CH), 122.3 (CH), 112.1 (CH), 86.7 (C), 70.7 (CH2), 22.6 (CH2), 
10.8 (CH3). Data consistent with that reported in literature.255  
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6.12 Synthesis of (2-propoxyphenyl)-λ3-iodanediyl diacetate, 339. 
To 338 (2.20 g, 8.39 mmol, 1 eq) was added 39% AcOOH in 
AcOH (3.93 g solution, 1.53 g AcOOH, 20.1 mmol, 2.4 eq) 
dropwise over 1 hour, and the mixture stirred at 31 °C. The 
solution turned from orange, then yellow. After complete addition of AcOOH, the 
temperature was increased to 45 °C, and the mixture stirred for 2 h. The reaction 
was monitored by 1H NMR spectroscopy. After the signals for 338 had completely 
disappeared, the excess AcOOH and AcOH were removed at room temperature 
under high vacuum on a rotary evaporator, giving 339 (2.31 g, 72%) as a pale 
yellow solid. M.p. 98 – 99 °C (decomposition); (lit. 97.2 – 98 °C). IR (film): 1646, 
1275 cm−1; δH (500 MHz, CDCl3): 8.15 – 8.12 (1H, m, ArH), 7.58 – 7.54 (1H, m, ArH), 
7.14 – 7.10 (1H, m, ArH), 7.04 – 7.00 (1H, m, ArH), 4.11 (2H, t, J = 7.0 Hz, 
OCH2CH2CH3), 1.97 (6H, s, C(O)CH3), 1.88 (2H, sextuplet, J = 7.0 Hz, OCH2CH2CH3), 
1.07 (3H, t, J = 7.0 Hz, OCH2CH2CH3); δC (125 MHz, CDCl3): 176.7 (C=O), 155.8 (C), 
137.7 (CH), 134.4 (CH), 122.6 (CH), 113.7 (C), 112.8 (CH), 71.2 (CH2), 22.4 (CH2), 
20.4 (CH3), 10.6 (CH3). Data consistent with that reported in literature.255 
 
6.13 Synthesis of ArI=NSO2R, 340 – 343. 
 
4-Methyl-N-[(2-propoxyphenyl)-λ3-iodanylidene]benzene 
sulfonamide, 40. KOH (150 mg, 2.67 mmol, 2.5 eq) and TsNH2 
(182 mg, 1.06 mmol, 1 eq) were dissolved in MeOH (4.1 cm3), 
and the solution cooled to 0 °C. 339 (440 mg, 1.16 mmol, 1.09 
eq) was added, and the mixture stirred at 0 °C for 2.5 h. The 
resulting yellow solution was allowed to warm to room temperature over a further 
30 min. Then, the solution was added to H2O (27 cm3), and a pale yellow precipitate 
was formed. The mixture was cooled to −78 °C to induce further precipitation. 
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Upon reaching room temperature the precipitate was filtered off, washed with 
nhexane (10 cm3), and dried under high vacuum to give 340 (311 mg, 68%) as a 
pale yellow powder. M.p. 109 – 110 °C (decomposition); (lit. 96 – 96.4 °C). IR (film): 
1579 (C=C), 1170 (S=O) cm−1; δH (500 MHz, CDCl3): 7.83 (2H, d, J = 8.2 Hz, ArH), 
7.66 – 7.62 (1H, m, ArH), 7.42 – 7.38 (1H, m, ArH), 7.18 (2H, d, J = 8.2 Hz, ArH), 7.09 
– 7.04 (1H, m, ArH), 6.90 – 6.86 (1H, m, ArH), 4.05 (2H, t, J = 7.1 Hz, OCH2CH2CH3), 
2.36 (3H, s, ArCH3), 1.82 (2H, sextuplet, J = 7.1 Hz, OCH2CH2CH3), 1.03 (3H, t, J = 7.1 
Hz, OCH2CH2CH3); δC (125 MHz, CDCl3): 154.5 (C), 142.0 (C), 140.3 (C), 132.4 (CH), 
129.4 (CH), 129.3 (CH), 127.0 (CH), 124.1 (CH),  112.3 (CH), 103.3 (C), 71.6 (CH2), 
22.3 (CH2), 21.4 (CH3), 10.8 (CH3); HRMS (ES+) calcd. for C16H19INO3S [MH]+: 
432.0125, found: 432.0126. Data consistent with that reported in literature.255 
 
4-Nitro-N-[(2-propoxyphenyl)-λ3-iodanylidene]benzene 
sulfonamide, 341. KOH (150 mg, 2.67 mmol, 2.5 eq) was 
dissolved in MeOH (4.1 cm3), and 4-nitrobenzenesulfon 
amide (214 mg, 1.06 mmol, 1 eq) added. The mixture was 
cooled to 0 °C, and 339 (440 mg, 1.16 mmol, 1.09 eq) was 
added. The mixture was stirred at 0 °C for 2.5 h. The resulting yellow mixture was 
allowed to warm to room temperature over a further 30 min. The solution was 
then added to H2O (27 cm3), and a pale yellow precipitate was formed. The mixture 
was cooled to −78 °C to induce further precipitation. Upon reaching room 
temperature, the precipitate was filtered off, washed with nhexane (10 cm3), and 
dried under high vacuum to give 341 (264 mg, 54%) as a pale yellow powder. M.p. 
131 – 132 °C (decomposition). IR (film): 3093 (C−H), 1517, 1347 (S=O), 1121 
(S=O) cm−1; δH (500 MHz, CDCl3): 8.20 (2H, d, J = 8.8 Hz, ArH), 8.09 (2H, d, J = 8.8 
Hz, ArH), 7.59 (1H, d, J = 8.0 Hz, ArH), 7.43 (1H, t, J = 8.0 Hz, ArH), 7.06 (1H, t, J = 
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8.0 Hz, ArH), 6.90 (1H, d, J = 8.0 Hz, ArH), 4.06 (2H, t, J = 7.1 Hz, OCH2CH2CH3), 1.83 
(2H, sextuplet, J = 7.1 Hz, OCH2CH2CH3), 1.05 (3H, t, J = 7.1 Hz, OCH2CH2CH3); δC 
(125 MHz, CDCl3): 154.5 (C), 149.23 (C), 149.20 (C), 133.1 (CH), 129.5 (CH), 128.2 
(CH), 124.3 (CH), 123.9 (CH), 112.6 (CH), 103.0 (C), 71.6 (CH2), 22.3 (CH2), 10.5 
(CH3); HRMS (ES+) calcd. for C15H15IN2NaIO5S [MNa]+: 484.9639, found: 484.9634. 
 
2-Nitro-N-[(2-propoxyphenyl)-λ3-iodanylidene]benzene 
sulfonamide, 342. KOH (150 mg, 2.67 mmol, 2.5 eq) was 
dissolved in MeOH (4.1 cm3), and 2-nitrobenzenesulfonamide 
(214 mg, 1.06 mmol, 1 eq) added. The mixture was cooled to 
0 °C, and 339 (440 mg, 1.16 mmol, 1.09 eq) was added. The 
mixture was stirred at 0 °C for 2.5 h. The resulting yellow mixture was allowed to 
warm to room temperature over a further 30 min. The solution was then added to 
H2O (27 cm3), and a pale yellow precipitate was formed. The mixture was cooled 
to −78 °C to induce further precipitation. Upon reaching room temperature, the 
precipitate was filtered off, washed with nhexane (10 cm3), and dried under high 
vacuum to give 342 (284 mg, 58%) as a pale yellow solid. M.p. 132 – 133 °C 
(decomposition). IR (film): 3088 (C−H), 2974 (C−H), 2941 (C−H), 2882 (C−H), 
1579, 1541, 1365 (S=O) cm−1; δH (500 MHz, CDCl3): 8.24 – 8.21(1H, m, ArH), 7.85 
– 7.81 (1H, m, ArH), 7.64 – 7.55 (3H, m, ArH), 7.47 – 7.41 (1H, m, ArH), 7.19 – 7.14 
(1H, m, ArH), 6.95 – 6.91 (1H, m, ArH), 4.09 (2H, t, J = 7.0 Hz, OCH2CH2CH3), 1.85 
(2H, sextuplet, J = 7.0 Hz, OCH2CH2CH3), 1.05 (3H, t, J = 7.0 Hz, OCH2CH2CH3); δC 
(125 MHz, CDCl3): 154.4 (C), 147.5 (C), 136.8 (C), 132.6 (CH), 132.1 (CH), 131.8 
(CH), 130.7 (CH), 129.0 (CH), 124.5 (CH), 123.7 (CH), 112.4 (CH), 104.5 (C), 71.6 
(CH2), 22.3 (CH2), 10.5 (CH3); HRMS (ES+) calcd. for C15H15IN2NaIO5S [MNa]+: 
484.9639, found: 484.9639.  
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5-Methyl-N-[(2-propoxyphenyl)- λ3-iodanylidene]pyridine 
-2-sulfonamide, 343. KOH (150 mg, 2.67 mmol, 2.5 eq) and 5-
methylpyridine-2-sulfonamide (183 mg, 1.06 mmol, 1 eq) were 
dissolved in MeOH (4.1 cm3), and the solution cooled to 0 °C. 
339 (440 mg, 1.16 mmol, 1.09 eq) was added, and the mixture 
stirred at 0 °C for 2.5 h. The resulting yellow solution was allowed to warm to room 
temperature over a further 30 min. The solution was then added to H2O (27 cm3), 
and a pale yellow precipitate was formed. The mixture was cooled to −78 °C to 
induce further precipitation. Upon reaching room temperature, the precipitate 
was filtered off, washed with nhexane (10 cm3), and dried under high vacuum to 
give 343 (280 mg, 61%) as a pale yellow solid. M.p. 127 – 128 °C (decomposition). 
IR (film): 1585, 1460, 1152 (S=O) cm−1; δH (500 MHz, CDCl3): 8.40 (1H, s, ArH), 8.00 
– 7.96 (1H, m, ArH), 7.93 (1H, d, J = 8.0 Hz, ArH), 7.70 – 7.65 (1H, m, ArH), 7.46 – 
7.40 (1H, m, ArH), 7.25 – 7.20 (1H, m, ArH), 6.95 – 6.91 (1H, m, ArH), 4.10 (2H, t, J 
= 7.0 Hz, OCH2CH2CH3), 2.41 (3H, s, ArCH3), 1.86 (2H, sextuplet, J = 7.0 Hz, 
OCH2CH2CH3), 1.07 (3H, J = 7.0 Hz, OCH2CH2CH3); δC (125 MHz, CDCl3): 158.9 (C), 
154.5 (C), 148.2 (CH), 138.6 (CH), 135.5 (C), 132.0 (CH), 128.6 (CH), 124.2 (CH), 
119.1 (CH), 112.0 (CH), 105.7 (C), 71.3 (CH2), 22.3 (CH2), 18.4 (CH3), 10.6 (CH3); 
HRMS (ES+) calcd. for C15H17IN2NaO3S [MNa]+: 454.9897, found: 454.9899.  
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6.14.1 General method for aziridination of alkenes in flow. 
A custom flow system was assembled by connecting computer controlled 
Tricontinent C3000 syringe pumps to a XXL-S-01 three-input flow reactor 
purchased from Little Things Factory. As only two inputs A and B were used, the 
third input C was blocked off; the reactor had a total reaction volume of 4.5 cm3 
(including tubing carrying away solution to thermal quench) when used in this 
way. 
 
ArI=NSO2R (0.10 mmol, 1 eq) was dissolved in CH2Cl2 (2.0 cm3) to give solution A; 
vigorous shaking was sometimes necessary for complete dissolving. Alkene (1.00 
mmol, 10 eq for aromatic alkenes and norbornene; 2.00 mmol, 20 eq for 
cycloheptene) and (pyr)4Cu(OTf)2 (0.01 mmol, 0.1 eq) were dissolved in 
anhydrous MeCN (2.0 cm3) to give solution B. Solutions A and B were combined in 
the XXL-S-01 microreactor at room temperature, with a residence time of 10 min. 
The outlet stream was quenched thermally at −78 °C. Upon completion of the run, 
additional quantities of CH2Cl2 and MeCN were passed through the microreactor 
at A and B respectively to ensure all the product was collected.  
 
Figure 6.3: Flow reactor used for aziridinations. 
B A C 
out 
tubing 
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The resulting mixture was concentrated under vacuum and purified by gradient 
column chromatography (5:1 nhexane:EtOAc, then 3:1 nhexane:EtOAc) to give the 
following products: 
 
2-Phenyl-1-tosylaziridine, 253. Using 340 (44 mg, 
0.102 mmol), styrene (105 mg, 1.01 mmol) and 
(pyr)4Cu(OTf)2 (7 mg, 0.010 mmol), 253 (23 mg, 82%) 
was produced as a clear oil. Other data as previously 
reported. 
 
2-(Naphthalen-2-yl)-1-tosylaziridine, 344. 
Using 340 (44 mg, 0.102 mmol), 2-vinyl 
naphthalene (155 mg, 1.01 mmol) and 
(pyr)4Cu(OTf)2 (7 mg, 0.010 mmol), 344 (23 
mg, 70%) was produced as a clear oil. IR (film): 1597 (C=C), 1324 (S=O), 1161 
(S=O) cm−1; δH (500 MHz, CD2Cl2): 7.91 (2H, d, J = 8.1 Hz, ArH), 7.87 – 7.82 (3H, m, 
ArH), 7.78 (1H, s, ArH), 7.55 – 7.49 (2H, m, ArH), 7.41 (2H, d, J = 8.1 Hz, ArH), 7.34 
– 7.30 (1H, m, ArH), 3.93 (1H, dd, J = 4.5, 7.2 Hz, ArCH), 3.06 (1H, d, J = 7.2 Hz, CHH), 
2.56 (1H, d, J = 4.5 Hz, CHH), 2.47 (3H, s, ArCH3); δC (125 MHz, CD2Cl2): 145.0 (C), 
134.9 (C), 133.2 (C), 133.1 (C), 132.6 (C), 129.8 (CH), 128.4 (CH), 127.9 (CH), 127.7 
(CH), 127.6 (CH), 126.5 (CH), 126.3 (CH), 126.1 (CH), 123.9 (CH), 41.1 (CH), 36.0 
(CH2), 21.4 (CH3); m/z (ES+) 346 [MNa]+; HRMS (ES+) calcd. for C19H17NNaO2S 
[MNa]+: 346.0872, found: 346.0875. Data consistent with that published in 
literature.19  
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2-(p-Tolyl)-1-tosylaziridine, 345. Using 340 (44 
mg, 0.102 mmol), 4-methylstyrene (119 mg, 1.01 
mmol) and (pyr)4Cu(OTf)2 (7 mg, 0.010 mmol), 345 
(20 mg, 68%) was produced as a clear oil. IR (film): 
1597 (C=C), 1323 (S=O), 1161 (S=O) cm−1; δH (500 MHz, CDCl3): 7.88 (2H, d, J = 8.2 
Hz, ArH), 7.35 (2H, d, J = 8.2 Hz, ArH), 7.13 – 7.11 (4H, m, ArH), 3.76 (1H, dd, J = 4.5, 
7.2 Hz, ArCH), 2.99 (1H, d, J = 7.2 Hz, CHH), 2.45 (3H, s, ArCH3), 2.40 (1H, d, J = 4.5 
Hz, CHH), 2.33 (3H, s, ArCH3); δC (125 MHz, CDCl3): 144.6 (C), 138.2 (C), 135.1 (C), 
132.0 (C), 129.7 (CH), 129.3 (CH), 127.9 (CH), 126.5 (CH), 41.1 (CH), 35.8 (CH2), 
21.7 (CH3), 21.2 (CH3); m/z (ES+) 310 [MNa]+; HRMS (ES+) calcd. for C16H17NNaO2S 
[MNa]+: 310.0872, found: 310.0875. Data consistent with that published in 
literature.28 
 
2-(m-Tolyl)-1-tosylaziridine, 346. Using 340 (44 
mg, 0.102 mmol), 3-methylstyrene (119 mg, 1.01 
mmol) and (pyr)4Cu(OTf)2 (7 mg, 0.010 mmol), 346 
(20 mg, 68%) was produced as a clear oil. IR (film): 
1597 (C=C), 1325 (S=O), 1161 (S=O) cm−1; δH (500 MHz, CDCl3): 7.87 (2H, d, J = 8.3 
Hz, ArH), 7.33 (2H, d, J = 8.3 Hz, ArH), 7.18 (1H, t, J = 7.9 Hz, ArH), 7.08 (1H, d, J = 
7.9 Hz, ArH), 7.03 – 6.99 (2H, m, ArH), 3.74 (1H, dd, J = 4.5, 7.2 Hz, ArCH), 2.96 (1H, 
d, J = 7.2 Hz, CHH), 2.43 (3H, s, ArCH3), 2.38 (1H, d, J = 4.5 Hz, CHH), 2.30 (3H, s, 
ArCH3); δC (125 MHz, CDCl3): 144.6 (C), 138.3 (C), 135.04 (C), 134.97 (C), 129.8 
(CH), 129.1 (CH), 128.5 (CH), 128.0 (CH), 127.2 (CH), 123.7 (CH), 41.1 (CH), 35.9 
(CH2), 21.7 (CH3), 21.3 (CH3);  m/z (ES+) 310 [MNa]+; HRMS (ES+) calcd. for 
C16H17NNaO2S[MNa]+: 310.0872, found: 310.0867. Data consistent with that 
published in literature.28  
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3-Tosyl-3-azatricyclo[3.2.1.02,4]octane, 347. Using 340 
(44 mg, 0.102 mmol), norbornene (95 mg, 1.01 mmol) and 
(pyr)4Cu(OTf)2 (7 mg, 0.010 mmol), 347 (19 mg, 71%) was 
produced as a clear oil. IR (film): 2968 (C−H), 2874 (C−H), 
1599 (C−H), 1351 (S=O), 1158 (S=O) cm−1; δH (500 MHz, CDCl3): 7.81 (2H, d, J = 8.1 
Hz, ArH), 7.32 (2H, d, J = 8.1 Hz, ArH), 2.92 – 2.91 (2H, m, NCH), 2.45 – 2.43 (5H, m, 
ArCH3 and RR’R’’CH), 1.51 – 1.43 (3H, m, R2CHH, CH2), 1.27 – 1.22 (2H, m, CH2), 
0.77 – 0.73 (1H, m, R2CHH); δC (125 MHz, CDCl3): 144.1 (C), 135.9 (C), 129.6 (CH), 
127.7 (CH), 42.0 (CH), 35.8 (CH), 28.3 (CH2), 25.6 (CH2), 21.6 (CH3); m/z (ES+) 286 
[MNa]+; HRMS (ES+) calcd. for C14H17NNaO2S[MNa]+: 286.0872, found: 286.0873. 
Data consistent with that reported in literature.255 
 
1-[(2-Nitrophenyl)sulfonyl]-2-phenylaziridine, 348. 
Using 342 (47 mg, 0.102 mmol), styrene (105 mg, 1.01 
mmol) and (pyr)4Cu(OTf)2 (7 mg, 0.010 mmol), 348 (24 
mg, 77%) was produced as a clear oil. IR (film): 1543 
(C=C), 1336 (S=O), 1167 (S=O) cm−1; δH (500 MHz, CDCl3): 8.26 – 8.23 (1H, m, ArH), 
7.78 – 7.72 (3H, m, ArH), 7.36 – 7.29 (5H, m, ArH), 4.04 (1H, dd, J = 4.8, 7.2 Hz, 
ArCH), 3.25 (1H, d, J = 7.2 Hz, CHH), 2.63 (1H, d, J = 4.8 Hz, CHH); δC (125 MHz, 
CDCl3): 148.6 (C), 134.7 (C), 134.5 (CH), 132.2 (CH), 132.1 (C), 131.3 (CH), 128.7 
(CH), 128.6 (CH), 126.6 (CH), 124.5 (CH), 42.9 (CH), 38.1 (CH2); m/z (ES+) 327 
[MNa]+; HRMS (ES+) calcd. for C14H12N2NaO4S [MNa]+: 327.0410, found: 327.0406. 
Data consistent with that reported in literature.19  
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3-[(2-Nitrophenyl)sulfonyl]-3-azatricyclo[3.2.1.02,4]octane, 
349. Using 342 (47 mg, 0.102 mmol), norbornene (95 mg, 1.01 
mmol) and (pyr)4Cu(OTf)2 (7 mg, 0.010 mmol), 349 (21 mg, 
70%) was produced as a clear oil. IR (film): 2974 (C−H), 2877 
(C−H), 1544 (C=C), 1330 (S=O), 1123 (S=O) cm−1; δH (500 MHz, CDCl3): 8.19 – 8.14 
(1H, m, ArH), 7.76 – 7.70 (3H, m, ArH), 3.22 – 3.21 (2H, m, NCH), 2.57 – 2.54 (2H, 
m, RR’R’’CH), 1.55 – 1.50 (2H, m, CH2), 1.44 – 1.39 (1H, m, R2CHH), 1.31 – 1.26 (2H, 
m, CH2), 0.84 – 0.79 (1H, m, R2CHH); δC (125 MHz, CDCl3): 148.4 (C), 134.0 (CH), 
132.9 (C), 132.0 (CH), 130.5 (CH), 124.3 (CH), 44.3 (CH), 36.1 (CH), 28.2 (CH2), 25.4 
(CH2); m/z (ES+) 317 [MNa]+; HRMS (ES+) calcd. for C13H14N2NaO4S [MNa]+: 
317.0566, found: 317.0555. 
 
8-[(2-Nitrophenyl)sulfonyl]-8-azabicyclo[5.1.0]octane, 
350. Using 342 (47 mg, 0.102 mmol), cycloheptene (192 
mg, 2.00 mmol) and (pyr)4Cu(OTf)2 (7 mg, 0.010 mmol), 
350 (14 mg, 46%) was produced as a clear oil. IR (film): 
2924 (C−H), 2849 (C−H), 1592 (C=C), 1329 (S=O), 1161 (S=O) cm−1; δH (500 MHz, 
CDCl3): 8.24 – 8.20 (1H, m, ArH), 7.78 – 7.71 (3H, m, ArH), 3.28 – 3.22 (2H, m, NCH), 
2.05 – 1.88 (4H, m, CH2), 1.62 – 1.41 (5H, m, CH2), 1.26 – 1.16 (1H, m, CH2); δC (125 
MHz, CDCl3): 148.5 (C), 134.0 (CH), 133.0 (C), 132.2 (CH), 131.0 (CH), 124.4 (CH), 
46.9 (CH), 31.0 (CH2), 28.2 (CH2), 25.1 (CH2); m/z (ES+) 319 [MNa]+; HRMS (ES+) 
calcd. for C13H16N2NaO4S [MNa]+: 319.0723, found: 319.0729.  
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5-Methyl-2-[(2-phenylaziridin-1-yl)sulfonyl] 
pyridine, 351. Using 343 (44 mg, 0.102 mmol), 
styrene (105 mg, 1.01 mmol) and (pyr)4Cu(OTf)2 
(7 mg, 0.010 mmol), 351 (22 mg, 79%) was 
produced as a clear oil. IR (film): 1572 (C=C), 1327 (S=O), 1171 (S=O) cm−1; δH (500 
MHz, CDCl3): 8.57 – 8.55 (1H, m, ArH), 8.02 (1H, d, J = 8.0 Hz, ArH), 7.72 (1H, d, J = 
8.0 Hz, ArH), 7.32 – 7.24 (5H, m, ArH), 4.00 (1H, dd, J = 4.7, 7.2 Hz, PhCH), 3.20 (1H, 
d, J = 7.2 Hz, CHH), 2.51 (1H, d, J = 4.7 Hz, CHH), 2.44 (3H, s, ArCH3); δC (125 MHz, 
CDCl3): 153.3 (C), 150.8 (CH), 138.3 (C), 138.2 (CH), 134.9 (C), 128.5 (CH), 128.4 
(CH), 126.7 (CH), 122.8 (CH), 41.4 (CH), 36.0 (CH2), 18.6 (CH3); m/z (ES+) 297 
[MNa]+; HRMS (ES+) calcd. for C14H14N2NaO2S [MNa]+: 297.0668, found: 297.0670. 
Data consistent with that published in literature.197 
 
5 - Methyl - 2-[[2-(naphthalen-2-yl)aziridin-1-
yl]sulfonyl]pyridine, 352. Using 343 (44 mg, 
0.102 mmol), 2-vinylnaphthalene (155 mg, 1.01 
mmol) and (pyr)4Cu(OTf)2 (7 mg, 0.010 mmol), 
352 (24 mg, 73%) was produced as a clear oil. IR (film): 3051 (C−H), 1572 (C=C), 
1325 (S=O), 1170 (S=O) cm−1; δH (500 MHz, CDCl3): 8.58 – 8.53 (1H, m, ArH), 8.04 
(1H, d, J = 8.0 Hz, ArH), 7.81 – 7.76 (4H, m, ArH), 7.73 – 7.69 (1H, m, ArH), 7.49 – 
7.44 (2H, m, ArH), 7.34 – 7.30 (1H, m, ArH), 4.15 (1H, dd, J = 4.7, 7.2 Hz, ArCH), 3.28 
(1H, d, J = 7.2 Hz, CHH), 2.61 (1H, d, J = 4.7 Hz, CHH), 2.42 (3H, s, ArCH3); δC (125 
MHz, CDCl3): 153.9 (C), 150.9 (CH), 138.3 (C), 138.2 (CH), 133.2 (C), 133.1 (C), 
132.4 (C), 128.4 (CH), 127.8 (CH), 127.7 (CH), 126.4 (CH), 126.35 (CH), 126.32 
(CH), 123.9 (CH), 122.8 (CH), 41.7 (CH), 36.1 (CH2), 18.6 (CH3); m/z (ES+) 347 
[MNa]+;  HRMS (ES+) calcd.  for C18H16N2NaO2S [MNa]+:  347.0825, found: 347.0822.  
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Data consistent with that published in literature.197 
 
2-[[2-(4-Chlorophenyl)aziridin-1-yl]sulfonyl] 
-5-methylpyridine, 353. Using 343 (44 mg, 
0.102 mmol), 4-chlorostyrene (139 mg, 1.00 
mmol) and (pyr)4Cu(OTf)2 (7 mg, 0.010 mmol), 
353 (24 mg, 76%) was produced as a clear oil. IR (film): 1572 (C=C), 1326 (S=O), 
1170 (S=O) cm−1; δH (500 MHz, CDCl3): 8.46 (1H, s, ArH), 7.88 (1H, d, J = 8.1 Hz, 
ArH), 7.66 (1H, d, J = 8.1 Hz, ArH), 7.21 (2H, d, J = 8.5 Hz, ArH), 7.13 (2H, d, J = 8.5 
Hz, ArH), 3.83 (1H, dd, J = 4.7, 7.1 Hz, ArCH), 3.04 (1H, d, J = 7.1 Hz, CHH), 2.39 (1H, 
d, J = 4.7 Hz, CHH), 2.35 (3H, s, ArCH3); δC (125 MHz, CDCl3): 153.4 (C), 151.3 (CH), 
139.1 (C), 138.6 (CH), 134.5 (C), 134.3 (C), 129.1 (CH), 128.5 (CH), 123.1 (CH), 40.9 
(CH), 36.2 (CH2), 18.8 (CH3); m/z (ES+) 331 [MNa]+; HRMS (ES+) calcd. for 
C14H13ClN2NaO2S [MNa]+: 331.0278, found: 331.0281. Data consistent with that 
published in literature.285 
 
5-Methyl-2-[[2-(m-tolyl)aziridin-1-yl]sulfonyl] 
pyridine, 354. Using 343 (44 mg, 0.102 mmol), 3-
methylstyrene (119 mg, 1.01 mmol) and 
(pyr)4Cu(OTf)2 (7 mg, 0.010 mmol), 354 (24 mg, 
82%) was produced as a clear oil. IR (film): 1655 (C=C), 1327 (S=O), 1172 (S=O) 
cm−1; δH (500 MHz, CDCl3): 8.57 – 8.55 (1H, m, ArH), 8.02 (1H, d, J = 8.0 Hz, ArH), 
7.74 – 7.70 (1H, m, ArH), 7.20 – 7.16 (1H, m, ArH), 7.10 – 7.05 (3H, m, ArH), 3.96 
(1H, dd, J = 4.7, 7.2 Hz, ArCH), 3.18 (1H, d, J = 7.2 Hz, CHH), 2.50 (1H, d, J = 4.7 Hz, 
CHH), 2.50 (3H, s, ArCH3), 2.30 (3H, s, ArCH3); δC (125 MHz, CDCl3): 153.3 (C), 150.8 
(CH), 138.3 (C), 138.2 (C), 138.1 (CH), 134.9 (C), 129.1 (CH), 128.4 (CH), 127.3 
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(CH), 123.9 (CH), 122.8 (CH), 41.3 (CH), 36.1 (CH2), 21.3 (CH3), 18.6 (CH3); m/z 
(ES+) 311 [MNa]+; HRMS (ES+) calcd. for C15H16N2NaO2S [MNa]+: 311.0825, found: 
311.0824. 
 
6.14.2 Alternative flow synthesis of 344 and 346 in a PTFE tubing flow 
reactor 
A custom flow system was assembled by connecting computer controlled 
Tricontinent C3000 syringe pumps to a custom built flow reactor constructed out 
of 1/16” ID PTFE tubing and a T-mixer (Figure 6.4). 
 
340 (0.10 mmol, 1 eq) was dissolved in CH2Cl2 (2.0 cm3) to give solution A. Alkene 
(1.00 mmol, 10 eq) and (pyr)4Cu(OTf)2 (0.01 mmol, 0.1 eq) were dissolved in 
anhydrous MeCN (2.0 cm3) to give solution B. Solutions A and B were combined in 
the tube reactor at room temperature, with a residence time of 10 min. The outlet 
stream was quenched thermally at −78 °C. Upon completion of the run, additional 
quantities of CH2Cl2 and MeCN were passed through the tube reactor at A and B 
respectively to ensure all the product was collected. The resulting mixure was 
concentrated under vacuum and purified by gradient column chromatography 
(5:1 nhexane:EtOAc, then 3:1 nhexane:EtOAc) to give the following products:  
 
Figure 6.4. Schematic of the flow reactor used for aziridinations. 
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2-(Naphthalen-2-yl)-1-tosylaziridine, 344. 
Using 340 (44 mg, 0.102 mmol), 2-vinyl 
naphthalene (155 mg, 1.01 mmol) and 
(pyr)4Cu(OTf)2 (7 mg, 0.010 mmol), 344 (24 
mg, 73%) was produced as a clear oil. Other data as previously reported. 
 
2-(m-Tolyl)-1-tosylaziridine, 346. Using 340 (44 
mg, 0.102 mmol), 3-methylstyrene (119 mg, 1.01 
mmol) and (pyr)4Cu(OTf)2 (7 mg, 0.010 mmol), 346 
(20 mg, 68%) was produced as a clear oil. Other data 
as previously reported. 
 
6.15 General method for the aziridination of alkenes and subsequent ring 
opening in flow. 
A custom flow system was assembled by connecting computer controlled 
Tricontinent C3000 syringe pumps to a custom built flow reactor constructed out 
of 1/16” ID PTFE tubing and T-mixers (Figure 6.5). 
 
ArI=NSO2R (0.10 mmol, 1 eq) was dissolved in CH2Cl2 (2.0 cm3) to give solution A. 
Alkene (0.50 mmol, 5.0 eq) and (pyr)4Cu(OTf)2 (0.01 mmol, 0.1 eq) were dissolved 
in anhydrous MeCN (2.0 cm3) to give solution B. Solution C was made by dissolving  
 
Figure 6.5. Schematic of the flow reactor used for telescoped reactions. 
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the nucleophile and acid in a suitable solvent (4.0 cm3); details are given for each 
entry. Solutions A and B were combined in the first section of the flow reactor at 
room temperature, with a residence time of 10 min. Solution C was then added in 
the second section of the flow reactor at room temperature, with a residence time 
of 10 min. The outlet stream was quenched into a solution of NEt3 (0.50 mmol) in 
CHCl3 (2 cm3) for alcohol ring openings, or saturated aq NaHCO3 (5 cm3) for HCl or 
MeCN ring openings. Upon completion of the run, additional quantities of CH2Cl2 
were passed through the flow reactor to ensure all the product was collected. The 
resulting mixture was concentrated under vacuum and purified by gradient 
column chromatography (3:1 nhexane:EtOAc, then 1:1 nhexane:EtOAc) to give the 
following products: 
 
N–(2–Methoxy–2–phenylethyl)–2–nitrobenzene 
sulfonamide, 355. Using 342 (47 mg, 0.102 mmol) 
to make solution A; styrene (53 mg, 0.509 mmol) and 
(pyr)4Cu(OTf)2 (7 mg, 0.010 mmol) to make solution B; H2SO4 (15 mg, 0.153 mmol) 
in MeOH (4.0 cm3) to make solution C, 355 (25 mg, 73%) was obtained as a clear 
oil. IR (film): 3342 (N−H), 2932 (C−H), 1575 (C=C), 1343 (S=O), 1167 (S=O) cm−1; 
δH (500 MHz, CDCl3): 8.11 – 8.06 (1H, m, ArH), 7.91 – 7.87 (1H, m, ArH), 7.75 – 7.69 
(2H, m, ArH), 7.35 – 7.27 (3H, m, ArH), 7.23 – 7.20 (2H, m, ArH), 5.88 (1H, dd, J = 
3.0, 8.1 Hz, NH), 4.25 (1H, dd, J = 3.6, 9.2 Hz, ArCH), 3.43 – 3.37 (1H, m, CHH), 3.16 
(3H, s, OCH3), 3.15 – 3.10 (1H, m, CHH); δC (125 MHz, CDCl3): 148.0 (C), 138.0 (C), 
134.0 (C), 133.5 (CH), 132.8 (CH), 131.0(CH), 128.7 (CH), 128.5 (CH), 126.6 (CH), 
125.4 (CH), 82.0 (CH), 56.8 (CH3), 50.0 (CH2); m/z (ES+) 359 [MNa]+; HRMS (ES+) 
calcd. for C15H16N2NaO5S [MNa]+: 359.0672, found: 359.0674.  
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N-[2-(Benzyloxy)-2-phenylethyl]-2-nitrobenzene 
sulfonamide, 356. Using 342 (47 mg, 0.102 mmol) 
to make solution A; styrene (53 mg, 0.509 mmol) and 
(pyr)4Cu(OTf)2 (7 mg, 0.010 mmol) to make solution 
B; MsOH (29 mg, 0.302 mmol) in BnOH (4.0 cm3) to 
make solution C, 356 (23 mg, 55%) was obtained as a clear oil. IR (film): 3337 
(N−H), 1593 (C=C), 1345 (S=O), 1169 (S=O) cm−1; δH (500 MHz, CDCl3): 8.09 – 8.05 
(1H, m, ArH), 7.87 – 7.82 (1H, m, ArH), 7.73 – 7.66 (2H, m, ArH), 7.40 – 7.25 (10H, 
m, ArH), 5.92 (1H, dd, J = 3.1, 8.3 Hz, NH), 4.51 (1H, dd, J = 3.6, 9.1 Hz, (BnO)CH), 
4.44 (1H, d, J = 11.4 Hz, OCHHPh), 4.23 (1H, d, J = 11.4 Hz, OCHHPh), 3.50 – 3.44 
(1H, m, CHH), 3.27 – 3.21 (1H, m, CHH); δC (125 MHz, CDCl3): 148.0 (C), 138.1 (C), 
137.3 (C), 133.9 (C), 133.4 (CH), 132.7 (CH), 130.9 (CH), 128.8 (CH), 128.7 (CH), 
128.5 (CH), 127.96 (CH), 127.95 (CH), 126.7 (CH), 125.5 (CH), 79.6 (CH), 70.8 
(CH2), 50.0 (CH2); m/z (ES+) 435 [MNa]+; HRMS (ES+) calcd. for C21H20N2NaO5S 
[MNa]+: 435.0985, found: 435.0987. 
 
N–(2–Chloro–2–phenylethyl)–2–nitrobenzene 
sulfonamide, 357. Using 342 (47 mg, 0.102 
mmol) to make solution A; styrene (53 mg, 0.509 
mmol) and (pyr)4Cu(OTf)2 (7 mg, 0.010 mmol) to make solution B; HCl (2M in Et2O, 
1.0 cm3, 2.0 mmol) in CH2Cl2 (3.0 cm3) to make solution C, 357 (19 mg, 55%) was 
obtained as a clear oil. IR (film): 3346 (N−H), 1594 (C=C), 1348 (S=O), 1166 (S=O) 
cm−1; δH (500 MHz, CDCl3): 8.14 – 8.09 (1H, m, ArH), 7.92 – 7.88 (1H, m, ArH), 7.78 
– 7.73 (2H, m, ArH), 7.37 – 7.29 (5H, m, ArH), 5.83 – 5.70 (1H, m, NH), 4.95 (1H, dd, 
J = 5.8, 8.1 Hz, ArCH), 3.72 – 3.66 (1H, m, CHH), 3.63 – 3.57 (1H, m, CHH); δC (125 
MHz, CDCl3): 147.9 (C), 137.5 (C), 134.0 (C), 133.8 (CH), 133.0 (CH), 130.7 (CH), 
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129.2 (CH), 129.0 (CH), 127.1 (CH), 125.6 (CH), 61.4 (CH), 51.0 (CH2); m/z (ES+) 
363 [MNa]+; HRMS (ES+) calcd. for C14H13ClN2NaO4S [MNa]+: 363.0177, found: 
363.0183. 
 
N-(2-Methoxy-2-phenylethyl)-5-methylpyridine-
2-sulfonamide, 358. Using 343 (44 mg, 0.102 
mmol) to make solution A; styrene (53 mg, 0.509 
mmol) and (pyr)4Cu(OTf)2 (7 mg, 0.010 mmol) to make solution B; H2SO4 (15 mg, 
0.153 mmol) in MeOH (4.0 cm3) to make solution C, 358 (20 mg, 64%) was 
obtained as a clear oil. IR (film): 3245 (N−H), 1572 (C=C), 1332 (S=O), 1171 (S=O) 
cm−1; δH (500 MHz, CDCl3): 8.56 – 8.50 (1H, m, ArH), 7.88 – 7.85 (1H, m, ArH), 7.69 
– 7.65 (1H, m, ArH), 7.35 – 7.27 (3H, m, ArH), 7.25 – 7.21 (2H, m, ArH), 5.34 (1H, 
dd, J = 2.8, 9.2 Hz, NH), 4.25 (1H, dd, J = 3.7, 9.3 Hz, ArCH), 3.25 – 3.29 (1H, m, CHH), 
3.20 (3H, s, OCH3), 3.13 – 3.06 (1H, m, CHH), 2.43 (3H, s, ArCH3); δC (125 MHz, 
CDCl3): 154.9 (C), 150.6 (CH), 138.3 (C), 138.0 (CH), 137.2 (C), 128.7 (CH), 128.4 
(CH), 126.7 (CH), 121.7 (CH), 82.4 (CH), 56.8 (CH3), 49.8 (CH2), 18.5 (CH3); m/z 
(ES+) 329 [MNa]+; HRMS (ES+) calcd. for C15H18N2NaO3S [MNa]+: 329.0930, found: 
329.0927. 
 
5-Methyl-2-[(2-methyl-4-phenyl-4,5-dihydro-
1H-imidazol-1-yl)sulfonyl]pyridine, 359. Using 
343 (44 mg, 0.102 mmol) to make solution A; 
styrene (53 mg, 0.509 mmol) and (pyr)4Cu(OTf)2 (7 mg, 0.010 mmol) to make 
solution B; BF3 (0.23 g of 15% BF3 in MeCN solution; 0.52 mmol) in MeCN (4.0 cm3) 
to make solution C, 359 (23 mg, 71%) was obtained as a clear oil. IR (film): 1651, 
1356 (S=O), 1173 (S=O) cm−1;  δH (500 MHz, CDCl3):  8.55 – 8.49 (1H, m, ArH), 7.93  
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– 7.86 (1H, m, ArH), 7.75 – 7.68 (1H, m, ArH), 7.31 – 7.22 (3H, m, ArH), 7.15 (2H, d, 
J = 7.5 Hz, ArH), 5.09 – 5.01 (1H, m, ArCH), 4.27 (1H, t, J = 10.0 Hz, CHH), 3.70 (1H, 
dd, J = 8.1, 10.0 Hz, CHH), 2.46 (3H, s, ArCH3), 2.45 – 2.44 (3H, m, CH3); δC (125 MHz, 
CDCl3): 157.2 (C), 153.5 (C), 150.8 (CH), 141.8 (C), 138.3 (CH), 138.2 (C), 128.7 
(CH), 127.6 (CH), 126.6 (CH), 122.4 (CH), 67.0 (CH), 56.0 (CH2), 18.6 (CH3), 16.9 
(CH3); m/z (ES+) 316 [MH]+; HRMS (ES+) calcd. for C16H18N3O2S [MH]+: 316.1114, 
found: 316.1116. 
 
N-(2-Methoxy-2-phenylpropyl)-2-nitrobenzene 
sulfonamide, 360. Using 342 (47 mg, 0.102 mmol) 
to make solution A; α-methylstyrene (60 mg, 0.508 
mmol) and (pyr)4Cu(OTf)2 (7 mg, 0.010 mmol) to make solution B; H2SO4 (15 mg, 
0.153 mmol) in MeOH (4.0 cm3) to make solution C, 360 (24 mg, 67%) was 
obtained as a clear oil. IR (film): 3346 (N−H), 1593 (C=C), 1355 (S=O), 1168 (S=O) 
cm−1; δH (500 MHz, CD2Cl2): 8.02 – 7.98 (1H, m, ArH), 7.88 – 7.84 (1H, m, ArH), 7.77 
– 7.70 (2H, m, ArH), 7.35 – 7.32 (4H, m, ArH), 7.30 – 7.25 (1H, m, ArH), 5.70 – 5.60 
(1H, m, NH), 3.35 – 3.29 (1H, m, CHH), 3.25 – 3.21 (1H, m, CHH), 3.07 (3H, s, OCH3), 
1.63 (3H, s, CH3); δC (125 MHz, CD2Cl2): 147.8 (C), 141.7 (C), 133.55 (C), 133.46 
(CH), 132.8 (CH), 130.9 (CH), 128.4 (CH), 127.7 (CH), 126.1 (CH), 125.2 (CH), 78.1 
(C), 54.4 (CH2), 50.3 (CH3), 20.3 (CH3); m/z (ES+) 373 [MNa]+; HRMS (ES+) calcd. for 
C16H18N2NaO5S [MNa]+: 373.0829, found: 373.0831.  
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N–(2–Ethoxy–2–phenylpropyl)–2–nitrobenzene 
sulfonamide, 361. Using 342 (47 mg, 0.102 mmol) 
to make solution A; α-methylstyrene (60 mg, 0.508 
mmol) and (pyr)4Cu(OTf)2 (7 mg, 0.010 mmol) to make solution B; H2SO4 (15 mg, 
0.153 mmol) in EtOH (4.0 cm3) to make solution C, 361 (21 mg, 56%) was obtained 
as a clear oil. IR (film): 3350 (N−H), 1593 (C=C), 1352 (S=O), 1169 (S=O) cm−1; δH 
(500 MHz, CD3CN): 7.99 – 7.95 (1H, m, ArH), 7.89 – 7.85 (1H, m, ArH), 7.83 – 7.76 
(2H, m, ArH), 7.39 – 7.30 (4H, m, ArH), 7.29 – 7.24 (1H, m, ArH), 5.94 – 5.71 (1H, m, 
NH), 3.26 – 3.21 (3H, m, CH2 and OCHH), 3.16 – 3.09 (1H, m, OCHH), 1.11 (3H, t, J = 
6.9 Hz, OCH2CH3); δC (125 MHz, CD3CN): 148.3 (C), 143.1 (C), 134.4 (CH), 133.4 
(CH), 133.2 (C), 130.9 (CH), 128.7 (CH), 127.9 (CH), 126.5 (CH), 125.5 (CH), 78.0 
(C), 58.2 (CH2), 54.1 (CH2), 21.4 (CH3), 15.2 (CH3); m/z (ES+) 387 [MNa]+; HRMS 
(ES+) calcd. for C17H20N2NaO5S [MH]+: 387.0985, found: 387.0980. 
 
N–[2–Methoxy–2–(naphthalene–2–yl)ethyl]–
2–nitrobenzenesulfonamide, 362. Using 342 
(47 mg, 0.102 mmol) to make solution A; 2-
vinylnaphthalene (78 mg, 0.506 mmol) and (pyr)4Cu(OTf)2 (7 mg, 0.010 mmol) to 
make solution B; H2SO4 (15 mg, 0.153 mmol) in MeOH (4.0 cm3) to make solution 
C, 362 (28 mg, 71%) was obtained as a clear oil. IR (film): 3351 (N−H), 1594 (C=C), 
1343 (S=O), 1167 (S=O) cm−1; δH (500 MHz, CDCl3): 8.01 – 7.98 (1H, m, ArH), 7.81 
– 7.74 (4H, m, ArH), 7.67 (1H, s, ArH), 7.62 – 7.57 (2H, m, ArH), 7.50 – 7.46 (2H, m, 
ArH), 7.33 – 7.29 (1H, m, ArH), 5.91 (1H, dd, J = 3.7, 7.8 Hz, NH), 4.43 (1H, dd, J = 
3.8, 8.5 Hz, ArCH), 3.56 – 3.50 (1H, m, CHH), 3.31 – 3.25 (1H, m, CHH), 3.22 (3H, s, 
OCH3); δC (125 MHz, CDCl3): 147.8 (C), 135.4 (C), 134.0 (C), 133.4 (C), 133.2 (CH), 
133.1 (C),  132.7 (CH),  130.7 (CH),  128.7 (CH), 127.9 (CH), 127.8 (CH),  126.5 (CH),  
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126.3 (CH), 126.0 (CH), 125.3 (CH), 123.9 (CH), 82.0 (CH), 57.0 (CH3), 49.9 (CH2); 
m/z (ES+) 409 [MNa]+; HRMS (ES+) calcd. for C19H18N2NaO5S [MNa]+: 409.0829, 
found: 409.0827. 
 
N–[2–Chloro–2–(naphthalene–2–yl)ethyl]–
5–methylpyridine–2–sulfonamide, 363. 
Using 343 (44 mg, 0.102 mmol) to make 
solution A; 2-vinylnaphthalene (78 mg, 0.506 mmol) and (pyr)4Cu(OTf)2 (7 mg, 
0.010 mmol) to make solution B; HCl (2M in Et2O, 1.0 cm3, 2.0 mmol) in CH2Cl2 (3.0 
cm3) to make solution C, 363 (18 mg, 49%) was obtained as a crystalline solid. M.p. 
131 – 132 °C. IR (film): 3276 (N−H), 1601 (C=C), 1333 (S=O), 1170 (S=O) cm−1; δH 
(500 MHz, CDCl3): 8.43 – 8.38 (1H, m, ArH), 7.86 – 7.83 (1H, m, ArH), 7.83 – 7.77 
(4H, m, ArH), 7.65 – 7.60 (1H, m, ArH), 7.53 – 7.48 (2H, m, ArH), 7.46 – 7.42 (1H, m, 
ArH), 5.53 – 5.45 (1H, m, NH), 5.18 (1H, dd, J = 6.5, 7.8 Hz, ArCH), 3.78 – 3.71 (1H, 
m, CHH), 3.70 – 3.63 (1H, m, CHH), 2.37 (3H, s, ArCH3); δC (125 MHz, CDCl3): 154.7 
(C), 150.5 (CH), 138.1 (CH), 137.4 (C), 135.1 (C), 133.4 (C), 132.9 (C), 128.9 (CH), 
128.1 (CH), 127.7 (CH), 127.0 (CH), 126.8 (CH), 126.7 (CH), 124.3 (CH), 121.7 (CH), 
62.1 (CH), 50.7 (CH2), 18.5 (CH3); m/z (ES+) 383 [MNa]+; HRMS (ES+) calcd. for 
C18H17ClN2NaO2S [MNa]+: 383.0591, found: 383.0593. 
 
N-[2-Methoxy-2-(m-tolyl)ethyl]-2-nitrobenzene 
sulfonamide, 364. Using 342 (47 mg, 0.102 mmol) 
to make solution A; 3-methylstyrene (60 mg, 0.508 
mmol) and (pyr)4Cu(OTf)2 (7 mg, 0.010 mmol) to 
make solution B; H2SO4 (15 mg, 0.153 mmol) in MeOH (4.0 cm3) to make solution 
C, 364 (27 mg, 76%) was obtained as a clear oil. IR (film): 3341 (N−H), 1593 (C=C),  
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1345 (S=O), 1167 (S=O) cm−1; δH (500 MHz, CDCl3): 8.11 – 8.07 (1H, m, ArH), 7.91 
– 7.86 (1H, m, ArH), 7.75 – 7.69 (2H, m, ArH), 7.21 (1H, t, J = 7.5 Hz, ArH), 7.10 (1H, 
d, J = 7.5 Hz, ArH), 7.03 – 6.99 (2H, m, ArH), 5.87 (1H, dd, J = 2.8, 8.3 Hz, NH), 4.21 
(1H, dd, J = 3.5, 9.2 Hz, ArCH), 3.42 – 3.36 (1H, m, CHH), 3.15 (3H, s, OCH3), 3.15 – 
3.09 (1H, m, CHH), 2.32 (3H, s, ArCH3); δC (125 MHz, CDCl3):148.0 (C), 138.5 (C), 
138.0 (C), 134.0 (C), 133.4 (CH), 132.8 (CH), 131.0 (CH), 129.3 (CH), 128.7 (CH), 
127.2 (CH), 125.4 (CH), 123.6 (CH), 82.0 (CH), 56.8 (CH3), 50.0 (CH2), 21.4 (CH3); 
m/z (ES+) 373 [MNa]+; HRMS (ES+) calcd. for C16H18N2NaO5S [MNa]+: 373.0829, 
found: 373.0830. 
 
N–[2–Ethoxy–2–(m–tolyl)ethyl]–2–nitrobenzene 
sulfonamide, 365. Using 342 (47 mg, 0.102 mmol) 
to make solution A; 3-methylstyrene (60 mg, 0.508 
mmol) and (pyr)4Cu(OTf)2 (7 mg, 0.010 mmol) to 
make solution B; H2SO4 (15 mg, 0.153 mmol) in EtOH (4.0 cm3) to make solution C, 
365 (29 mg, 78%) was obtained as a clear oil. IR (film): 3346 (N−H), 1593 (C=C), 
1361 (S=O), 1169 (S=O) cm−1; δH (500 MHz, CDCl3): 8.12 – 8.06 (1H, m, ArH), 7.92 
– 7.86 (1H, m, ArH), 7.76 – 7.69 (2H, m, ArH), 7.20 (1H, t, J = 7.4 Hz, ArH), 7.09 (1H, 
d, J = 7.4 Hz, ArH), 7.04 – 7.00 (2H, m, ArH), 5.93 (1H, dd, J = 3.5, 9.3 Hz, NH), 4.32 
(1H, dd, J = 3.5, 9.3 Hz, ArCH), 3.43 – 3.35 (2H, m, OCHH and CHH), 3.26 – 3.18 (1H, 
m, OCHH), 3.12 – 3.06 (1H, m, CHH), 2.32 (3H, s, ArCH3), 1.13 (3H, t, J = 7.0 Hz, 
OCH2CH3); δC (125 MHz, CDCl3): 148.1 (C), 138.6 (C), 138.4 (C), 133.9 (C), 133.5 
(CH), 132.7 (CH), 131.0 (CH), 129.1 (CH), 128.6 (CH), 127.1 (CH), 125.4 (CH), 123.5 
(CH), 80.0 (CH), 64.6 (CH2), 50.1 (CH2), 21.4 (CH3), 15.1 (CH3); m/z (ES+) 387 
[MNa]+; HRMS (ES+) calcd. for C17H20N2NaO5S [MNa]+: 387.0985, found: 387.0983.  
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5-Methyl-2-[[2-methyl-4-(m-tolyl)-4,5-dihydro 
-1H-imidazol-1-yl]sulfonyl]pyridine, 366. Using 
343 (44 mg, 0.102 mmol) to make solution A; 3-
methylstyrene (60 mg, 0.508 mmol) and 
(pyr)4Cu(OTf)2 (7 mg, 0.010 mmol) to make solution B; BF3 (0.23 g of 15% BF3 in 
MeCN solution; 0.52 mmol) in MeCN (4.0 cm3) to make solution C, 366 (26 mg, 
77%) was obtained as a clear oil. IR (film): 1650, 1356 (S=O), 1174 (S=O) cm−1; δH 
(500 MHz, CDCl3): 8.55 – 8.51 (1H, m, ArH), 7.92 – 7.87 (1H, m, ArH), 7.74 – 7.69 
(1H, m, ArH), 7.17 (1H, t, J = 7.7 Hz, ArH), 7.05 (1H, d, J = 7.7 Hz, ArH), 6.96 – 
6.91(2H, m, ArH), 5.05 – 4.97 (1H, m, ArCH), 4.25 (1H, t, J = 10.0 Hz, CHH), 3.69 (1H, 
dd, J = 8.0, 10.0 Hz, CHH), 2.46 (3H, s, ArCH3), 2.45 – 2.44 (3H, m, CH3), 2.29 (3H, s, 
ArCH3); δC (125 MHz, CDCl3): 157.1 (C), 153.5 (C), 150.8 (CH), 141.7 (C), 138.3 (C), 
138.2 (CH), 138.1 (C), 128.5 (CH), 128.3 (CH), 127.2 (CH), 123.7 (CH), 122.5 (CH), 
67.0 (CH), 55.9 (CH2), 21.4 (CH3), 18.6 (CH3), 16.9 (CH3); m/z (ES+) 330 [MH]+; 
HRMS (ES+) calcd. for C17H20N3O2S [MH]+: 330.1271, found: 330.1275. 
 
N-[2-Methoxy-2-(p-tolyl)ethyl]-2-nitrobenzene 
sulfonamide, 367. Using 342 (47 mg, 0.102 mmol) 
to make solution A; 4-methylstyrene (60 mg, 0.508 
mmol) and (pyr)4Cu(OTf)2 (7 mg, 0.010 mmol) to make solution B; H2SO4 (15 mg, 
0.153 mmol) in MeOH (4.0 cm3) to make solution C, 367 (26 mg, 73%) was 
obtained as a clear oil. IR (film): 3345 (N−H), 1593 (C=C), 1344 (S=O), 1167 (S=O) 
cm−1; δH (500 MHz, CDCl3): 8.10 – 8.05 (1H, m, ArH), 7.90 – 7.86 (1H, m, ArH), 7.75 
– 7.68 (2H, m, ArH), 7.13 (2H, d, J = 8.2 Hz, ArH), 7.09 (2H, d, J = 8.2 Hz, ArH), 5.86 
(1H, dd, J = 3.0, 8.3 Hz, NH), 4.21 (1H, dd, J = 3.6, 9.1 Hz, ArCH), 3.41 – 3.35 (1H, m, 
CHH), 3.16 – 3.09 (1H, m, CHH), 3.14 (3H, s, OCH3), 2.33 (3H, s, ArCH3); δC (125 
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MHz, CDCl3): 148.0 (C), 138.3 (C), 135.0 (C), 134.0 (C), 133.4 (CH), 132.8 (CH), 
131.0 (CH), 129.4 (CH), 126.5 (CH), 125.4 (CH), 81.7 (CH), 56.7 (CH3), 50.0 (CH2), 
21.2 (CH3); m/z (ES+) 373 [MNa]+; HRMS (ES+) calcd. for C16H18N2NaO5S [MNa]+: 
373.0829, found: 373.0830. 
 
N-[2-Chloro-2-(p-tolyl)ethyl]-2-nitrobenzene 
sulfonamide, 368. Using 342 (47 mg, 0.102 
mmol) to make solution A; 4-methylstyrene (60 
mg, 0.508 mmol) and (pyr)4Cu(OTf)2 (7 mg, 0.010 mmol) to make solution B; HCl 
(2M in Et2O, 1.0 cm3, 2.0 mmol) in CH2Cl2 (3.0 cm3) to make solution C, 368 (21 mg, 
58%) was obtained as a clear oil. IR (film): 3342 (N−H), 1593 (C=C), 1348 (S=O), 
1166 (S=O) cm−1; δH (500 MHz, CDCl3): 8.13 – 8.08 (1H, m, ArH), 7.92 – 7.87 (1H, 
m, ArH), 7.78 – 7.72 (2H, m, ArH), 7.18 (2H, d, J = 8.2 Hz, ArH), 7.13 (2H, d, J = 8.2 
Hz, ArH), 5.80 – 5.67 (1H, m, NH), 4.92 (1H, dd, J = 5.9, 8.0 Hz, ArCH), 3.71 – 3.64 
(1H, m, CHH), 3.63 – 3.56 (1H, m, CHH), 2.33 (3H, s, ArCH3); δC (125 MHz, CDCl3): 
147.9 (C), 139.2 (C), 134.5 (C), 134.0 (C), 133.7 (CH), 133.0 (CH), 130.7 (CH), 129.6 
(CH), 127.0 (CH), 125.6 (CH), 61.3 (CH), 51.0 (CH2), 21.2 (CH3); m/z (ES+) 377 
[MNa]+; HRMS (ES+) calcd. for C15H15ClN2NaO4S [MNa]+: 377.0333, found: 
377.0334. 
 
N-[2-(3-Chlorophenyl)-2-methoxyethyl]-2-nitro 
benzenesulfonamide, 369. Using 342 (47 mg, 
0.102 mmol) to make solution A; 3-chlorostyrene 
(70 mg, 0.505 mmol) and (pyr)4Cu(OTf)2 (7 mg, 
0.010 mmol) to make solution B; H2SO4 (30 mg, 0.306 mmol) in MeOH (4.0 cm3) to 
make solution C, 369 (18 mg, 48%) was obtained as a clear oil. IR (film): 3347 
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(N−H), 1595 (C=C), 1345 (S=O), 1165 (S=O) cm−1; δH (500 MHz, CDCl3): 8.10 – 8.05 
(1H, m, ArH), 7.93 – 7.89 (1H, m, ArH), 7.81 – 7.75 (2H, m, ArH), 7.34 – 7.29 (2H, m, 
ArH), 7.27 – 7.24 (1H, m, ArH), 7.20 – 7.15 (1H, m, ArH), 5.83 (1H, dd, J = 3.4, 7.5 
Hz, NH), 4.26 (1H, dd, J = 3.6, 8.7 Hz, ArCH), 3.48 – 3.41 (1H, m, CHH), 3.22 – 3.15 
(1H, m, CHH), 3.19 (3H, s, OCH3); δC (125 MHz, CDCl3): 147.9 (C), 140.5 (C), 134.5 
(C), 133.7 (CH), 133.6 (C), 132.9 (CH), 130.8 (CH), 130.0 (CH), 128.5 (CH), 126.6 
(CH), 125.4 (CH), 125.0 (CH), 81.2 (CH), 56.9 (CH3), 49.7 (CH2); m/z (ES+) 393 
[MNa]+; HRMS (ES+) calcd. for C15H15ClN2NaO5S [MNa]+: 393.0282, found: 
393.0284. 
 
N-[2-(4-Chlorophenyl)-2-methoxyethyl]-2-
nitrobenzenesulfonamide, 370. Using 342 
(47 mg, 0.102 mmol) to make solution A; 4-
chlorostyrene (70 mg, 0.505 mmol) and (pyr)4Cu(OTf)2 (7 mg, 0.010 mmol) to 
make solution B; H2SO4 (15 mg, 0.153 mmol) in MeOH (4.0 cm3) to make solution 
C, 370 (30 mg, 79%) was obtained as a clear oil. IR (film): 3344 (N−H), 1595 (C=C), 
1345 (S=O), 1166 (S=O) cm−1; δH (500 MHz, CDCl3): 8.06 – 8.02 (1H, m, ArH), 7.90 
– 7.86 (1H, m, ArH), 7.76 – 7.68 (2H, m, ArH), 7.27 (2H, d, J = 8.4 Hz, ArH), 7.16 (2H, 
d, J = 8.4 Hz, ArH), 5.85 (1H, dd, J = 3.5, 8.0 Hz, NH), 4.24 (1H, dd, J = 3.6, 8.7 Hz, 
ArCH), 3.44 – 3.36 (1H, m, CHH), 3.16 (3H, s, OCH3), 3.16 – 3.09 (1H, m, CHH); δC 
(125 MHz, CDCl3): 148.0 (C), 136.6 (C), 134.3 (C), 134.0 (C), 133.5 (CH), 132.8 (CH), 
130.9 (CH), 128.9 (CH), 127.9 (CH), 125.4 (CH), 81.4 (CH), 56.9 (CH3), 49.8 (CH2); 
m/z (ES+) 393 [MNa]+; HRMS (ES+) calcd. for C15H15ClN2NaO5S [MNa]+: 393.0282, 
found: 393.0284.  
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N-[2-(Benzyloxy)-2-(4-chlorophenyl)ethyl]-
2-nitrobenzenesulfonamide, 371. Using 342 
(47 mg, 0.102 mmol) to make solution A; 4-
chlorostyrene (70 mg, 0.505 mmol) and 
(pyr)4Cu(OTf)2 (7 mg, 0.010 mmol) to make 
solution B; MsOH (29 mg, 0.302 mmol) in BnOH (4.0 cm3) to make solution C, 371 
(28 mg, 61%) was obtained as a clear oil. IR (film): 3362 (N−H), 1595 (C=C), 1345 
(S=O), 1168 (S=O) cm−1; δH (500 MHz, CDCl3): 8.03 – 7.98 (1H, m, ArH), 7.85 – 7.80 
(1H, m, ArH), 7.72 – 7.63 (2H, m, ArH), 7.37 – 7.28 (5H, m, ArH), 7.25 – 7.19 (4H, m, 
ArH), 5.87 (1H, dd, J = 3.7, 8.0 Hz, NH), 4.48 (1H, dd, J = 3.7, 8.5 Hz, ArCH), 4.41 (1H, 
d, J = 11.4 Hz, OCHH), 4.22 (1H, d, J = 11.4 Hz, OCHH), 3.47 – 3.41 (1H, m, CHH), 
3.24 – 3.18 (1H, m, CHH); δC (125 MHz, CDCl3): 148.0 (C), 137.0 (C), 136.7 (C), 134.4 
(C), 133.9 (C), 133.4 (CH), 132.8 (CH), 130.7 (CH), 129.0 (CH), 128.6 (CH), 128.10 
(CH), 128.09 (CH), 127.9 (CH), 125.4 (CH), 78.9 (CH), 70.9 (CH2), 49.9 (CH2); m/z 
(ES+) 469 [MNa]+; HRMS (ES+) calcd. for C21H19ClN2NaO5S [MNa]+: 469.0595, 
found: 469.0599. 
 
5-Methyl-2-[[4-(4-chlorophenyl)-2-methyl 
- 4, 5 - dihydro - 1H - imidazol - 1 - yl]sulfonyl] 
pyridine, 372. Using 343 (44 mg, 0.102 
mmol) to make solution A; 4-chlorostyrene (70 mg, 0.505 mmol) and 
(pyr)4Cu(OTf)2 (7 mg, 0.010 mmol) to make solution B; BF3 (0.23 g of 15% BF3 in 
MeCN solution; 0.52 mmol) in MeCN (4.0 cm3) to make solution C, 372 (25 mg, 
70%) was obtained as a clear oil. IR (film): 1650, 1356 (S=O), 1172 (S=O) cm−1; δH 
(500 MHz, CDCl3): 8.52 – 8.48 (1H, m, ArH), 7.91 – 7.87 (1H, m, ArH), 7.74 – 7.69 
(1H, m, ArH),  7.26 (2H, d, J = 8.4 Hz, ArH), 7.09 (2H, d, J = 8.4 Hz, ArH), 5.06 – 5.00  
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(1H, m, ArCH), 4.27 (1H, t, J = 10.0 Hz, CHH), 3.66 (1H, dd, J = 7.9, 10.0 Hz, CHH), 
2.46 (3H, s, ArCH3), 2.44 – 2.42 (3H, m, CH3); δC (125 MHz, CDCl3): 157.7 (C), 153.5 
(C), 150.7 (CH), 140.4 (C), 138.32 (CH), 138.29 (C), 133.4 (C), 128.8 (CH), 128.0 
(CH), 122.4 (CH), 66.3 (CH), 56.0 (CH2), 18.6 (CH3), 16.9 (CH3); m/z (ES+) 350 
[MH]+; HRMS (ES+) calcd. for C16H17ClN3O2S [MNa]+: 350.0725, found: 350.0726. 
 
N–[2–(4–Fluorophenyl)–2–methoxyethyl]–
2–nitrobenzenesulfonamide, 373. Using 
342 (47 mg, 0.102 mmol) to make solution A; 
4-fluorostyrene (62 mg, 0.508 mmol) and (pyr)4Cu(OTf)2 (7 mg, 0.010 mmol) to 
make solution B; H2SO4 (15 mg, 0.153 mmol) in MeOH (4.0 cm3) to make solution 
C, 373 (28 mg, 77%) was obtained as a clear oil. IR (film): 3345 (N−H), 1605 (C=C), 
1344 (S=O), 1114 (S=O) cm−1; δH (500 MHz, CDCl3): 8.09 – 8.05 (1H, m, ArH), 7.91 
– 7.86 (1H, m, ArH), 7.76 – 7.69 (2H, m, ArH), 7.20 (2H, dd, J = 5.4, 8.6 Hz, ArH), 
7.01 (2H, t, J = 8.6 Hz, ArH), 5.85 (1H, dd, J = 3.1, 8.3 Hz, NH), 4.24 (1H, dd, J = 3.7, 
8.9 Hz, ArCH), 3.41 – 3.35 (1H, m, CHH), 3.15 (3H, s, OCH3), 3.14 – 3.09 (1H, m, 
CHH); δC (125 MHz, CDCl3): 162.7 (d, J = 249.0 Hz, (CF)), 148.0 (C), 134.0 (C), 133.8 
(d, J = 3.0 Hz, (C)), 133.5 (CH), 132.8 (CH), 130.9 (CH), 128.3 (d, J = 8.3 Hz, (CH)), 
125.4 (CH), 115.7 (d, J = 22.1 Hz, (CH)), 81.3 (CH), 56.8 (CH3), 49.9 (CH2); m/z (ES+) 
377 [MNa]+; HRMS (ES+) calcd. for C15H15FN2NaO5S [MNa]+: 377.0578, found: 
377.0574.  
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N-[2-Chloro-2-(4-fluorophenyl)ethyl]-2-nitro 
benzenesulfonamide, 374. Using 342 (47 mg, 
0.102 mmol) to make solution A; 4-fluorostyrene 
(62 mg, 0.508 mmol) and (pyr)4Cu(OTf)2 (7 mg, 0.010 mmol) to make solution B; 
HCl (2M in Et2O, 1.0 cm3, 2.0 mmol) in CH2Cl2 (3.0 cm3) to make solution C, 374 (19 
mg, 52%) was obtained as a clear oil. IR (film): 3356 (N−H), 1605 (C=C), 1348 
(S=O), 1165 (S=O) cm−1; δH (500 MHz, CDCl3): 8.11 – 8.07 (1H, m, ArH), 7.91 – 7.88 
(1H, m, ArH), 7.78 – 7.73 (2H, m, ArH), 7.31 (2H, dd, J = 5.1, 8.6 Hz, ArH), 7.02 (2H, 
t, J = 8.6 Hz, ArH), 5.81 – 5.70 (1H, m, NH), 4.96 (1H, dd, J = 6.0, 7.9 Hz, ArCH), 3.70 
– 3.63 (1H, m, CHH), 3.62 – 3.56 (1H, m, CHH); δC (125 MHz, CDCl3): 162.9 (d, J = 
249.0 Hz, (CF)), 147.9 (C), 134.0 (C), 133.8 (CH), 133.5 (d, J = 4.0 Hz, (C)), 133.1 
(CH), 130.7 (CH), 129.1 (d, J = 8.0 Hz, (CH)), 125.6 (CH), 116.9 (d, J = 21.1 Hz, (CH)), 
60.7 (CH), 51.1 (CH2); m/z (ES+) 381 [MNa]+; HRMS (ES+) calcd. for 
C14H12ClFN2NaO4S [MNa]+: 381.0083, found: 381.0074. 
 
N–[2–Ethoxy–2–(4–fluorophenyl)ethyl]–5–
methylpyridine–2–sulfonamide, 375. Using 
343 (44 mg, 0.102 mmol) to make solution A; 
4-fluorostyrene (62 mg, 0.508 mmol) and (pyr)4Cu(OTf)2 (7 mg, 0.010 mmol) to 
make solution B; H2SO4 (15 mg, 0.153 mmol) in EtOH (4.0 cm3) to make solution C, 
375 (21 mg, 61%) was obtained as a clear oil. IR (film): 3275 (N−H), 1604 (C=C), 
1332 (S=O), 1171 (S=O) cm−1; δH (500 MHz, CDCl3): 8.54 – 8.50 (1H, m, ArH), 7.88 
– 7.84 (1H, m, ArH), 7.70 – 7.65 (1H, m, ArH), 7.21 (2H, dd, J = 5.6, 8.5 Hz, ArH), 
7.00 (2H, t, J = 8.5 Hz, ArH), 5.32 (1H, dd, J = 3.2, 9.1 Hz, NH), 4.35 (1H, dd, J = 3.8, 
9.2 Hz, ArCH), 3.40 – 3.24 (3H, m, OCH2 and CHH), 3.10 – 3.03 (1H, m, CHH), 2.43 
(3H, s, ArCH3), 1.15 (3H, t, J = 7.0 Hz, OCH2CH3);  δC (125 MHz, CDCl3):  162.6 (d, J =   
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246.0 Hz, (CF)), 154.9 (C), 150.6 (CH), 138.1 (CH), 137.2 (C), 134.8 (d, J = 3.0 Hz, 
(C)), 128.2 (d, J = 8.0 Hz, (CH)), 121.7 (CH), 115.5 (d, J = 22.1 Hz, (CH)), 79.9 (CH), 
64.5 (CH2), 49.8 (CH2), 18.5 (CH3), 15.2 (CH3); m/z (ES+) 361 [MNa]+; HRMS (ES+) 
calcd. for C16H19FN2NaO3S [MNa]+: 361.0993, found: 361.0993. 
 
5-Methyl-2-[[4-(4-fluorophenyl)-2-methyl 
- 4 , 5 - dihydro - 1H - imidazol - 1 - yl]sulfonyl] 
-pyridine, 376. Using 343 (44 mg, 0.102 
mmol) to make solution A; 4-fluorostyrene (62 mg, 0.508 mmol) and 
(pyr)4Cu(OTf)2 (7 mg, 0.010 mmol) to make solution B; BF3 (0.23 g of 15% BF3 in 
MeCN solution; 0.52 mmol) in MeCN (4.0 cm3) to make solution C, 376 (25 mg, 
74%) was obtained as a clear oil. IR (film):1651, 1357 (S=O), 1174 (S=O) cm−1; δH 
(500 MHz, CDCl3): 8.55 – 8.49 (1H, m, ArH), 7.92 – 7.88 (1H, m, ArH), 7.75 – 7.70 
(1H, m, ArH), 7.13 (2H, dd, J = 5.3, 8.6 Hz, ArH), 6.98 (2H, t, J = 8.6 Hz, ArH); 5.07 – 
5.00 (1H, m, ArCH), 4.27 (1H, t, J = 10.0 Hz, CHH), 3.67 (1H, dd, J = 8.0, 10.0 Hz, 
CHH), 2.46 (3H, s, ArCH3), 2.44 – 2.42 (3H, m, CH3); δC (125 MHz, CDCl3): 162.2 (d, 
J = 246.1 Hz, (CF)), 157.4 (C), 153.6 (C), 150.7 (CH), 138.3 (CH), 138.2 (C), 137.7 
(d, J = 3.0 Hz, (C)), 128.2 (d, J = 8.0 Hz, (CH)), 122.4 (CH), 115.5 (d, J = 21.1 Hz, (CH)) 
66.3 (CH), 56.1 (CH2), 18.6 (CH3), 16.8 (CH3); m/z (ES+) 334 [MH]+; HRMS (ES+) 
calcd. for C16H17FN3O2S [MH]+: 334.1020, found: 334.1017.  
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6.16 Synthesis of PhI=NTs 
TsNH2 (1.00 g, 5.84 mmol, 1 eq) and KOH (0.84 g, 15.0 mmol, 
2.6 eq) were dissolved in MeOH (10 cm3), and the solution 
cooled to 0 °C. PhI(OAc)2 (1.88 g, 5.84 mmol, 1.0 eq) was 
added to the solution, and the mixture stirred at 0 °C for 10 
min. The reaction mixture was then allowed to warm to room temperature and 
stirred for another 3 h, giving a yellow solution. H2O (70 cm3) was then added to 
the solution, and a pale yellow precipitate formed. The mixture was cooled to −78 
°C to induce further precipitation. 
 
Upon reaching room temperature, the precipitate was filtered off, washed with 
nhexane and dried under high vacuum to give PhI=NTs (1.55 g, 71%) as a pale 
yellow powder. M.p. 101 – 104 °C (decomposition); (lit. 102 – 104 °C). IR (film): 
1561 (C=C), 1127 (S=O) cm−1; δH (400 MHz, (CD3)2SO): 7.70 (2H, d, J = 7.7 Hz, ArH), 
7.46 (1H, t, J = 7.7 Hz, ArH), 7.44 (2H, d, J = 7.9 Hz, ArH), 7.30 (2H, t, J = 7.7 Hz, ArH), 
7.07 (2H, d, J = 7.9 Hz, ArH), 2.28 (3H, s, ArCH3); δH (100 MHz, (CD3)2SO): 142.7 (C), 
140.5 (C), 133.7 (CH), 130.9 (CH), 130.6 (CH), 129.1 (CH), 126.6 (CH), 117.8 (C), 
21.3 (CH3). Data consistent with that reported in literature.55  
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6.17 Synthesis of Jacobsen’s chiral diimine ligand 
N,N’-[(1R,2R)-Cyclohexane-1,2-diyl]bis[1-(2,6-dichloro 
phenyl)methanimine], 67. (1R,2R)-cyclohexane-1,2-
diamine (5.00 g, 43.8 mmol, 1 eq) and 2,6-dichloro 
benzaldehyde (15.3 g, 87.6 mmol, 2 eq) were dissolved in 
EtOH (350 cm3) and heated to 100 °C with stirring for 1 h. 
The solution was cooled to room temperature, and a white 
solid crystallized out. The precipitate was filtered off, and dried under high vacuum 
to give 67 (15.19 g, 81%) as a white solid. M.p. 162 – 163 °C; (lit. 149 – 150 °C). IR 
(film): 2930 (C—H), 2855 (C—H), 1644, 1557 cm−1; δH (500 MHz, CDCl3): 8.47 (2H, 
s, ArCH), 7.27 (4H, d, J = 8.1 Hz, ArH), 7.16 (2H, t, J = 8.1 Hz, ArH), 3.65 – 3.56 (2H, 
m, (C=N)CH), 1.95 – 1.81 (6H, m, CH2), 1.57 – 1.45 (2H, m, CH2); δC (125 MHz. 
CDCl3): 156.6 (CH), 134.9 (C), 132.9 (C), 130.0 (CH), 128.6 (CH), 75.0 (CH), 32.9 
(CH2), 24.3 (CH2); m/z (ES+) 427 [MH]+; HRMS (ES+) calcd. for C20H19Cl4N2 [MH]+: 
427.0297, found: 427.0297. Data consistent with that reported in literature.60 
 
6.18 General procedure for enantioselective aziridinations with styrene 
Styrene (0.50 mmol, 5.0 eq), CuI/II catalyst (0.010 
mmol, 0.1 eq) and chiral ligand (0.0125 mmol, 0.125 
eq) were dissolved in solvent (1 cm3), and the solution 
cooled to 0 °C. N-Tosyl aryliminoiodane (0.10 mmol, 1 eq) was added, and the 
solution stirred at 0 °C until all the aryliminoiodane had dissolved.60, 62 The solution 
was then loaded directly onto a column, and purified by gradient column 
chromatography (5:1 nhexane:EtOAc, then 3:1 nhexane:EtOAc) to give 253. 
Enantioselectivity was determined by chiral HPLC (Daicel Chiralcel OJ, 
hexane:iPrOH 7:3, 0.70 cm3/min, 254 nm, 30 °C).  
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6.19 Synthesis of 2-phenyl-2H-chromene (386) 
(E)-1-(2-Hydroxyphenyl)-3-phenylprop-2-en-1-one (5.00 g, 
22.3 mmol, 1 eq) was dissolved in CH2Cl2 (200 cm3), and NaBH4 
(2.54 g, 67.1 mmol, 3.0 eq) added. The mixture was stirred, and EtOH (20 cm3) 
added, causing bubbles to form. After 3 h, more EtOH (200 cm3) was added to 
quench any remaining NaBH4, and stirred for 1 h. The solvent was removed on a 
rotary evaporator, and aq saturated NaCl (100 cm3) added. The mixture was 
extracted with CH2Cl2 (5 × 20 cm3), organic extracts combined, and dried with 
MgSO4. To this solution was added AcOH (4 cm3) dissolved in CH2Cl2 (16 cm3), and 
the solution stirred at room temperature for 4 h. 
 
The solution was then extracted with saturated aq NaCl (5 × 10 cm3), and the 
organic layer dried with MgSO4. The solvent was removed on a rotary evaporator 
to give an oil. This was purified by column chromatography (5:1 nhexane:CH2Cl2) 
to give 386 (2.88 g, 62%) as a clear oil. IR (film): 3028 (C—H), 1640, 1605 cm−1, δH 
(500 MHz, CDCl3): 7.45 (2H, d, J = 7.5 Hz, ArH), 7.37 (2H, t, J = 7.5 Hz, ArH), 7.32 
(1H, t, J = 7.5 Hz, ArH), 7.11 (1H, t, J = 7.6 Hz, ArH), 7.01 (1H, d, J = 7.6 Hz, ArH), 6.86 
(1H, t, J = 7.6 Hz, ArH), 6.79 (1H, d, J = 7.6 Hz, ArH), 6.53 (1H, dd, J = 1.5, 9.9 Hz, 
C=CH), 5.93 – 5.90 (1H, m, PhCH), 5.80 (1H, dd, J = 3.5, 9.9 Hz, C=CH); δC (125 MHz, 
CDCl3): 153.2 (C), 140.8 (C), 129.5 (CH), 128.7 (CH), 128.4 (CH), 127.0 (CH), 126.6 
(CH), 124.9 (CH), 124.0 (CH), 121.3 (C), 121.2 (CH), 116.0 (CH), 77.2 (CH). Data 
consistent with that reported in literature.286  
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6.20 Synthesis of Manganese(III) 5,10,15-tris(pentafluorophenyl)corrole 
CF3SO2H (1 cm3) was dissolved in CH2Cl2 (10 
cm3). 100 µL of this solution was added to 
pentafluorobenzaldehyde (2.00 g, 10.2 mmol, 1 
eq), and the mixture stirred at room 
temperature for 5 min. Pyrrole (1.03 g, 15.4 
mmol, 1.5 eq) was then added, and the mixture 
quickly formed a tar. After stirring for 20 min, 
CH2Cl2 (100 cm3) was added to dissolve the 
mixture, and 2,3-dichloro-5,6-dicyano-1,4-
benzoquinone (2.78 g, 12.2 mmol, 1.2 eq) dissolved in PhMe/THF (1:1, 10 cm3) 
added. The mixture was stirred for another 10 min, then silica gel (100 cm3) added. 
The mixture was stirred for another 5 min. The solvent was removed on a rotary 
evaporator, and the silica flushed with a mixture of CH2Cl2/nhexane (1:2, 100 cm3). 
The purple-black solution was then put on a rotary evaporator to remove organic 
solvents. The purple black solid which was obtained was dissolved in MeOH (50 
cm3), and Mn(OAc)2·4H2O (1.00 g, 4.1 mmol, 0.4 eq) added. The black solution was 
heated to 80 °C, and stirred for 3 h. The solvent was then removed on a rotary 
evaporator, CH2Cl2 (50 cm3) added, and extracted with saturated aq NaCl (5 × 10 
cm3). The organic layer was dried with MgSO4, solvent removed in vacuo, and 
purified by column chromatography (CH2Cl2/MeOH 100:1) to give MnIII(TPFC) (38 
mg, 1%) as a dark green-black solid. M.p. > 300 °C. IR (film): 1650, 1518, 1486, 
1035 cm−1; HRMS (ES+) calcd. for C37H8F15MnN4 [M]∙+: 847.9884, found: 847.9886; 
UV/Vis (CHCl3): λmax [nm] (lgε) = 397 (4.62), 416 (4.69), 480 (4.49), 599 (4.15). 
Data consistent with that reported in literature.273-275  
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6.21 Aziridination of 2-phenyl-2H-chromene 
2-Phenyl-1-tosyl-1,1a,2,7b-tetrahydrochromeno[3,4-b] 
azirine, 389. 2-Phenyl-2H-chromene (386) (100 mg, 0.48 
mmol, 1 eq) was dissolved in MeCN (2 cm3). Cu(OTf)2 (17 
mg, 0.047 mmol, 0.1 eq) was added, and the solution cooled 
to 0 °C. PhI=NTs (448 mg, 1.20 mmol, 2.5 eq) was added to 
the solution 0.5 eq at a time, only adding the next 0.5 eq 
when all the PhI=NTs had dissolved. After 3 h, the mixture was purified by column 
chromatography (nhexane:EtOAc 5:1), giving 389 (9 mg, 5%) as a white solid. M.p. 
190 – 192 °C. IR (film): 1596 (C=C), 1325 (S=O), 1158 (S=O) cm−1, δH (500 MHz, 
CD2Cl2): 7.90 (2H, d, J = 8.3 Hz, ArH), 7.43 (2H, d, J = 8.3 Hz, ArH), 7.37 – 7.28 (6H, 
m, ArH), 7.25 (1H, t, J = 7.8 Hz, ArH), 6.97 (1H, t, J = 7.8 Hz, ArH), 6.80 (1H, d, J = 7.8 
Hz, ArH), 5.48 – 5.45 (1H, m, PhCH), 4.05 (1H, d, J = 7.3 Hz, NCH), 3.83 (1H, dd, J = 
1.2, 7.3 Hz, NCH), 2.49 (3H, s, ArCH3); δC (125 MHz, CD2Cl2): 152.1 (C), 145.2 (C), 
137.5 (C), 135.0 (C), 130.6 (CH), 130.0 (CH), 129.4 (CH), 128.78 (CH), 128.76 (CH), 
127.7 (CH), 127.0 (CH), 121.7 (CH), 118.5 (C), 118.0 (CH), 72.5 (CH), 45.3 (CH), 
38.6 (CH), 21.4 (CH3); m/z (ES+) 400 [MNa]+; HRMS (ES+) calcd. for C22H19NNaO3S 
[MNa]+: 400.0978, found: 400.0976. 
 
ArI=NTs 340 could also be used with similar yield to PhI=NTs, although the 
reaction with 340 occurred faster. It is not possible to accurately determine the 
diastereoselectivity as the crude 1H NMR spectrum of 389 is complex. 
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6.22 X-ray crystallography 
Crystal Data for 298: C12H15FN2O4S (M = 302.32 g/mol): 
monoclinic, space group P21/n (no. 14), a = 6.70613(9) Å, b = 
8.92562(11) Å, c = 21.9646(3) Å, β = 91.7362(13)°, V = 1314.12(3) 
Å3, Z = 4, T = 150(2) K, μ(CuKα) = 2.471 mm-1, Dcalc = 1.528 g/cm3, 5727 reflections 
measured (8.054° ≤ 2Θ ≤ 157.56°), 2782 unique (Rint = 0.0239, Rsigma = 0.0330) 
which were used in all calculations. The final R1 was 0.0402 (I > 2σ(I)) and wR2 was 
0.1104 (all data). 
 
Crystal Data for 301: C18H23NO5S (M = 365.43 g/mol): 
triclinic, space group P1 (no. 1), a = 8.6291(3) Å, b = 
9.4332(3) Å, c = 12.4474(4) Å, α = 82.659(3)°, β = 
70.506(3)°, γ = 68.236(3)°, V = 887.04(6) Å3, Z = 2, T = 
150.01(10) K, μ(CuKα) = 1.871 mm-1, Dcalc = 1.368 g/cm3, 7775 reflections 
measured (7.534° ≤ 2Θ ≤ 157.94°), 4416 unique (Rint = 0.0299, Rsigma = 0.0416) 
which were used in all calculations. The final R1 was 0.0436 (I > 2σ(I)) and wR2 was 
0.1167 (all data). 
 
Crystal Data for 305: C11H14N2O2S (M = 238.30 g/mol): monoclinic, 
space group P21/n (no. 14), a = 15.2033(5) Å, b = 5.10542(13) Å, c 
= 15.6074(6) Å, β = 108.006(4)°, V = 1152.11(7) Å3, Z = 4, T = 
150(2) K, μ(CuKα) = 2.403 mm-1, Dcalc = 1.374 g/cm3, 5511 reflections measured 
(7.094° ≤ 2Θ ≤ 156.968°), 2276 unique (Rint = 0.0287, Rsigma = 0.0338) which were 
used in all calculations. The final R1 was 0.0372 (I > 2σ(I)) and wR2 was 0.1081 (all 
data).  
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Crystal Data for 306: C16H16N2O2S (M = 300.37 g/mol): monoclinic, 
space group P21/n (no. 14), a = 8.2360(2) Å, b = 21.1919(5) Å, c = 
8.4904(2) Å, β = 103.856(3)°, V = 1438.78(6) Å3, Z = 4, T = 200(2) 
K, μ(CuKα) = 2.050 mm-1, Dcalc = 1.387 g/cm3, 9198 reflections measured (8.344° ≤ 
2Θ ≤ 157.522°), 3064 unique (Rint = 0.0455, Rsigma = 0.0497) which were used in all 
calculations. The final R1 was 0.0448 (I > 2σ(I)) and wR2 was 0.1278 (all data). 
 
Crystal Data for 339: C13H17IO5 (M = 380.16 g/mol): monoclinic, 
space group P21/n (no. 14), a = 8.44405(16) Å, b = 12.0095(2) Å, c 
= 14.7747(3) Å, β = 91.8705(17)°, V = 1497.48(5) Å3, Z = 4, T = 
150(2) K, μ(CuKα) = 16.935 mm-1, Dcalc = 1.686 g/cm3, 12604 reflections measured 
(9.492° ≤ 2Θ ≤ 157.332°), 3160 unique (Rint = 0.0516, Rsigma = 0.0319) which were 
used in all calculations. The final R1 was 0.0343 (I > 2σ(I)) and wR2 was 0.1022 (all 
data). 
 
Crystal Data for 343: C15H17IN2O3S (M = 432.26 g/mol): 
monoclinic, space group P21/n (no. 14), a = 8.92490(6) Å, b = 
12.07710(8) Å, c = 15.53550(13) Å, β = 98.2881(7)°, V = 
1657.04(2) Å3, Z = 4, T = 150(2) K, μ(CuKα) = 16.484 mm-1, Dcalc 
= 1.733 g/cm3, 16679 reflections measured (9.312° ≤ 2Θ ≤ 
156.092°), 3503 unique (Rint = 0.0323, Rsigma = 0.0198) which were used in all 
calculations. The final R1 was 0.0302 (I > 2σ(I)) and wR2 was 0.0816 (all data).  
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Crystal Data for 363: C18H17ClN2O2S (M = 
360.84 g/mol): monoclinic, space group P21/c 
(no. 14), a = 11.48668(7) Å, b = 7.37203(6) Å, c 
= 20.25344(15) Å, β = 106.0333(7)°, V = 1648.35(2) Å3, Z = 4, T = 150(2) K, μ(CuKα) 
= 3.347 mm-1, Dcalc = 1.454 g/cm3, 32278 reflections measured (8.008° ≤ 2Θ ≤ 
156.154°), 3520 unique (Rint = 0.0368, Rsigma = 0.0191) which were used in all 
calculations. The final R1 was 0.0332 (I > 2σ(I)) and wR2 was 0.0930 (all data). 
 
Crystal Data for 389: C22H19NO3S (M = 377.44 g/mol): 
monoclinic, space group P21/n (no. 14), a = 6.18278(6) Å, b = 
18.31757(16) Å, c = 16.08632(16) Å, β = 94.3033(10)°, V = 
1816.69(3) Å3, Z = 4, T = 150(2) K, μ(CuKα) = 1.771 mm-1, Dcalc = 1.380 g/cm3, 
34789 reflections measured (7.326° ≤ 2Θ ≤ 147.312°), 3652 unique (Rint = 0.0502, 
Rsigma = 0.0200) which were used in all calculations. The final R1 was 0.0326 (I > 
2σ(I)) and wR2 was 0.0845 (all data). 
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